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Abstract 
Molecular interactions are fundamental to communication between different parts 
of the cell or of an organism. These interactions can be weak and transient or 
strong and semi-permanent. In the case of the adaptive immune system, strong 
interactions between foreign antigens and specific antibodies lead to a cascade of 
events comprising the immune response. This phenomenon has been exploited by 
industry to produce high affinity binding molecules that have been used as 
therapeutics or diagnostics and engineered antibodies have been at the forefront of 
these industries. More recently, novel non-immunoglobulin binding proteins, have 
been similarly engineered to produce high affinity binding proteins that can 
potentially replace the binding function(s) of antibodies or even surpass them. The 
OB-fold is a high affinity binding protein domain which has previously been 
engineered to bind to Hen Egg-white Lysozyme (HEL) with nanomolar affinity as 
a proof-of-concept technology and has been given the name OBodies. This thesis 
explores this concept further with an OBody (D7) engineered to bind to the small 
molecule progesterone (P4) with potential applications to detect P4 in cow’s milk 
to evaluate pregnancy. Obody-P4 binding was characterised with an optimized 
ELISA system. This was followed by the engineering of improved versions of this 
OBody using phage display technology and structural characterisation of one such 
Obody-P4 complex using X-ray Crystallography. The three-dimensional structure 
provided surprising insights into the nature of the molecular interactions between 
P4 and the OBody. During phage display selection a new signal sequence was 
fortuitously discovered that provided an advantage during phage display. The new 
signal sequence was investigated and characterised using mutants of GFP and a 
DARPin sequence to uncover the nature of the selective advantage. The 
combination of this new signal sequence and thermostable OBody libraries further 
demonstrates the potential of this system to produce robust bio-sensors for 
diagnostic and therapeutic applications.  
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5 
1 Introduction  
1.1 Proteins and specific molecular interactions 
Proteins have evolved to play many different roles in organisms such as enzymes, 
structural components, molecular transport, regulation, energy storage, molecular 
motors, signalling and immune proteins, to name a few. The signalling and 
immune systems primarily involve specific molecular interactions with signalling 
pathways permitting specific protein-protein interactions that are accurate enough 
to differentiate between phosphorylation status of a single amino acid on the 
interacting surface of the protein(s). Proteins can also interact with other proteins 
to form multi-complex structures that transmit an extracellular signal to produce 
an intracellular response. Similarly proteins can produce an immune response 
with the help of antibodies which are specific in recognising antigens but ignore 
intrinsic proteins of the host organism (Garrett & Grisham, 2004). 
 
Molecular specificity primarily depends on binding through non-covalent 
interactions with another protein or ligand (Sali, Glaeser, Earnest, & Baumeister, 
2003). In general, tight interactions are involved in immune functions whereas 
weaker interactions are involved in signalling functions. This can be the result of 
the adaptation of the interacting surfaces during protein evolution (Steemson, 
Baake, Rakonjac, Arcus, & Liddament, 2014). Antibodies are a good example of 
proteins involved in this kind of molecular specificity. They have a modifiable 
interacting surface which supports specific binding to a variety of ligands. These 
ligands are often called antigens in an immune system context.  
 
There have been some fundamental features observed in high binding affinity 
between protein and ligand. They have to have geometric complementarity of 
interacting surfaces (Mitchell, Kerr, & Ten Eyck, 2001). These interacting 
surfaces are made up of polar or hydrophobic groups which bind only to their 
respective groups in the interacting partner protein or ligand.  Highly ordered 
water molecules at the binding surface have also been found to contribute to 
protein-ligand binding (Wilson & Finlay, 1998). The binding of protein and 
ligand is generally thermodynamically favourable for the stability of the protein 
(Böhm, 2005). Molecular recognition can be exploited to design in vitro 
diagnostics to detect antigens via specific binding and to design capturing agents 
Chapter One 
 
6 
for affinity chromatography in columns that can be routinely regenerated 
(Lofblom et al., 2010). Antibodies have a binding surface formed of variable 
regions that are sequence independent and obey all features of good protein-ligand 
interactions. The immune system, responsible for producing antibodies in 
vertebrates to external biochemical threats (Binz, Amstutz, & Pluckthun, 2005) 
has been exploited by hybridoma technology to produce tight binding and highly 
specific antibodies against certain ligands and these have been used in clinical 
diagnostics for example. This was done by the fusion of antibody producing B-
cells with an immortal myeloma cancer cell line and the resulting hybridoma cells 
being propagated indefinitely in tissue culture (Lee, Iorno, Sierro, & Christ, 
2007). Antibodies have also risen to prominence as pharmaceutical agents due to 
their capacity to be engineered to bind specific targets in the body (Hoogenboom, 
2005; Kim, Park, & Hong, 2005; A. J. Smith, 2015). 
 
1.2 Antibodies  
The dominant class of proteins involved in molecular specificity is currently 
immunoglobulin antibodies and antibody fragments. Libraries of DNA constructs 
encoding variable regions of antibodies (greater than 1011 different clones) have 
been made in vitro. In combination with display technology, specific clones may 
be isolated by displaying their respective proteins on the surface of a cell or 
phage. This approach has led to efficient production of large antibody libraries 
and isolation of tight binding and specific clones. The binding surfaces of 
antibodies are formed from six hypervariable regions also called Complementarity 
Determining Regions (CDR) constituted by three variable loops from the heavy 
chain and three from the light chain. They are encoded by independent germline 
segments which are shuffled and come together to produce a variable binding 
surface (Hoogenboom, 2005).  
 
When an antigen is encountered, the immune system produces a variety of these 
antibodies (Figure 1.1). The antibody clones with the closest match are selected 
by the immune system via specific binding. These specific clones are randomly 
mutated and exposed to the same antigen resulting in selection of high affinity and 
specific antibody clones. Display technology makes good use of this system 
in vitro, i.e. it does not require the use of a mammalian host. 
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Figure 1.1 Antibody generation in the immune system 
(1) Antibody binding surface is made up of variable regions of heavy (H) and light (L) 
chains, which are the result of combinations of V, D and J gene segments. (2) Each 
binding surface is made up of different combinations of three H and L variable regions 
(CDR) (3) When a collection of such clones (library) is exposed to an antigen (red 
triangle, Ag), a specific clone with a weak binding (low affinity) complementary surface is 
selected by the immune system 4) This particular clone is randomly mutated (somatic 
hypermutation) to introduce another round of selection with the antigen, resulting in a 
high affinity antibody with a unique binding surface (green asterisk) [adapted with 
permission from (Hoogenboom, 2005)].  
 
However, antibodies have their limitations: they are bivalent and multidomain, 
dependent on intrachain disulphide bonds, are relatively large in size and typically 
need to be glycosylated. This can give them unfavourable solution properties such 
as a tendency to aggregate (Lofblom et al., 2010). Single domain antibodies, with 
half the interface area comprised of three hypervariable loops are alternatives, 
though they lack the stability of multi-domain antibodies (Nian et al., 2016). 
There is a clear need for molecules which expand the range of applications over 
and above those that are currently available with antibodies. To overcome these 
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limitations and to avoid intellectual property issues, work on non-immunoglobulin 
protein scaffolds has taken off rapidly in the last decade (Gebauer & Skerra, 2009; 
Jost & Pluckthun, 2014; Nygren & Skerra, 2004).  
 
Scaffolds are protein domains with binding surfaces that support a wide range of 
amino acids that confer to it the ability to bind to specific ligands (Binz et al., 
2005). These binding domains are produced by site directed random mutagenesis 
or phage display technology from soluble monomeric proteins or extramembrane 
domains of cell surface receptors. Some change conformation on binding and 
others follow a more rigid lock and key model. Ideally, they can be selected for 
specific properties and expressed in large quantities in simple microbial 
expression systems. They are ideal for in vitro diagnostics as they can 
demonstrate properties that are advantageous for “reagents” such as high stability 
and/or low production costs.  
 
Four popular non-immunoglobulin scaffolds (Figure 1.2) will be covered in detail. 
Designed Ankyrin Repeat Proteins (DARPin) are modified ankyrin proteins 
involved in protein-protein interactions in various parts of the cell (Binz et al., 
2004). Monobodies are derived from the extracellular domain of human 
fibronectin III (Koide, Wojcik, Gilbreth, Hoey, & Koide, 2012). Anticalins are 
modified lipocalin proteins which are small monomeric globular proteins involved 
in transport of poorly water soluble molecules (Arne Skerra, 2001). Affibodies are 
derived from three-helix bundle Z domain of Staphylococcal protein A (Nygren, 
2008). Nanofitins and engineered lymphocyte receptors called Repebodies are 
other examples (Steemson et al., 2014).  
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Figure 1.2 Cartoon representation of popular non-immunoglobulin scaffolds  
A cartoon representation of the labelled non-immunoglobulin scaffolds (orange) are 
shown bound to respective protein ligands (grey) [used with permission from (Löfblom 
& Frejd, 2011)]. 
 
1.3 Non-immunoglobulin scaffolds 
1.3.1 DARPins 
DARPins are repeating modular protein regions (domains) with adjacent loops 
that can be modified by point mutations, insertions, deletions or repeat domain 
shuffling and as such are capable of binding different antigens (Binz et al., 2004) 
(Figure 1.3). 
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Figure 1.3 Cartoon representation of a DARPin 
N-terminal (green) and C-terminal (cyan) capping domains with repeat domains (blue) 
showing randomised residues (red sticks) [used with permission from (Binz et al., 2004)]. 
 
Each domain consists of 33 amino acid residues starting with a short peptide chain 
called the β-turn and forming two anti-parallel -helices ending as a loop 
connecting the β-turn of the adjacent domain, with the binding surface 
(7 residues) comprising of the β-turn and the first -helix of every domain. 
DARPins exploit the modular nature (2 to 4 modules) of scaffolds which may 
assist in attaining low nanomolar affinity to ligands (Binz et al., 2004). The 
capping repeats are special terminal domains protecting the hydrophobic core and 
a distinct number of thermostable, monomeric domains can be designed between 
them with randomised positions occurring in the β-turn and the first -helix of 
every domain. This gives a DARPin library very large theoretical diversity of 1015 
to 1023 distinct clones (Binz et al., 2004). 
 
A DARPin is one-tenth the size of an antibody. It is highly thermostable with 
melting temperatures close to 100°C and few flexible regions making it resistant 
to proteolytic damage. DARPins interact with their targets with a rigid body 
conformation that often shows high affinity and specificity. The large interaction 
surface, the diversity from addition and shuffling of domains makes it an ideal 
candidate as a non-immunoglobulin scaffold with functions that range from 
enzyme inhibition to anchoring proteins together.  
 
Both phage and ribosome display technologies (using a consensus sequence-based 
approach) have been used to engineer DARPins. DARPins have some advantages 
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over antibodies and antibody fragments as they can be fused to other chemical 
agents or proteins of varying function. With regards to therapeutics, their smaller 
size has an advantage in intracellular penetration for precise targeting and also the 
lack of extra domains avoids interaction with the host immune system. Rapid 
renal clearance and allosteric inhibition where inhibition occurs by binding of a 
scaffold at a different non-active site on the target protein, are other advantages. 
DARPins lack cysteines in contrast to antibodies which need cysteine based 
interchain disulphide bonds to function. Instead, with DARPins cysteines can be 
used for fusion of its thiol groups to cytotoxins or radioactive isotopes for cancer 
treatment and imaging. Two or more DARPins of affinities to different targets or 
different epitopes of the same target can be engineered in the same molecule 
extending multi-functionality with affinity (Stumpp, Binz, & Amstutz, 2008).  
 
A proof-of-concept example for the application of DARPins was reported using 
Maltose Binding Protein (MBP) as a target. The binding surface of the DARPin 
resulted in a complementary concave shape with its randomised binding residues 
enriched in aromatic amino acids, with tyrosines contributing to both hydrogen 
bonds and hydrophobic contacts with lysines of MBP, indicating a good fit with 
respect to shape and charge. The binding affinity (Kd) was 4.4 nM and consisted 
of 6 hydrogen bonds and 3 hydrophobic interactions between MBP and the 
specific DARPin with tyrosine contributing to four hydrogen bonds. The remnant 
hydrogen bonds were contributed by aspartic acid and tryptophan, the latter amino 
acid sharing hydrophobic interactions with Leucine and Phenylalanine to MBP 
(Binz et al., 2004).  
 
1.3.2 Monobodies 
Monobodies are modified Fibronectin Type III domains (FN3) which are small 
globular protein domains of 90 to 100 amino acids. Monobodies are highly stable 
like DARPins and are made up of 7 anti-parallel β-strands that come together as a 
β-sandwich. The loops connecting these strands (B- G) show variability of amino 
acids as seen in other scaffolds (Figure 1.4) (Jacobs et al., 2012). 
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Figure 1.4 Cartoon representation of a Monobody  
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(1) Monobody model showing MBP specific Monobody (cyan/blue) binding to target 
MBP (grey) via its three loops (red/pink/yellow) (2) Detailed model of Monobody 
showing β-sheets (G, F, C and D) and mutated loops (FG, BC and DE). β-sheets (A, B and 
E) are hidden from view.  [used with permission from (Koide et al., 2012)].  
 
In the Monobody, β-strands A, B and E form one β-sheet and β-strands C, D, F 
and G form another β-sheet. The loops connecting these strands are structurally 
homologous to the CDR loops of antibodies. They come together to form a 
contiguous binding surface at the binding site of the target protein. Monobodies 
are not dependent on intradomain disulphide bonds in contrast to their antibody 
counterparts (Koide et al., 2012). 
 
Display technology has been used to select tight binding Monobodies. A 
picomolar affinity clone has been selected to vascular endothelial growth factor 
receptor-2 (VEGFR2) protein using a type of display technology called mRNA 
display. A library of Monobodies was made with 21 residues mutated in three 
loops BC, DE and FG (named after adjoining β-strands) providing a theoretical 
diversity of up to 1027 clones. Monobodies have been selected for a variety of 
targets both intracellular and extracellular(Jacobs et al., 2012). 
 
Monobody binding surface diversity has also been reported to be introduced into 
the β-sheet G-F-C-D obtaining stronger Monobodies than ‘loop only’ 
Monobodies. The buried surface area contributed by a Monobody binding another 
protein domain called Abl SH2 is 880 Å2 (Koide et al., 2012). 
 
1.3.3 Anticalins 
Anticalins are modified lipocalin proteins which are small monomeric proteins 
(like Monobodies) of 160 to 180 residues made up of 8 anti-parallel β-strands 
coming together to form a β-barrel. The four loops that join these strands on one 
end of the β-barrel form a binding pocket (Figure 1.5) (Arne Skerra, 2001). 
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Figure 1.5 Cartoon representation of an Anticalin  
Anticalin model showing how the β-barrel is made up of β-sheets (A-H) and four 
numbered loops (1-4) on one end forming the binding pocket. The ligand biliverdin IX is 
shown as a ball and stick Figure in the binding pocket [used with permission from (Arne 
Skerra, 2001)]. 
 
The β-barrel of the Anticalin is conserved in most lipocalins whereas the four 
loops forming the binding surface show high variability in their amino acid 
composition and conformations. The other end of the barrel is closed off by short 
loops forming a hydrophobic core. The β-sheets are hydrogen bonded with strand 
H binding with strand A to close the barrel (Arne Skerra, 2001). 
 
 Anticalins are highly stable often with melting temperatures over 70°C. 
Picomolar affinity Anticalins have been produced and the very high affinity is 
thought to be due to the ability of the ligand to bury itself deep in the binding 
pocket aided by aromatic side chains and hydrogen bonds. Anticalins are excreted 
rapidly through the kidneys making them useful in radioisotope-based imaging.  
Two Anticalins can be fused to each other to improve affinity by binding to two 
different areas on the same target or two separate targets. Anticalins have been 
developed for two cancer drug targets, cytotoxic T-lymphocyte antigen-4 (CTLA-
4) and vascular endothelial growth factor (VEGF) (A. Skerra, 2008). 
Chapter One 
 
15 
 
1.3.4 Affibodies 
Affibodies are engineered protein scaffolds made up of three α-helices based on 
the B-domain in the immunoglobulin-binding region of Staphylococcal protein A. 
Affibodies were one of the first non-immunoglobulin scaffolds to be engineered 
to bind chosen ligands (Fiedler & Skerra, 2014). Affibodies have fast folding 
kinetics, are thermostable and have no cysteines (Figure 1.6). 
 
Figure 1.6 Cartoon representation of an Affibody structure   
Affibody Structure showing binding surface. The binding surface consists of 13 mutated 
positions numbered according to residue and located in the red coloured region on two 
of the three α-helices in an Affibody. [used with permission from (Ståhl, Kronqvist, 
Jonsson, & Löfblom, 2013)].  
 
The binding surface of an Affibody comprises of helices one and two which 
provide 13 amino acid positions for randomisation using phage display 
technology to create Affibody libraries (Lofblom et al., 2010). An Affibody is 
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relatively small (6 kDa in size) and comprises only 58 amino acids. An Affibody 
phage library can have a diversity of up to 2013- 1017 unique clones. The 
interaction surface of Affibodies made up of -helices is different when compared 
to the loops used by antibody formats and other non-immunoglobulin scaffolds. 
The interaction surface is generally non-polar in nature and buries up to 900 Å2 
per Affibody. There is often conformational change during binding (induced fit). 
An engineered Affibody has a melting temperature ~57°C and is capable of 
functional blocking similar to DARPins (Nygren, 2008). 
 
Affibodies have affinities ranging from micromolar to picomolar values. Their 
affinity has been improved by helix shuffling or sequence alignment with directed 
combinatorial mutagenesis. Affibodies can also be synthesized using chemical 
methods as an alternative to recombinant bacterial methods, making it easier to 
attach other chemicals. Two Affibodies with different binding properties can be 
fused to each other in a modular fashion like DARPins. Affibodies are also 
compatible with a variety of display systems, from cell based bacterial display to 
cell-free ribosome display methods. The B- domain used to construct affibodies 
was modified for chemical stability (named Z- domain) thus losing affinity to the 
Fab component of antibodies making it less immunogenic and opening up the 
possibility of in vivo applications. Affibodies designed to target human epidermal 
growth factor receptor (HER2) have shown rapid biodistribution and blood 
clearance allowing quality imaging of tumours in mouse models (Lofblom et al., 
2010). 
 
Affibodies have been fused to foreign agents ranging from radionucleotides to 
cytotoxins for various diagnostic and therapeutic applications. Affibodies have 
been fused to colorimetric enzymes or used as capture agents in ELISA, fused to 
fluorophores in fluorescent based in vitro diagnostics or used as polymerase 
inhibitors in PCR when designed to have high affinity to DNA polymerases 
(Lofblom et al., 2010). 
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1.4 OBodies 
Oligosaccharide-oligonucleotide Binding folds (OB-fold) are small, single protein 
domains found in diverse organisms in nature from humans to thermophilic 
organisms. The wide distribution of this domain suggests the potential for both 
therapeutic and diagnostic applications due to its ubiquity. Many OB-fold 
domains lack disulphide bonds and use both the binding surface and loops for 
intermolecular interactions unlike loop dependent antibodies (Steemson et al., 
2014) (Figure 1.7). 
 
Figure 1.7 Schematic of OB-fold domain model 
Oligomer Binding fold (OB-fold) consisting of five numbered β-sheets coming together to 
form a β-barrel with binding surface (dotted circle) surrounded by loops L1, L3 and L4 
(black) [used with permission from (Murzin, 1993)]. 
  
OB-fold domains are non-immunoglobulin scaffolds made up of a five-stranded 
closed β-barrel (capped by an -helix between β3 and β4 strands) with Greek key 
topology. OB-folds have been found to bind to ligands or proteins at the same 
location on one side of the β-barrel and binding is facilitated by residues from 
loops 1, 3 and 4 (Murzin, 1993). This key feature seems to be conserved in 
OB-folds found in all three kingdoms. Therefore, it appears that OB-folds evolved 
a structure tolerant to mutation and a binding face which could support a wide 
variety of sequences. A detailed representation of an OB-fold is shown in Figure 
1.8 (2). 
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Figure 1.8 Cartoon representation of an OB-fold  
(1) Model of an OB-fold, starting with (N)-terminus followed by numbered (β)-sheets 
and (L)oops ending with the (C)-terminus. (2) topology of β-barrel spread out with β-
sheets (marked in red) placed side to side showing hydrogen-bonds holding them 
together (β1:18-30, β2:31-41, β3:44-53, β4:64-76, β5:83-94 amino acids). β1(AB,18-30) 
has been repeated on the other side (A*B*) to show closing side of β-barrel (β1-β4); S- 
Shear number. [adapted with permission from (Arcus, 2002)]. 
 
The β-barrel is described by the number of strands (n) and the shear number (S), 
the latter being the number of residues that are displaced to enclose the β-barrel. 
S=10 refers to 10 amino acids from A to A* [Figure 1.8 (2)].  β2, β4 and β5 
Chapter One 
 
19 
strands are interrupted by loops or bulges between them with an α-helix between 
β3 and β4. β-strands are held side by side with hydrogen bonds. There are OB-
folds of S=10 and S=8, for example the ssDNA binding protein has S=10 and the 
cold shock DNA binding domain has S=8. The binding face in the S=10 OB-fold 
is made up of β2 and β3 strands in the center and bounded by loop 1 at the bottom 
left, loop 4 at the top and loop 2 at the top right as shown in Figure 1.8 (1) (Arcus, 
2002). OB-folds in different organisms use this binding face as a catalytic site or 
to bind to nucleic acids, proteins or oligosaccharides as shown in Figure 1.9. 
  
2
0
 
                             
Figure 1.9 Examples of OB-fold domains  
Six examples of OB-fold domains are shown. β-sheet, -helices and loops are shown in blue, red and yellow respectively. Binding surface residues are shown as 
ball and stick figures; (a) N-terminal domain of Staphylococcal enterotoxin B, (b) N-terminal domain of Streptococcal superantigen SPE-c, part of dimer interface, 
(c) B5 subunit of Escherichia coli (E.coli) Shiga like toxin, (d) structure of Cell division control protein Cdc13,(e) cold shock DNA binding domain, (f) catalytic site of 
E.coli inorganic pyrophosphatase- PPase [used with permission from (Arcus, 2002)]. 
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OB-folds that have evolved from a common ancestor are clustered together into 
superfamilies. The bacterial enterotoxin superfamily has an OB-fold with the 
binding face specialised to bind to cell surface proteins or oligosaccharides. The 
nucleic acid binding superfamily has an OB-fold with the binding face specialised 
to bind to nucleic acids. The nucleic acid binding face uses central aromatic 
residues to accommodate the nucleotide base while using peripheral positively 
charged loops to bind to the phosphate backbone. The inorganic pyrophosphatase 
superfamily are groups of enzymes that uses the OB-fold binding face and its 
extended loops to form a cavity which is the active site for binding of metal ions 
and pyrophosphate (Arcus, 2002). When β-sheets of different OB-fold domains 
are superimposed, the helices and the ligand binding site align well showing 
sequence independent structural conservation (Murzin, 1993). 
 
OB-folds have been modified in research. The anticodon recognition domain 
(OB-fold) of Aspartyl t-RNA synthetase from Pyrobaculum aerophilum was 
previoulsy engineered to bind hen egg-white lysozyme as a proof-of-concept 
(Steemson et al., 2014). Phage display technology was used to select for OB-fold 
clones. These engineered OB-folds have been named OBodies (Figure 1.10). This 
OBody scaffold has high thermal stability, is soluble, lacks disulphide bonds and 
tolerates mutation of up to 22% of the amino acid residues at the surface and in 
the loops. An OBody library was created by randomising 17 residues on its 
binding surface. The crystal structure of this OBody with lysozyme showed 
1800 Å2 buried surface area between the proteins with hydrophobic residues in the 
center surrounded by polar and charged residues. (Steemson et al., 2014). 
 
Figure 1.10 Engineered OB-fold (OBody) to lysozyme 
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(1) Model of OBody (blue) showing binding surface with mutated residues (numbered, 
green stick Figures) surrounded by numbered loops (L1-L4) (2) Model of OBody in 
complex with lysozyme (green) showing interaction at binding site with loop residues. 
[used with permission from (Steemson et al., 2014)].  
 
These binding proteins, antibodies and non-immunoglobulin scaffolds have been 
engineered using various techniques ranging from the native immune system of 
mammals to in vitro selection techniques such as phage display and ribosome 
display. The following figure summarises key features of different non-
immunoglobulin scaffolds (Fig 1.11) 
 
Figure 1.11 Comparison between non-immunoglobulin scaffolds 
The features of the four most popular scaffolds (monobody = FN3 scaffold) with OBodies 
and few others are shown with relation to original domain, secondary structure, area of 
randomisation and size of scaffold (MW) along with their PDB structures. [used with 
permission from (Vazquez-Lombardi et al., 2015)]. 
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1.5 Techniques in protein engineering 
Traditionally the techniques for protein engineering required mammals or were 
labour intensive and expensive. Hybridomas were used to generate monoclonal 
Antibodies in mammals (Figure 1.12). This technology was based on using hybrid 
cells resulting from the fusion of an antibody producing lymphocyte with a 
tumour cell.  
 
Figure 1.12 Hybridoma technology  
The target antigen is injected into the mouse and antibody forming B-cells (from spleen) 
are isolated and fused to tumour (myeloma) cells producing hybridomas. The successful 
hybridomas are selected (using selective media) and screened for target specific 
antibodies (by limited dilution cloning). The specific monoclonal antibodies are 
harvested by clonal expansion. [used with permission from (Ruigrok, Levisson, Eppink, 
Smidt, & van der Oost, 2011)].  
 
Hybridoma technology exploits the mammalian immune system in which a 
diverse set of B-cell lymphocytes each expressing a different antibody clone are 
exposed to a target antigen to produce target specific antibodies. The B-cells 
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carrying these specific antibodies are subjected to random mutations in the genes 
for the surface binding loops, a process called somatic hypermutation. This 
two-step process results in antibody clones with high affinity to the target antigen 
(Hoogenboom, 2005). 
 
Later, libraries were made by cloning genes for antibody fragments into bacteria 
to produce antibodies. They were generated by ligating DNA fragments into 
lambda phage or plasmid DNA for subsequent transformation into Escherichia 
coli. These antibodies were screened by binding to radiolabelled target antigen. 
The screening approach limited the number of recombinants to 106 due to the 
limitation of growing a large number of agar plates for individual clones 
(Hoogenboom, 2005) (FitzGerald, 2000). This led to the invention of display 
technology which did not require mammals nor was limited by the screening 
approach. 
 
1.6 Display technology 
Display technology was invented when antibodies were successfully displayed on 
the surface of filamentous phage (G. P. Smith, 1985) and combined with PCR 
based gene diversity generation. This meant that each phage (or phagemid 
particle) containing the gene coding for the antibody variant had the equivalent 
antibody displayed on its surface, and phage display was born (Figure 1.13). 
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Figure 1.13 Phage display cycle  
A diverse gene library is cloned into a phagemid and transformed into E. coli., with each 
cell containing an antibody variant (POI, protein of interest) which is produced on the 
surface of phagemid particles with a helper phage. These phagemid particles are made 
to bind to a target antigen and non-specific antibody variants are washed away. The 
specific antibody variants are eluted and amplified for sequence analysis and 
subsequent rounds of selection using target antigen until desired antibody variant is 
obtained. [used with permission from (Ruigrok et al., 2011)].  
 
The advantage of phage display is the ability to generate antibody libraries with 
huge diversity from non-immunized mammals including humans as well as from 
artificially synthesized genes. Further, the genotype is directly linked to the 
phenotype by packaging of the DNA in phage and display of single clones on the 
exterior. Another critical step is the ability to select and then amplify chosen 
clones. Newer display technologies such as ribosome and yeast display have also 
become popular in generating monoclonal antibodies and other peptides. The 
display technologies share four steps with the immune system, 1) generating gene 
diversity similar to a diverse library of non-immunized B-cell lymphocytes, 2) 
coupling of phenotype to genotype similar to each B-cell coding for the surface 
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displayed antibody clone, 3) selective pressure with the target antigen and 4) 
amplification to generate target specific antibodies. It is important to note that 
there are only a few specific clones in a library of millions of non-specific clones. 
Therefore screening is challenging and display technologies must get around this 
problem by multiple rounds of selection with target antigen and then amplification 
of the selected clones (Hoogenboom, 2005).  
 
1.6.1 Ribosome display 
Ribosome and mRNA display are in vitro techniques that rely on a stable complex 
between the coding mRNA and the generated antibody fragment (Figure 1.14).  
 
 
Figure 1.14 Ribosome and mRNA display  
In Ribosome display (A), the coupling is between ribosome (yellow), mRNA (red strand) 
and antibody fragment (blue). In mRNA display (B), the coupling is between puromycin 
(green) at one end connecting the antibody fragment to the mRNA (red) via a DNA linker 
(dark blue strand). [used with permission from (FitzGerald, 2000)]. 
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In ribosome display, direct connection of the gene with its antibody fragment is 
done by ‘freezing’ the ribosome in translation with the mRNA that encodes the 
antibody fragment. The ribosome-mRNA-protein (antibody) complex is stabilized 
in the following ways, 1) controlling magnesium ion concentration 2) addition of 
chloramphenicol to terminate translation and 3) cooling down the translating 
protein lacking stop codons. The protein of interest coupled with its mRNA is 
separated and DNA is regenerated by reverse transcription PCR. The generated 
genes that encode these antibodies can be used for subsequent rounds of selection 
(FitzGerald, 2000). The advantage of this display technology is its ‘in built’ 
affinity improvement process due to errors resulting from reverse transcription. 
This leads to generation of antibodies or peptides with very high affinity 
analogous to somatic hypermutation mentioned for antibodies (Hoogenboom, 
2005). The other advantage of in vitro display technology is the large initial 
library diversity due to the absence of an E.coli transformation step (FitzGerald, 
2000). 
 
1.6.2 mRNA display 
In mRNA display (Figure 1.13), a small molecule called Puromycin that 
resembles the aminoacyl end of transfer RNA (tRNA) is used to form a covalent 
complex between the mRNA and its antibody fragment. This is done by attaching 
puromycin to the end of a small ssDNA linker. The other end of the DNA linker is 
attached to the mRNA. When the ribosome reaches the junction between DNA 
and mRNA, it ‘freezes’ resulting in puromycin forming a covalent bond with the 
antibody fragment at the ribosomal aminoacyl site. The gene responsible for the 
antibody is recovered similar to ribosome display using reverse transcription 
(FitzGerald, 2000). Both these technologies can use in vivo or in vitro translation 
for producing proteins of interest on a large scale (Hoogenboom, 2005) though 
production of stable complexes are susceptible to ribonucleases and are 
cumbersome to produce (FitzGerald, 2000). 
 
1.6.3 Yeast display 
The yeast Saccharomyces cerevisiae has been successfully used to display 
antibodies on its surface. The antibodies are fused to alpha-agglutinin yeast 
adhesion receptor and displayed on the cell wall. Potential antibodies are 
‘hand-picked’ via flow cytometry using fluorescent target proteins. This allows 
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screening for target specific antibodies down to nanomolar concentration binding 
to target protein. It has the added advantage of selecting for antibodies based on 
their kinetic properties, expression level or their binding to different sites of the 
target protein. Phage display using yeast for producing gene diversity has also 
been explored with libraries up to 1014 recombinants made (Hoogenboom, 2005).  
 
1.7 Phage display 
There are two types of phage based on its interaction with host cell: Lytic phage 
where phage assembly in the host cell cytoplasm leads to cell death and release of 
phage (e.g. T7 phage) and lysogenic phage where phage assembly leaves the host 
cell intact and the phage are exported from the cell (e.g. filamentous phage). 
 
Filamentous phage (e.g. M13) which depend on the F-pilus of E. coli are most 
commonly used for phage display. The phage is 900 nm x 7 nm wide, the length 
depending on the ssDNA inside. The viral coat is made up of 2700 copies of 
major coat protein pVIII and capped at both ends with minor coat proteins (pIII, 
pVI, pVII, pIX) (Figure 1.15) (Wilson & Finlay, 1998). 
Chapter One 
 
29 
 
Figure 1.15 Schematic of filamentous phage  
Diagram of M13 filamentous phage showing single stranded (ss)DNA in the inner cavity 
and major coat protein pVIII and other minor coat proteins- pIII, pVI, pVII, pIX on the 
outer surface. The gene of interest is fused to gene III (gIII, green rectangle) which 
results in the protein of interest (POI) being displayed in fusion with pIII (minor coat 
protein, green circle) on the surface of phage [adapted with permission from (Wilson & 
Finlay, 1998)]. 
 
The two coat proteins pIII and pVIII on filamentous phage have been used for the 
display of foreign peptides on their N-terminal end. Both these proteins have 
signal sequences on their N-terminal end which allow for export through the inner 
membrane of E. coli (Figure 1.15). These proteins are anchored into the inner 
membrane via their C-terminal hydrophobic domains (Fuh & Sidhu, 2000) 
followed by cleavage of the signal sequence by signal peptidase (Marvin, 
Symmons, & Straus, 2014; Wilson & Finlay, 1998). Foreign peptides have been 
inserted between these coat proteins and their signal sequences for display on the 
phage surface as shown in Figure 1.14 (Paschke & Hohne, 2005). The coat protein 
pVIII has been successful in displaying only small peptides as opposed to pIII 
which can display large proteins (Wilson & Finlay, 1998). Nanomolar affinity 
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proteins and libraries of 1010 individual clones have been engineered with phage 
display (FitzGerald, 2000). 
 
Filamentous bacteriophage (or genus Inovirus) infect gram negative bacteria and 
are secreted in large amounts without killing the host cells. They can produce up 
to 1013 phage per ml of culture. The pVIII protein is made up of 50 amino acids 
and thousands of these proteins form the rod containing a central cavity that 
houses single stranded DNA (ssDNA). This hollow cylinder is closed by two pairs 
of minor proteins pVI-pIX and pIII-pVI at either ends as shown in Fig 1.16 
(Rakonjac, Bennett, Spagnuolo, Gagic, & Russel, 2011). 
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Figure 1.16 Structure of filamentous phage coat proteins pVIII and pIII 
A) α-helical Structure of pVIII (PDB: 2c0w) showing packing with relation to other pVIII 
forming the major coat. B) Filamentous phage showing all coat proteins. C) structure of 
N1 and N2 domains of pIII (PDB: 1g3p) with illustration of entire pIII below it. SS: signal 
sequence, G: glycine linker, C: C-domain of pIII, TM: transmembrane α-helix. [adapted 
with permission from (Rakonjac et al., 2011)] 
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pVIII contains a signal sequence and is inserted into the inner membrane via YidC 
translocase with an N-terminal part (-) in the periplasm, a transmembrane helix in 
the inner membrane and a C-terminal part (+) in the cytoplasm. When the phage is 
assembled, the pVIII units stack against each other via hydrophobic interactions. 
The positively charged C-terminal part is directed inwards and interacts with 
negatively charged phosphate of ssDNA. The length of the phage depends on the 
size of the ssDNA and the contribution of four minor proteins to initiation and 
termination of elongation. 
 
pVII and pIX are inner membrane proteins that initiate phage assembly. The 
C-terminal part of this complex interacts with packaging signal (PS) of ssDNA 
leading to its packaging. pIII and pVI form a terminal cap which is inserted into 
end of the phage and extruded. pVI is made up of three transmembrane α-helices 
with an N-terminal part in the periplasm and a C-terminal part in the cytoplasm as 
for the other coat proteins. pIII is also required for phage infection of host 
bacterium and is made up of three domains (N1, N2 and C) separated by glycine 
linkers. The C-terminal transmembrane α-helix anchors it to the inner membrane 
leaving five amino acids in cytoplasm as shown in Fig 1.16. 
 
pIII initiates infection by binding to F pilus on surface of E.coli via N2 domain. 
This binding uncovers the N1 domain that binds to conserved TolA in the inner 
membrane. This is assisted by spontaneous pilus retraction. The change in 
conformation is possible via a cis-trans isomerisation of proline 213 in the N2 
domain. This is followed by α-helical C-domain mediated viral uncoating, 
insertion of pIII in inner membrane, DNA entry into cytoplasm and insertion of 
pVIII in inner membrane as shown in Fig 1.17. All three domains of pIII and 
TolQRA complex are required for phage infection (Marvin et al., 2014). 
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Figure 1.17 Illustration of pIII mediated infection 
1) Binding of filamentous phage via N2 domain (blue oval) to F-pilus of gram negative 
bacteria (light blue appendage). 2) Pilus retraction and binding of N1 domain (green 
oval) to TolAIII (TolQRA) of inner membrane. 3) Opening of C domain and insertion of 
TM (pink) into inner membrane. 4) Entry of phage ssDNA into the cytoplasm with 
insertion of pVIII into inner membrane. TM – transmembrane α-helix of C domain (pIII). 
[adapted with permission from (Rakonjac et al., 2011)] 
 
pII, pV and pX are the only proteins which remain in the cytoplasm and assist 
with replication. The + strand acts as a template to produce a complementary – 
strand at the negative origin of replication with the help of RNA polymerase. This 
generates an RNA primer which dissociates to complete the rest of the – strand 
with the help of host DNA polymerase. This dsDNA is called the replicative form 
(RF) and is used to produce phage proteins and more + strands via a rolling circle 
mechanism with the help of pII. pV binds to + strand (ssDNA) and forms the 
packaging substrate (dimer) and inhibits pII induced replication. pV does not bind 
to ssDNA at the PS, the latter binds to phage export complex (pI/pXI/pIV) 
spanning the inner and outer membrane, leading to initiation of phage assembly 
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by interaction with pVII-pIX complex. pI contains an ATP binding domain and 
forms the inner membrane channel with pXI, whereas pIV forms a barrel like 
outer membrane channel made up of three rings with the N-terminal ring facing 
inward and interacting with the inner membrane channel. This contiguous channel 
is used for phage elongation and extrusion. pIV is a homologous to type II, III 
secretion and type IV pilin systems collectively referred to as secretins. pV is 
replaced by pVIII as phage is extruded from the cell with final release of the 
phage contributed by the pIII-pVI complex. 
 
The phage life cycle (Figure 1.18) involves all coat proteins being transported to 
the periplasm and anchored to the inner membrane. These proteins form the outer 
shell housing the phage DNA as the phage leaves the bacterial cell. It is important 
to note that different coat proteins use different channels in the inner membrane to 
reach the periplasm. pIII is exported through a general secretory channel (Sec 
translocase) in the inner membrane and pVIII is Sec independent. This has an 
impact on the type of proteins (e.g. antibodies) that can be displayed using pIII as 
Sec translocase exports only unfolded proteins (Wilson & Finlay, 1998). 
 
  
3
5
 
 
(1) Infection starts with binding of pIII of 
phage to the F-pilus of E. coli leading to (2) 
internalisation of its ssDNA also called (+) 
strand. The (+) strand is used as a template 
(3) to produce complementary (-) strand 
resulting in double stranded (ds)DNA called 
replicative form (RF). The dsDNA is used as 
template (4) to produce more (+) strands 
with the help of a phage protein (pII). The 
dsDNA is also used as a template (5) to 
produce phage proteins. The (+) strand is 
coated with another phage protein (pV) 
which (6) delivers it to the phage export 
channel (pI, pIV) to be coated with proteins 
before extrusion from cell. [adapted with 
permission from (Rakonjac et al., 2011)]. 
Figure 1.18 Filamentous phage life cycle  
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pIII is a minor coat protein where two-thirds of the N-terminal end is required for 
F-pilus adsorption to the host cell and infection, and one-third of the C-terminal 
end is required for capping and phage extrusion from the cell. The failure of 
capping leads to non-infectious phage whereas the failure of phage extrusion is 
lethal to the host cell. This is important because using pIII as a display protein 
may affect phage display based on the nature of the fusion protein (e.g. antibody) 
ranging from blocking phage infection of E.coli (Rakonjac et al., 2011; Wilson & 
Finlay, 1998) to failure of export of pIII across the inner membrane (Dammeyer & 
Tinnefeld, 2012).  
 
1.7.1 pIII as display protein in phage display 
The most common filamentous phage used in phage display is M13. The type of 
display can be monovalent (single display of POI) or polyvalent (multiple display) 
dependent on the vector (phage or phagemid) or helper phage used (Figure 1.19). 
Type 3+3, where a separate wild type (WT) gene III is provided by a separate 
plasmid from a helper phage is the preferred method for phage display as it selects 
for high affinity POIs, due to low display of number of the POI coupled to protein 
III on surface of phagemid particles. Type 3 where gene III is fused to gene for 
POI or type 33, where gene III and gene for POI are separately present in the same 
phage are reserved for the first round of selection to screen for the most binding 
clones due to increased display in number of POI on surface of phage 
(Hoogenboom, 2005). Type 3 and 33 favours low affinity due to combined 
binding from multiple low affinity POI and target interactions, also called avidity. 
One limitation of Type 3 display is the POI may interfere with phage infection 
due to absence of wt pIII required for adsorption to F-pilus in E. coli, which is 
overcome in type 33 and 3+3 due to separate wt gIII. These three formats have 
also been used with pVIII as a display protein (referred to as Type 8, 88 & 8+8) 
(Wilson & Finlay, 1998). 
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Figure 1.19 Different formats of phage display using pIII 
(1) Type (3) where wild type (wt) gene III (gIII, grey) is fused to gene for foreign protein 
(red). This leads to display of foreign protein (red circle, POI) on all pIII (grey oval). (2) 
Type (33) where a separate wt gIII is present. This leads to display of both wt pIII and 
foreign protein. (3) Type (3+3) where a separate wt gIII is provided by a separate plasmid 
from helper phage.  This leads to similar display as type (33). In type 3+3 the phage 
plasmid lacking a functional pIII is called a phagemid [adapted with permission from 
(Hwang, 2014)].  
 
1.7.2 Protein translocation systems for phage display using pIII coat 
protein 
Translocation is the process of export of proteins across a cell membrane. The 
POI produced in the cytoplasm of the host bacterial cell has to cross the inner 
membrane to be displayed on the surface of the phage. The general secretory 
pathway (SEC) is known to transport unfolded proteins from the cytoplasm into 
the periplasm (E.g. display protein pIII). The twin arginine translocation pathway 
(TAT) is known to transport folded and cofactor proteins from the cytoplasm into 
the periplasm (Figure 1.20) 
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Figure 1.20 Inner membrane translocation pathways in bacteria 
Sec based translocation of unfolded proteins by two sub-pathways (a) co-translational 
via SRP, (b) post-translational via SecB. (c) Tat based translocation of folded proteins. 
The translating ribosome with 5’-3’mRNA is shown as the yellow structure; (1) SecA = 
Sec pathway motor protein, (2) SecB = Sec-post-translational pathway specific 
chaperone, (3) TatABC = Tat pathway export channel, (4) SecYEG = Sec pathway export 
channel, (5) PMF = proton motive force and (6) ATP & GTP = energy sources [adapted 
with permission from (Natale, Bruser, & Driessen, 2008)]. 
 
The Sec pathway consists of ATP dependent motor protein SecA and a channel 
protein complex SecYEG (together called the Sec translocase) to export unfolded 
proteins with a N-terminal signal sequence. Unfolded proteins are recognized by 
either a molecular chaperone called SecB or a signal recognition particle (SRP) 
based on the signal sequence of the POI. The SecB chaperone binds to a fully 
translated protein (post-translational) and prevents it from folding to its native 
state and delivers it to the Sec translocase for export into the periplasm. SRP binds 
to the signal sequence and delivers the translating ribosome directly (co-
translational) to the Sec translocase with the help of its receptor - FtsY, resulting 
in the protein being threaded into the periplasm. SecB is used to translocate 
secretory proteins whereas SRP is used for membrane proteins (Natale et al., 
2008).  
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The Tat pathway consists of Tat A, B and C protein sub units in the inner 
membrane which are together responsible for protein translocation of folded 
proteins from cytoplasm to periplasm using proton motive force (PMF). Protein 
translocation in these three systems is dependent on chemical groups or proton 
movement. Sec translocase exports post translated unfolded proteins using ATP 
and in case of co-translation, GTP is preferred.  
  
Protein signal sequences dictate the translocation pathway that a protein chooses 
to exit the cytoplasm into the periplasm. They are conserved across all domains of 
life and have a three-part structure consisting of a positively charged N-terminal 
segment, a hydrophobic core and a polar C-terminal segment. The signal sequence 
is usually found at the N-terminal end of the protein sequence and they have a 
cleavage site recognised by signal peptidases (Figure 1.21). 
 
 
Figure 1.21 Structures of Tat and Sec signal sequences 
Signal sequences that direct proteins to Tat or Sec pathway show a three-part structure; 
Tat has a conserved twin arginine (RR) amino acid sequence, Z denotes a polar amino 
acid and Φ denotes hydrophobic amino acids, n-region- N-terminal end of signal 
sequence, h-region- Hydrophobic core of signal sequence, c-region- C-terminal end of 
signal sequence. Sec has no conserved sequences. The arrow shows the cleavage site in 
both signal sequence by signal peptidases. [used with permission from (Natale et al., 
2008)].  
 
SecB transports proteins that have more hydrophobic amino acids.  SRP transports 
proteins that have a positively charged N-terminal end, which make electrostatic 
interactions with membrane phospholipids. There is no sequence homology 
between signal sequences in the Sec pathway. There are two arginines conserved 
in the signal sequence of proteins exported by the Tat pathway. They occur at the 
junction of their longer N-terminal ends and the hydrophobic core of the signal 
sequence (Natale et al., 2008). 
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1.7.2.1 Phage display using post-translational Sec pathway 
Phage display via the post-translational Sec pathway uses a specific chaperone 
called SecB which binds to the core region of the POI and stabilizes it in an 
unfolded state after exiting the ribosome (Figure 1.17b). SecB is required for 
maintaining the POI in an unfolded state and has a preference for hydrophobic 
and basic amino acids in the mature POI. It does not bind to the signal sequence 
of the POI. SecB delivers the unfolded POI to SecA of the Sec translocase system. 
In the absence of SecB, the signal sequence guides the protein to SecA using 
general chaperones. SecA is an ATPase (in the Sec translocase system) and binds 
to the signal sequence and core region of the POI. SecA is located in the inner 
membrane bound to negatively charged phospholipids and associated with the 
SecYEG complex (also in the inner membrane) to form the protein conducting 
channel (PCC). SecA couples POI export through the inner membrane with ATP 
binding and hydrolysis. The PCC forms a hydrophilic channel for POIs to be 
exported from the cytoplasm to the periplasm (Natale et al., 2008). 
 
1.7.2.2 Phage display using co-translational Sec pathway (SRP) 
SRP shares the Sec translocase system to export POIs and it is better at exporting 
fast folding and stable cytoplasmic proteins like DARPins, GFP (Nangola, 
Minard, & Tayapiwatana, 2010) or thioredoxin when compared to SecB, which 
may be inefficient in maintaining them in an unfolded form. Highly stable POIs 
have been displayed at levels up to 700-fold above conventional SecB route due 
to faster translocation through Sec translocase. POIs dependent on cytoplasmic 
cofactors for folding are poor candidates for SRP route (Steiner, Forrer, Stumpp, 
& Pluckthun, 2006). 
 
1.7.2.3 Phage display using Tat pathway 
The Tat pathway exports only folded POIs and has no preference for chaperones 
except when cofactors like molybdenum or nickel have to be added before protein 
folding and subsequent targeting to the Tat translocase. Tat translocase is made up 
of Tat A, B and C (Figure 1.17c). Tat B and C binds to the twin arginine motif of 
signal sequences when folded POIs are delivered by chaperones. This leads to the 
recruitment of Tat A leading to softening of the inner membrane and a 
conformational change in both Tat B and C then causes translocation of the POI 
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into the periplasm (Natale et al., 2008). In phage display using coat protein pIII 
which contains cysteines and requires an oxidising environment to form a 
functional protein, pIII has to be separately exported via Sec pathway and fused to 
the POI in the periplasm if the Tat pathway is to be employed for phage display 
(Nangola et al., 2010). 
 
1.7.3 Phage display using pVIII coat protein 
Phage display has been attempted on the amino terminus of the major coat protein 
pVIII. There are 2700 copies per phage particle (Figure 1.14) making it an ideal 
candidate for selection of low affinity POIs due to high avidity but a poor 
candidate for high affinity POIs. pVIII can display only short peptides less than 10 
amino acids due to the spatial constraints from pVIII on the phage surface as well 
as the metabolic stress of making thousands of copies. pVIII has to be expressed 
in large quantities in a natural phage life cycle making it difficult if the fusion 
peptide is toxic to the cell. The other limitations of pVIII as a display protein is 
reduced diversity of phage library due to incompatibility with certain codons 
(Rodi & Makowski, 1999). 
 
The minor proteins pVII and pIX lack signal sequences and spontaneously insert 
into the inner membrane of gram negative bacteria. However, phage display using 
pVII and pIX has been attempted successfully on the N terminal end and requires 
a signal sequence (Rakonjac et al., 2011). 
 
1.7.4 T7 phage display 
 
T7 is a double stranded DNA phage used for phage display. It is encapsulated in 
an icosahedral shell made up of 415 copies of protein 10. A variant called 10B is 
used to display peptides on its surface. This type of phage is released by the lysis 
of the cell, removing restrictions to export of proteins from cytoplasm to the 
periphery of the host bacteria (Rosenberg et al., 1996) (Wilson & Finlay, 1998). It 
is a robust structure capable of being resistant to harsh physical conditions and 
also multiplies rapidly. It is capable of phage display libraries up to 109 
recombinants. However display of peptides is limited to a size of 50 amino acids 
due to spatial constraints of the protein shell (Rosenberg et al., 1996). 
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1.8 Thesis Outline 
Protein folds from antibodies to non-immunoglobulin scaffolds are superior to 
small molecules in molecular recognition with regards to sensitivity and 
specificity from superior size and complexity. OB-folds are a non-
immunoglobulin scaffold which shows similar potential in molecular recognition 
of proteins or ligands. There are various techniques to exploit the potential of 
these protein folds as binding agents. Phage display is one such engineering 
technique and there are ways to optimize phage display of non-immunoglobulin 
scaffolds especially OBodies.  
 
This thesis focuses on characterisation of an OB-fold that binds to a small 
molecule, progesterone (P4) and using phage display to improve the binding 
affinity of this OBody towards P4. Chapter 2 summarise the experimental 
methods. Chapter 3 describes the production and characterisation of a naïve 
OBody called D7 that binds to P4. Chapter 4 involves the affinity maturation of 
OBodies including production and characterisation of the best P4 binding OBody 
B7. This chapter also describes the X-ray crystal structure of an OBody-P4 
complex. Chapter 5 describes the characterisation of a foreign signal sequence 
that enhances phage display of stable proteins including OBodies. Chapter 6 
provides a summary and discussion including future experiments. 
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2 Materials and methods 
2.1 General molecular biology 
2.1.1 Media and agar plates 
Media (7.1.1) were prepared using standard recipes or pre-made media were made 
in UP H2O and both autoclaved as per standard sterilization protocol (121°C for 
20 minutes) and stored at room temperature (~ 25°C). Agar plates were made by 
adding 15 g bacto-agar to liquid media (1L of 2xYT, LB) and autoclaving the 
solution. This was stored in liquid form at 50°C or in solid form (with antibiotic) 
as ~25 ml (small) or ~250 ml (large) plates at 4°C before using to grow E. coli 
colonies (25 -37°C). The recipes for the media are mentioned in the appendix. 
         
2.1.2 E. coli strains  
The genotypes are provided in 7.1.7. 
2.1.2.1 TG1  
This strain was used for phage display since it has an F-pilus for phage infection 
and amber suppression (UAG stop codon is translated as glutamine) between 
display protein (pIII) and foreign protein conducive to large scale expression of 
only the foreign protein in non-suppression strains (Carmen & Jermutus, 2002). 
2.1.2.2 DH5α  
This strain was used for transformation of engineered plasmids into competent 
E. coli cells due to deletion of genes recA and endA which results in superior 
plasmid retention (Phue, Lee, Trinh, & Shiloach, 2008). 
2.1.2.3 BL21(DE3)  
This strain was used for large scale expression of OBodies as it lacks Ion and 
OmpT proteases and contains T7 RNA polymerase gene from λDE3 phage for 
high protein expression under lacUV5 promoter (Jeong, Kim, & Lee, 2015). 
 
2.1.3 Induction of culture 
2.1.3.1 IPTG 
Isopropyl β-D-thiogalactopyranoside (IPTG) was used at 1/1000 stock 
concentration in culture media at OD600nm between 0.4 - 0.6. The stocks (1M) 
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were stored at -20°C. IPTG works by inhibiting lacI repression of the Lac operon 
resulting in protein synthesis (Marbach & Bettenbrock, 2012). 
2.1.3.2 Helper phage 
KM13 helper phage or M13K07δIII (hyperphage) were used for phage infection 
of E. coli TG1 containing phagemids (pOB2) at OD600nm between 0.4 – 0.6 to 
produce OBody displaying phagemid particles. Hyperphage lacks the gene for 
pIII thus resulting in increased display of OBody displaying pIII (instead of wild 
type pIII) (Rondot, Koch, Breitling, & Dubel, 2001) 
 
2.1.4 Plasmids 
The sequences of empty vectors and cloned inserts are provided in appendix 7.1.8 
and 7.2 respectively. 
2.1.4.1 pOB2 
A second generation (Pyrobaculum aerophilum Aspartyl t-RNA synthetase) naïve 
OBody library (2GPATS) was used as the insert for this phagemid. A phagemid is 
plasmid which contains most of the genes in a phage but needs a helper phage for 
phagemid particle replication (G. P. Smith & Petrenko, 1997). This phagemid is 
named after the insert, pOB2 (P. aerophilum OBody 2nd generation) and used as 
OBody gene libraries (plasmid) in E. coli TG1 (for phage selections). This is a 
periplasmic expression strain. 
2.1.4.2 pET28b 
This is a standard protein expression plasmid from the pET system which uses a 
phage based T7 RNA polymerase for protein synthesis under the control of lac 
operon (Grossman, Kawasaki, Punreddy, & Osburne, 1998; Pan & Malcolm, 
2000). This is a cytoplasmic expression strain. 
2.1.4.3 pPROEX-HTb 
This is another protein expression plasmid which is a hybrid promoter of trp and 
lacUV5 promoters which leads to high expression of proteins and minimal leaky 
expression (de Boer, Comstock, & Vasser, 1983). This is a cytoplasmic 
expression strain. 
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2.1.4.4 pOPINM 
This is a protein expression plasmid with a MBP fusion tag and is based on a 
modified pTriex2 plasmid which uses the standard T7 lac operon for protein 
expression. The pOPIN system is a suite of similar plasmids with different fusion 
tags which can be used for cloning of insert (gene) with a single set of primers 
(Berrow et al., 2007). This is a cytoplasmic expression strain. 
 
2.2 Protein expression and purification in E.coli cytoplasm 
2.2.1 Protein expression and extraction 
 A colony was looped using disposable sterile loops and added into 10 ml LB 
using appropriate antibiotic and grown overnight. This starter culture was added 
to a larger 1000 ml LB with appropriate antibiotic and incubated in a shaking 
incubator at 37°C, 200 rpm until OD600 0.4 – 0.6, then induced with 1ml 1mM 
IPTG and incubated overnight with shaking. This culture was transferred to 
plastic pots and centrifuged at 6500 rpm for 20 minutes. The supernatant was 
discarded and the pellet was re-suspended with 10 ml binding buffer (TBS with 
20mM imidazole, 7.1.3.1). A sonicator (Misonix XL-2020) was used to lyse the 
cells in the culture with a micro-tip at setting 5 for 15 second bursts alternating 
with 30 seconds rest (6 cycles) on ice. The lysed cells containing protein of 
interest was centrifuged again at 13000 rpm for 20 minutes. The supernatant was 
purified consecutively with three filters, 1.2 μM, 0.45 μM and 0.2 μM and used 
for Immobilized Metal-ion Affinity Chromatography (IMAC) purification on Fast 
protein liquid chromatography (FPLC). 
 
2.2.2 Protein purification  
2.2.2.1 Immobilized metal-ion affinity chromatography (IMAC) 
IMAC is a protein purification method where imidazole ring of histidine (from 
polyhistidine residues of tagged protein of interest) interacts with a metal ion 
(Ni2+) in an IMAC column. This tagged protein can be then separately eluted 
using high concentrations of imidazole which competes as the electron donor (to 
Ni2+) with histidine from the tagged POI (Bornhorst & Falke, 2000).    
 
GE Histrap HP 5 ml Nickel Sepharose column (stored in 20% ethanol) was 
prepared by using the following solutions* (in order): 
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25 ml UP H20 
10 ml EDTA 
25 ml 50mM NaOH 
7 ml NiCl2 
10 ml binding buffer (TBS with 10mM imidazole) 
*Note: 10 ml UP H2O was loaded into the column between every solution 
EDTA is used to chelate Ni2+, NaOH as a cleaning agent and NiCl2 to recharge the 
Ni2+ resin. The filtered supernatant (containing OBody) is then manually loaded 
into the column slowly to maximize polyhistidine based binding to the column. 
The column was then washed with 5 column volumes of binding buffer on FPLC 
(Amersham Biosciences) and then eluted with elution buffer (TBS with 1 M 
imidazole) over a gradient spanning 75 ml using FPLC. The fractions containing 
eluted (purified) OBody (indicated by 280 nm absorbance on FPLC and 
confirmed by 16.5% SDS-PAGE, 2.2.3.2) was concentrated using 10000 kDa 
(Millipore) concentrator at 3700 rpm to a volume of ~5 ml. The concentrator was 
equilibrated with the following solutions before loading IMAC fractions 
containing OBody. 
5 ml 10% Tween-80 (T80)  
5 ml binding buffer (TBS with 20mM imidazole)  
2.2.2.2 Size exclusion chromatography (SEC) 
SEC is a protein purification method which separates proteins on the basis of 
molecular size using porous material which traps proteins and elutes by steric 
exclusion leading to larger proteins being eluted first (Hagel & Janson, 1992). 
This is used as a secondary purification method.   
 
A HiLoad 16/600 Superdex 75 prep grade column (S75 16/600, containing 
dextran with agarose as the porous medium) was loaded with the following 
solutions (in order): 
125 ml UP H2O 
125 ml SEC buffer (TBS without 20 mM imidazole)  
The concentrated protein (~5 ml) from IMAC purification was injected into a 5ml 
loop attached to the S75 16/600 column via the FPLC and eluted using SEC 
buffer. The loop was equilibrated before loading OBody as follows: 
10ml UP H2O 
10ml SEC buffer (TBS without 20 mM imidazole) 
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The fractions containing purified OBody were collected based on the 280nm 
absorbance on FPLC and analyzed using 16.5% SDS-PAGE (2.2.3.2). The 
fractions were measured using an UV spectrophotometer (Thermo scientific 
nanodrop) to determine the OBody concentration. The molecular weight and 
extinction coefficients of the protein were determined using Prot Param web 
server. 
 
2.2.3 Protein Analysis by SDS-PAGE 
2.2.3.1 Gel preparation 
The resolving layer (7.1.4.1) is poured into a (5) gel caster and covered with 
isopropan-2-ol (IPA, to prevent bubbles) for 1 hour until the gel solidifies. The 
IPA is poured out and stacking gel (7.1.4.2) is poured into the gel caster over the 
solidified resolving layer. Combs are placed in the stacking gel which carves out 
the wells in the gel. This is allowed to solidify for 40 minutes. Then the gel is 
used for protein analysis in a PAGE system or stored (wrapped in damp paper 
towel) at 4 °C.  Note that damp paper towels are placed over the gel caster during 
both gel solidification steps. The recipe for the SDS-PAGE reagents are 
mentioned in the appendix. 
2.2.3.2 Gel electrophoresis 
Protein (Obody) containing fractions were separately mixed with 4x SDS loading 
dye (7.1.4.3) in eppendorf tubes and heated to 95 oC for 5 minutes. These heated 
fractions were loaded separately onto wells in 16.5% SDS–PAGE gels immersed 
in 1x Tris-glycine buffer (in PAGE apparatus, 7.1.4.4) and run with a protein 
ladder (Bio-Rad Precision Plus) at 70 V (stacking layer) for 45 minutes and 150 V 
(resolving layer) for 35 minutes for best resolution.  
 
The gels were stained with Fairbanks A solution (7.1.4.5) and microwaved for 30 
seconds and shaken at 120 rpm for 30 minutes. It was de-stained with 10 % acetic 
acid and microwaved again for 30 seconds and shaken at 120 rpm overnight. At 
this stage, the protein can be visualized and images recorded using a scanner.  
 
2.2.4 Protein-ligand incubation 
The fractions containing highly purified protein (OBody) analysed by SDS-PAGE 
were pooled and measured using nanodrop. Then the OBody solution was 
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incubated with P4 (Steraloids # Q2600-000, stored in 100% DMSO) at 1:0.94 
molar ratio at 4 oC overnight. Graphpad molarity calculator web server was used 
for calculations. This mixture was highly concentrated using a 10000kDa 
(Millipore) concentrator (after SEC buffer equilibration).  
 
2.3 Protein crystallography 
2.3.1 Crystal trials 
2.3.1.1 Sitting drop vapor diffusion method 
Protein was purified as mentioned in 2.2.2. The concentrated protein-ligand 
mixture is loaded onto a robot liquid handler (TTPLabtech Mosquito) which 
mixes (100 nl:100 nl) protein-ligand solution with 96 well microplate screens 
(PEGRx HT - HR2-086, Crystal Screen HT - HR2-130, Index HT - HR2-134, and 
SaltRx HT - HR2-136) from Hampton Research. The microplates were sealed 
with crystal clear air tight covers and incubated at 18°C. The microplate screens 
were observed under the microscope for possible crystalline protein 
(microcrystals, needles or crystals).  
2.3.1.2 Hanging drop vapor diffusion method 
The wells with crystalline protein were fine-tuned by repeating the specific screen 
(1 μl:1 μl) in a 24 well format (hanging drop vapor diffusion method) by varying 
two parameters in X and Y axis (pH and concentration of precipitant) in VDX 
plates (Hampton Research). A 24 well grid describing the volume of individual 
reagents for the fine screens were designed using Hampton Research online tools. 
The protein solution was placed 1:1 on 22 mm silicone cover slips and sealed with 
grease (Glisseal – Borer Chemie) inverted on wells containing 500 μl of the 
crystallization condition (for vapor diffusion similar to sitting drop vapor 
diffusion).  
2.3.1.3 Other methods 
Batch seeding was a technique used for growing larger and high diffraction 
quality crystals. The existing crystals were diluted in fresh crystallization 
condition containing the precipitant (1:10 to 1:10000) and fresh purified protein (1 
μl) is added to individual dilutions (1 μl) to provide a nucleation site (seed) for 
growing new crystals.  
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Streak seeding is a similar seeding technique where fresh protein was added to 
fresh crystallization condition containing the precipitant (1:1) and allowed to 
reach equilibrium at 18 °C (3 hours). Then a cats’ whisker is dipped in the existing 
crystal condition and passed through the equilibrated mixture (1 μl) to grow new 
crystals.  
 
Optimization screens like additive screen (HR2-138) and silver bullet (HR2-096) 
were other fine screens used in a 96-well format with the fresh crystal condition 
containing the precipitant (10 μl: 90 μl) and incubated (1:1) with fresh protein 
using hanging drop vapor diffusion method to improve the size or quality of 
crystals. 
 
2.3.2 X-ray diffraction 
2.3.2.1 Testing of Cryoprotectants 
The fresh crystal condition (containing the precipitant) of the crystal grown (from 
fine screens) was mixed with different percentages of glycerol (10% to 20% v/v) 
and separately loaded onto a cryo-loop (Hampton Research) and irradiated with 
X-rays from X-ray diffractometer (Supernova X-ray source, with a gaseous 
nitrogen stream at 100 K) to obtain minimum ice rings during diffraction spot 
analysis. The crystal condition with the best cryoprotectant concentration (with 
minimum ice rings) was used to loop the crystal. 
2.3.2.2 X-ray diffraction of crystals 
The crystals were immersed in a drop of the best cryoprotectant condition and 
looped with a cryo-loop. The crystal in the loop was irradiated with X-rays on 
Supernova X-ray source to rule out salt crystals and screen for protein crystals 
from diffraction spot analysis. The crystals (or screen conditions) that diffracted 
as proteins were frozen in liquid nitrogen and sent to Australian Synchrotron 
(Melbourne, MX1 beam line, ADSC Quantum 210r detector) for X-ray diffraction 
and data collection.  
2.3.2.3 Data collection 
The raw diffraction data was collected in IMG and HDF5 formats for MX1 
(bending-magnet beamline) and MX2 (finely focused in-vacuum undulator 
beamline) respectively at the Australian Synchrotron and auto-processed (in HKL 
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format). Crystal annealing by blocking the nitrogen stream transiently was used to 
improve diffraction and data collection (Heras & Martin, 2005). 
 
2.3.3 Data Analysis and solving of structure 
2.3.3.1 Indexing and integration of diffraction data 
The intensities from raw diffraction data were indexed and assigned to the 
appropriate space group with unit cell dimensions and integrated into a single data 
(MTZ format) file with iMOSFLM (Battye, Kontogiannis, Johnson, Powell, & 
Leslie, 2011; Leslie & Powell, 2007). The MX2 beamline data was collected by 
Eiger detectors. Eiger2cbf program was used to convert diffraction images (HDF5 
format) into miniCBF format for further indexing and integration of these images 
with iMOSFLM. 
2.3.3.2 Data processing and reduction (scaling) 
Aimless (CCP4) was used to scale the integrated data from iMOSFLM into one 
set of structure factors and convert auto-processed files (in HKL format) from the 
Australian Synchrotron into MTZ format (P. Evans, 2006; Philip Evans, 2011; P. 
R. Evans & Murshudov, 2013). The processed diffraction data from aimless was 
further analysed using two software suites : CCP-4 (Winn et al., 2011) and Phenix 
(Adams et al., 2010). The data contains only the amplitudes (and positions) of the 
diffraction spots whereas the phases have to be computationally derived to solve 
the protein (crystal) structure (P. Evans & McCoy, 2008). Xtriage (Phenix) was 
used to analyse the quality of data (sets).  
2.3.3.3 Molecular replacement 
The data with highest resolution (Å) and completeness (%) was used for 
molecular replacement (MR) to solve the phase problem (Wlodawer, Minor, 
Dauter, & Jaskolski, 2008). The aimless files were used by Phaser (Phenix) 
(McCoy et al., 2007) to find a MR solution with the protein data bank (PDB) 
model of the fusion protein (MBP, PDB code 1OMP).  
2.3.3.4 Density fitting and model building 
The MR solution containing the protein model (PDB) were used with aimless files 
to build the MBP-OBody fusion model using Autobuild (Phenix) (Terwilliger et 
al., 2008). Pymol was used to place the OBody manually in the partially built 
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model to complete model building (The PyMOL Molecular Graphics System, 
Version 1.8 Schrödinger, LLC). 
2.3.3.5 Model refinement 
The MBP- B7 model was refined multiple times using Refine (Phenix) (P. V. 
Afonine, Grosse-Kunstleve, Adams, & Urzhumtsev, 2013; P. V. Afonine et al., 
2012; Pavel V. Afonine, Grosse-Kunstleve, Urzhumtsev, & Adams, 2009; Headd 
et al., 2012) and Refmac5 (CCP4) (Garib N. Murshudov et al., 2011; G. N. 
Murshudov, Vagin, & Dodson, 1997). Wincoot was used for manual refinement 
of the models and ligand fitting (P4) (Emsley & Cowtan, 2004). 
 
2.4 Functional characterisation 
2.4.1 ELISA of protein-ligand binding 
Enzyme-Linked Immunosorbent Assays (ELISA) are used to quantitatively 
measure the binding affinity of proteins to their ligands via equilibrium 
dissociation constants (Kd) derived from colour forming reactions (Friguet, 
Chaffotte, Djavadi-Ohaniance, & Goldberg, 1985) (Figure 2.1). The dissociation 
constant (M) is calculated as follows: 
𝐾𝑑 =
[𝐴][𝐵]
[𝐴𝐵]
 
for the equilibrium 𝐴𝐵 ↔ 𝐴 + 𝐵 
where [A] is the concentration of protein, [B] is the concentration of the ligand 
and [AB] is the concentration of bound protein (with ligand) (de Mol & Fischer, 
2008). 
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Figure 2.1 Schematic comparing different types of molecule immobilization 
in ELISA 
The antigen immobilized ELISA (A) shows immobilized ligand (biotinylated-P4) in a 
streptavidin coated plate. The P4 is bound by protein (OBody/antibody) which is in turn 
detected by a secondary antibody conjugated with HRP. HRP is an enzyme which 
catalyzes TMB and produces colour indicating presence of P4 binding protein. In 
antibody (OBody) immobilized ELISA (B), the OBody is coated in a ELISA plate well and 
biotinylated-P4 is added for detection with a secondary agent (streptavidin-HRP) which 
uses TMB to produce colour forming reactions. [Adapted with permission from (Bodmer, 
Tiefenauer, & Andres, 1989)]. 
 
The following 3 ELISA systems have been used to determine protein- ligand 
binding (Bodmer et al., 1989; Friguet, Chaffotte, Djavadi-Ohaniance, & 
Goldberg, 1995). 
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2.4.1.1 Antigen (P4/ligand) immobilized ELISA 
Progesterone 3-PEG11-biotin (P4, Cayman chemical #9000645) was immobilized 
at room temperature on a Nunc streptavidin (Wilchek, Bayer, & Livnah, 2006) 
microplate (300 μl) wells at 7.5 μg/ml (6.6 μM, 50 μl/well) in PBS (in triplicates). 
The positive and negative control used were biotin-P4 and PBS respectively. This 
was incubated for 1 hour (at room temperature) and washed with PBS using a 
plate washer (3x 300 μl). Skim milk (3% w/v) in PBS is used for blocking the 
wells to prevent non-specific binding of OBody to the plate surface. Reagent 
volumes (50 μl/well), repeated incubation (for 1 hour) and washing with PBS 
between steps are standard to these ELISA systems. The protein (Obody) solution 
with starting concentration of 5 μg/ml (4.4 μM) were added to the first 3 wells and 
serial dilutions (0.6x) were made (using PBS) in parallel (for triplicates) except 
for the positive and negative controls. Sigma # P1922 Anti-progesterone rat 
antibody (Anti-P4 Ab, at 1:1000 ratio with 3% w/v skim milk PBS) was used for 
detection of P4 in the positive and negative controls. PBS with 0.1% T20 was 
used for washing at this stage to eliminate non-specific binding. Secondary 
detection antibodies for the Obody and Anti-P4 Ab were anti-histag Ab 
(1 μg/well, Invitrogen # 37-2900) and anti-rat IgG Ab-HRP (Sigma # A9037 at 
1:4000, HRP- Horse Radish Peroxidase) respectively. Horseradish peroxidase 
(HRP) is an enzyme which catalyzes the colour forming reaction of 3,3',5,5'-
Tetramethylbenzidine (TMB). After incubation and washing, ultra-TMB 
(Thermoscientific # 34028) was added for detection of binding of OBody and P4. 
After 15 minutes, the colour forming reaction was stopped with 0.5 M H2SO4. The 
absorbance (Abs450) was measured at 450nm in precision mode using 
Thermoscientific Multiskan Go microplate spectrophotometer. The data was 
processed using Graphpad Prism with non-linear regression (Böhm, 2005) using 
the following equation (one-site total binding model) and illustrated in Figure 2.2. 
𝑌 =
𝐵𝑚𝑎𝑥 ∗ 𝑋
𝐾𝑑 + 𝑋
+ 𝑁𝑆 ∗ 𝑋 + 𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑 
 
where Bmax is the maximum specific binding (Abs450), Kd is the equilibrium 
dissociation constant and defines the concentration when 50% of protein is bound 
to ligand (half of Bmax), Y-axis refers to the absorbance at 450nm (Abs450) from 
the colour forming reaction which is a function of bound protein (with ligand) and 
X-axis refers to the variable concentrations of protein [A] or ligand [B]. NS is the 
Chapter Two 
 
54 
slope of nonspecific binding (y-axis/x-axis) and background refers to the amount 
of nonspecific binding with no added protein (OBody). 
 
 
Figure 2.2 Binding curve of protein-ligand binding from ELISA 
The closed circles in the graph show different concentrations of OBody (x-axis) added to 
constant concentration of immobilized ligand (e.g. biotinylated- P4) and the colour 
forming reaction from ELISA is a function of OBody-P4 binding measured as absorbance 
at 450nm (y-axis). The maximum absorbance (Bmax) is a function of maximum OBody-P4 
binding and the the OBody concentration (nM) producing absorbance equal to half of 
(Bmax) gives the binding affinity (Kd) which is when 50% of free OBody is in equilibrium 
with P4 bound OBody. The binding of protein-ligand shows a characteristic hyperbole 
starting with protein-ligand binding at low concentrations (of protein) reflected by 
steady increase in Abs 450nm and saturation of binding at high protein concentrations. 
 
2.4.1.2 Antibody (Obody / protein) immobilized ELISA 
This system is more accurate because small molecule ligands diffuse faster than 
large protein molecules and because of reduced steric hindrance from 
immobilization of large protein molecules (Bodmer et al., 1989). The OBody (D7) 
is immobilized at constant concentration (400nM) in PBS in flat bottom 96 well 
microplates (Greiner-bio one #655-101). Blocking, incubation and washing steps 
are same as antigen-immobilized ELISA (2.4.1.1). Biotinylated-P4 is added at 
decreasing concentrations starting from 44 μM. In this antibody-immobilized 
ELISA, streptavidin-HRP (Invitrogen #434323) is used to detect OBody-P4 
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binding.  The colour forming reaction was analysed via Abs450 values using 
Graphpad Prism, as in antigen-immobilized ELISA. 
2.4.1.3 Competition ELISA  
This system is highly accurate because antigen and antibody are allowed to 
interact freely without immobilization of a partner or partial denaturation of 
protein, thus reaching equilibrium. The resulting free protein is used for detection 
and gives a true picture of the binding between antigen and antibody (Hardy, 
Djavadi-Ohaniance, & Goldberg, 1997). Biotinylated-P4 was immobilized on a 
Nunc streptavidin plate. Another non-streptavidin 96 well microplate (Greiner-bio 
one #655-101) contains non-biotinylated P4 (Steraloids # Q2600-000) at different 
concentrations with constant concentration of OBody (D7). The OBody or 
positive control antibody (anti-P4 antibody, Ab) is incubated to allow binding at 
equilibrium between protein and ligand. This antigen-antibody (or OBody) 
mixture was added to the P4 (biotinylated) immobilized Nunc streptavidin plate. 
The unbound Obody (or anti-P4 Ab) binds to biotinylated P4 and gives an inverse 
binding curve. Incubation, blocking, washing, colour forming reaction and 
processing of Abs450 using non-linear regression is same as for antigen-
immobilized ELISA. 
 
2.4.2 SPR for protein-ligand binding 
Surface Plasmon Resonance (SPR) is a spectroscopic technique where binding of 
an analyte (protein) to an immobilized ligand on a sensor chip changes the 
refractive index and this is the best method to determine Kd (equilibrium) and 
kinetic parameters (Nieba, Krebber, & Pluckthun, 1996). The change in refractive 
index is measured in resonance units (1000 RU = 1 ng/mm2) (Fivash, Towler, & 
Fisher, 1998). The experiments are conducted with SA chip (GE Healthcare, 
carboxymethylated dextran pre-immobilized with streptavidin) in Biacore 3000. 
Two ligands are used to test for cross-specificity. Biotinylated -P4 is used to 
saturate the binding surface of the test flow cell and biotinylated-E2 (estradiol) 
is used to saturate the binding surface of the control flow cell. The OBody (in 
HBS-EP buffer, GE Healthcare) was flown over these flow cells at different 
concentrations and the maximum RU attained (after subtraction of E2 control) 
from saturation with protein is taken as the Bmax (Figure 2.3). 
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The equilibrium analysis is done using a non-linear regression similar to ELISA 
(also called langmuir binding isotherm) using BIAevaluation software (ver 4.1, 
Biacore AB). The change in refractive index at equilibrium (Req) is given by the 
following equation (in RU):   
𝑅𝑒𝑞 =  
𝐵𝑚𝑎𝑥 ∗ [𝐴]
𝐾𝑑 +  [𝐴]
  
 
where [A] is the concentration of the (analyte) protein, Kd is the equilibrium 
dissociation constant (μM) and Bmax is the maximum binding capacity (in RU), 
when all binding sites on the sensor surface are occupied (de Mol & Fischer, 
2008). 
 
 
Figure 2.3 SPR sensorgram from protein-ligand binding 
Different concentrations of analyte (right arrow, μM) flown over immobilized ligand 
(biotinylated-P4 on SA chip) creates a characteristic curve showing rapid association, 
plateau followed by rapid dissociation with time (x-axis). This is reflected by the change 
in refractive index (RU, y-axis). At the plateau, the rate of association is equal to the rate 
of dissociation (Req). The highest RU reflects maximum protein-ligand binding (Bmax). The 
analyte (OBody) concentration (nM) producing (Req) equal to half (Bmax) gives the binding 
affinity (Kd) similar to ELISA. [adapted with permission from (Munoz et al., 2010)].  
 
2.4.3 FTSA for thermo-stability of OBody 
Fluorescent Thermal Shift Assays (FTSA) or commonly known as Differential 
Scanning Fluorimetry (DSF) is a technique used by the pharmaceutical industry to 
test protein- ligand binding. It works on the principle that the fluorescent dye has 
a non-specific affinity to hydrophobic parts of a protein and fluoresces upon 
binding. This fluorescence is decreased by water in the protein buffer. Therefore, 
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protein unfolding due to temperature and binding of the dye to hydrophobic parts 
of the protein leads to fluorescence (Figure 2.4) and gives a good idea regarding 
the thermostability of the protein. Since ligand binding generally stabilizes the 
protein, this can be used as an indication of protein-ligand interaction (Boivin, 
Kozak, & Meijers, 2013).  
 
Figure 2.4 Graph of Fluorescent Thermal Shift Assay (FTSA) melt curve 
The folded protein unfolds with increases in temperature (x-axis) exposing the 
hydrophobic core to SYPRO orange leading to increase in fluorescence (y-axis, right). The 
increase in fluorescence follows a sigmoidal curve and is a function of the fraction of 
protein unfolding (y-axis, left) and the temperature at which 50% of the protein in 
unfolded is called melting temperature (Tm). [used with permission from (Boivin et al., 
2013)]. 
 
The melting temperature (Tm) is used to measure the thermostability and is the 
temperature at which 50% of protein is unfolded (Niesen, Berglund, & Vedadi, 
2007). The OBody (D7 and mutants) were subjected to Thermal shift assays using 
SYPRO-orange (Invitrogen) dye in Rotor-gene Q-PCR (Corbett Life Science). 
This dye excites maximally at 470 nm and emits at 569 nm. The following recipe 
was used: 
5x Sypro Orange dye (final concentration from stock 5000x) 
3 μg OBody (in PBS pH 7) 
In total 20 μl UP H2O 
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(Gain setting- 4)  
The data is processed as the first derivative of the melting curve  (δF/δT) 
(Bohling, Wittwer, King, & Elenitoba-Johnson, 1999) which is equal to change in 
fluorescence (δF) divided by the change in temperature (δT), plotted against the 
temperature (T); and the temperature of maximum (δF/δT) is the Tm (Gandham, 
Volk, & Gorenstein, 2015).  
 
2.5 DNA manipulation and analysis 
2.5.1 Cloning of Obody DNA sequences into E. coli 
The gene for the Obody (D7) was digested from the phagemid (pOB2) using NEB 
restriction enzymes NcoI, NotI or SacII and transferred into expression plasmids 
(pET28b, pPROEX HTb or pOPINM, 7.1.8) using custom primers (7.1.9) ordered 
from Integrated DNA Technologies (IDT, Singapore). The signal sequence and 
foreign fragment (YscC, 7.1) was not included in these cytoplasmic expression 
plasmids. The restriction enzyme digestion is explained in detail in 2.5.6. 
 
The insert (donor gene) and vector (recipient plasmid) which were digested using 
the same restriction enzymes was ligated using NEB T4 DNA Ligase (#M0202) in 
a vector to insert ratio of 1:3 and is explained in detail in 2.5.7. The ligated 
plasmid was transformed into electro-competent (EC) E. coli cells using 
electroporation or chemical transformation and is explained in detail in 2.5.8. 
 
2.5.2 Confirmation and storage of clones 
The resulting colonies on the plate were tested for successful cloning of donor 
insert into recipient plasmid by colony Polymerase Chain Reaction (PCR) where 
individual colonies were tested for successful ligation of transformed plasmid 
using flanking primers and is explained in detail in 2.5.4.1. The successful 
transformed colonies were grown in 5 ml LB cultures (with appropriate antibiotic) 
at 37°C overnight at 200 rpm in a shaking incubator. 
 
The E. coli cultures (grown overnight) were harvested for storage and plasmid 
purification. A part of the culture is stored (under sterile conditions) with 25% 
glycerol (v/v) at -80°C. The remaining culture was used for plasmid extraction 
with a commercial kit (QIAprep spin miniprep kit # 27106). The manufacturer’s 
protocol was used and the purified plasmid concentration measured by UV 
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spectroscopy (Thermo-scientific nanodrop). The plasmid with an appropriate 
primer was sent (to Massey Genome Sequencing) for confirmation of gene 
sequence (at recommended concentrations). The sequencing results were analysed 
using Geneious R8 (Biomatters) software.  
 
2.5.3 Primer design  
In silico design of PCR primers were done using Geneious (Biomatters) 
sequencing analysis software and ordered online using Integrated DNA 
Technologies (IDT, Singapore). Where applicable, primers were designed with 
restriction enzyme cut sites which matched the sites in plasmids used for cloning 
(as discussed in section 2.5.6). All the primers were delivered in lyophilized 
format which had to be reconstituted to 100 μM using TE buffer as per provided 
instructions. The 100 μM primers were diluted using UP H2O to 10 μM and used 
for PCR reactions.  
 
Primers for phage display libraries: The primers used in construction of Affinity 
Maturation (AM) library used NNK codons where N= G, A, T or C and K= G or 
T. This allows elimination of stop codons UAA and UGA, but UAG also called 
‘amber’ will be suppressed and replaced with glutamine in E. coli TG1 strain 
(Inokuchi et al. 1979). 
 
2.5.4 Polymerase Chain Reaction (PCR) 
PCR was used to magnify DNA fragments of interest using custom built primers 
which flanked both ends. Most of the PCR reactions were typically performed in 
15 μl reactions (final volume) for analysis of insert into vector backbone during 
sub-cloning or 50 μl reactions for amplification of DNA fragments for cloning or 
construction of phage library. Two polymerases were used depending on routine 
PCR reactions (Taq polymerase) or PCR with proofreading (Pfx Polymerase) for 
high fidelity DNA amplification for designing libraries. 
1) Taq polymerase (Invitrogen #10342) was used for most PCR reactions with the 
same protocol described in 2.5.4.1. scaled up 3.33x times for a 50 μl reaction. 
2) Invitrogen Platinum Pfx Polymerase (#11708) was used for site directed 
mutagenesis (to randomize DNA fragments for construction of Affinity 
maturation phage library) using primers with NNK codons. This enzyme is high 
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fidelity and has proofreading 3’ to 5’ exonuclease activity.  The following mixture 
was used: 
5 μl 10x amp buffer 
1.5 μl 10 mM dNTP 
1 μl 50 mM MgSO4 
0.4 μl pfx polymerase 
1.5 μl 10 μM primers (forward and reverse) 
1 μl 50 ng DNA template 
Up to 50 μl UP H2O  
This mixture is prepared on ice and run on a PCR machine with the following 
settings: 
1) 94 °C 3 minutes 
2) 94 °C 15 seconds 
3) 50 – 70 °C, 30 seconds (temperature varied with DNA fragments) 
4) 68 °C, 30 seconds (go to 2, x30 times) 
2.5.4.1 Colony PCR 
The individual colonies on a plate are stabbed with sterile pipette tips and 
incubated in separate 10 μl LB (with appropriate antibiotic) for 10 minutes at 
room temperature. This is used in PCR reaction mixtures, where every reaction 
mixture contains: 
1.5 μl 10x –MgCl2 (Taq) buffer 
0.45 μl 50 mM MgCl2 
0.3 μl 10 mM dNTP 
0.75 μl 10 μM primers (forward and reverse) 
0.15 μl Taq polymerase 
1 μl LB (containing the colony stab) 
Up to 15 μl UP H2O 
This mixture is prepared on ice and run on a PCR machine with the following 
settings: 
1) 95 °C 2 minutes 
2) 95 °C 20 seconds 
3) 55 °C 30 seconds  
4) 72 °C 45 seconds (go to 2, x29 times) 
5) 72 °C 5 minutes  
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The PCR products are analysed for the appropriate size of the inserts on a 1% 
DNA gel (section 2.5.5). The successful colonies (~9 μl of LB from colony stabs) 
are separately grown in 5 ml LB with 1/1000 final concentration recommended 
antibiotic at 37°C overnight.  
2.5.4.2 Overlap extension PCR (OE-PCR) 
Overlap extension PCR (Heckman & Pease, 2007) was used in gene modification, 
where two DNA fragments sharing identical terminal segments (from 
complementary primers) were fused with a second PCR reaction using only 
flanking primers (Figure 2.5). 
 
Figure 2.5 Illustration of Overlap-Extension PCR (OE-PCR) 
 The OE-PCR is a two-step PCR where the first-step (A, overlap) involves independent 
PCR to generate two fragments (DNA fragment- 1, 2 to be fused) to have overlapping 
ends. This is achieved by complementary (overlap) primers (at the fusion ends, in grey) 
which extend their nucleotide sequence into the overlapping fragment. In this 
illustration, DNA fragment 1 is generated by using a 5’- flanking primer (left arrow) and 
overlap primer (dark grey). Similarly, DNA fragment 2 is generated by 5’- flanking primer 
(right arrow) and complementary overlap primer (light grey). The second-step (B, 
extension) involves mixing these two generated fragments and generating single hybrid 
fragment using only flanking primers (arrows). This illustration shows annealing at 
complementary (fusion, in grey) ends during PCR leading to extension and generation of 
the hybrid fragment. [used with permission from (Cha-aim, Hoshida, Fukunaga, & Akada, 
2012)]. 
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2.5.5 DNA Agarose gel electrophoresis  
The agarose gel is prepared microwaving intermittently for 1 minute until solution 
clears. The solution (7.1.5.1) is then poured into a DNA gel caster with combs and 
allowed to set for 30 minutes. The PCR product (or DNA fragment) to be 
visualized is mixed separately with 10x DNA loading dye (in 10:1 ratio, 7.1.5.3) 
and then added to the wells in a solidified agarose gel in a DNA electrophoresis 
system. TAE running buffer (7.1.5.2) is used and the gel is run at 90V for 30 
minutes. A DNA ladder (Thermo-scientific 1Kb Plus) is run in parallel as a 
standard. DNA can then be visualized under blue light (due to SYBR-safe DNA 
gel stain). The gel with the DNA fragments of interest are excised under blue light 
(Invitrogen Safe Imager, wearing orange filter glasses) and DNA extracted using 
commercial kit (QIAquick Gel Extraction Kit # 28706) as per manufacturer’s 
protocol. 
 
2.5.6 Restriction enzyme digestion of DNA fragments 
The purified DNA fragments which were PCR amplified were restriction enzyme 
digested with the appropriate enzyme dictated by their gene sequence. This was 
done using New England Biolabs (NEB) restriction enzymes for 37°C for 2- 5 
hours with the following protocol: 
 
10 μl 10x cutsmart NEB buffer 
1 μl NEB enzyme (s) 
40 μl purified (gel extracted) DNA fragment 
Up to 100 μl UP H2O 
 
Double digestion with two appropriate enzymes or sequential digestion with one 
enzyme were done to obtain DNA fragments for sub-cloning into expression 
plasmids or gene modification for phage display. DNA was run on 1% agarose gel 
and required DNA fragment extracted and purified as mentioned in 2.5.5.  
 
2.5.7 Ligation of DNA fragments 
The insert and vector were ligated using the following reagents (for a 1:3 vector to 
insert ratio) and incubated at room temperature for 2 hours (or 18°C overnight). 
The reagents are: 
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30 fmol of digested vector 
90 fmol of digested insert 
1 μl NEB T4 DNA ligase (#M0202) 
4 μl 5x ligase buffer 
Up to 20 μl UP H2O 
 
The calculations for the quantity of insert and vector are as follows (bp = number 
of base pairs): 
Insert (ng)= 90 x bp x 600/ 106  
Vector (ng) = 30 x bp x 600/ 106 
 
2.5.8 Transformation of ligated plasmid 
The resulting ligation mixture was transformed into electro-competent (EC) or 
chemo-competent E. Coli DH5/BL21/TG1 strain cells using following protocols. 
2.5.8.1 Preparation of electro-competent (EC) E. coli cells 
The protocol for preparing EC E. coli cells for transforming plasmids (molecular 
cloning or construction of phage library) is as follows (all steps are done at 0 °C 
on ice unless mentioned otherwise): 
- Streak a LB plate from E. coli glycerol stock (- 80 °C, without plasmid) 
and grow 2 (500 ml) large LB cultures at 37°C. 
- At OD600 between 0.5 to 0.7, harvest cells by centrifugation at 3000g for 
15 minutes at 4°C. 
- The supernatant is discarded, and pellet resuspended in (1 L) 0.1 M hepes 
(pH 7.5) and centrifugation repeated. 
- The re-suspension of the cells (after discarding supernatant) and 
centrifugation are repeated with lower volumes successively. 
500 ml 0.1 M hepes  
20 ml 0.1 M hepes (with 10% glycerol)  
2.5 ml 10 % glycerol  
- The final suspension of EC E. coli cells (in 2.5ml 10% glycerol) is freshly 
used at required amounts for transformation of ligated phagemids (see 
2.6.1.3. for phage library construction) or made into (50 μl) aliquots and 
snap frozen in liquid nitrogen and stored at - 80 °C (for molecular cloning 
purposes). 
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2.5.8.2 Transformation of competent E. coli cells 
Electroporation: 
The EC E. coli cells stored at -80°C (as 50 μl aliquots) is thawed on ice for five 
minutes and 5 μl of ligation mixture added to it and then this mixture is 
transferred to a sterile electroporation cuvette (chilled on ice). The cuvette is 
transferred to Gene pulsar (Bio-Rad) electroporator and the EC E. coli cells 
shocked with the following settings: 
Resistance= 200 Ω 
Capacitance= 25 μFD 
Voltage= 2.5 kV 
The competent cells are recovered with 1ml SOC or LB and incubated at 37°C for 
1 hour. 
 
Chemical transformation:  
Chemically competent cells were made using a similar protocol as 2.5.8.1. but 
resuspended with TSB media (7.1.1.5). Chemically-competent cells stored 
at - 80 °C as 100 μl aliquots were thawed on ice for 5 minutes and 5 μl of ligation 
mixture added and incubated for 30 minutes. At the end of 30 minutes, the 
competent cells were subjected to 42 °C for 45 seconds and then recovered for 2 
minutes on ice. LB or SOC (1ml) is added for further recovery and the competent 
cells are incubated at 37°C for 1 hour. 
 
2.5.9 Bioinformatic tools 
DNA sequencing analysis, sequence alignments and modifications (and in silico 
protein translations) were done with Geneious (Biomatters) sequencing analysis 
software. The web-based BLAST (NCBI) and SWISS-MODEL server were used 
for in silico protein analysis and modelling respectively. Graphpad PRISM (ver. 
6) was used for statistical analysis of ELISA data. BIAevaluation software was 
used for analysis of Surface plasmon resonance (SPR) data. The FTSA data and 
phage ELISA graphs were processed using Microsoft Excel.  
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2.6 Phage library and selection 
This section refers to methods specific to construction of a phage library and 
phage selections (Chapter 4). 
2.6.1 Construction of Affinity Maturation (AM) phage library 
2.6.1.1 DNA Template and stop codon insertion 
To design an AM library, steps were taken to prevent re-selection of the original 
(D7) OBody. This was done by inserting stop codons to DNA sequences of D7 
mutants, C35S and double mutant (DM, C35S:C48S) which were used as 
templates (2.6.1.2). The expression strain for phage display is E. coli TG1. It does 
not use the stop codon UAG (amber) which is replaced with glutamine (Inokuchi 
et al. 1979). Taking this into consideration, a stop codon (TAA) was inserted into 
the DNA sequence of D7 mutants (positions 48 and 83 of C35S and DM 
respectively) to prevent re-selection of these mutants (chapter 5). Re-selection of 
these D7 mutants would result in pre-mature termination of expression and 
elimination of phage containing them. The stop codon was inserted via OE-PCR 
using complementary primers (containing TAA) which is explained in detail in 
2.5.4.2.  
2.6.1.2 Randomization of inserts 
The inserts (~5 μg) were generated with OE-PCR using D7 mutants (with stop 
codons) and another set of complementary primers containing NNK codons where 
N=G, A, T or C and K= G or T. This arrangement allows elimination of stop 
codons UAA and UGA (U and T are interchangeable) in an amber (UAG) 
suppressed E. coli TG1 leading to possibility of all 20 amino acids (Mena & 
Daugherty, 2005) in the randomized positions as shown for L4_DM library 
(Figure 2.6). 
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Figure 2.6 Sequence of randomisation scheme for loop (L4) on DM (stop) 
template 
The sequence of loop (L4) is shown (inside dashed red lines) as part of the bigger OBody 
(DM) sequence. The complementary primers (green, for OE-PCR) show randomized 
areas (grey, NNK for 6 amino acids). The overlapping fragments are generated 
separately with forward primer (left arrow, sequence not shown) and L4 reverse (green) 
for one fragment, and reverse primer (right arrow, sequence not shown) and L4 forward 
(green) for the second fragment. The extension step (OE-PCR) follows using only flanking 
primers (arrows, sequence not shown) to generate randomized (single, L4) DM 
fragments. The stop codon in DM template is shown as TAA (*).  
 
2.6.1.3 Ligation and transformation of library members 
The vector (phagemid, pOB2) backbone from D7 was generated in large amounts 
(~25 μg) and the D7 template removed using standard DNA restriction digestion 
with NEB enzymes SacII (#R0157) and NotIHF (#R3189) as described in 2.5.6. 
The randomized inserts from OE-PCR were digested using the same enzymes. 
The vector (~12.5 μg) and inserts (~2.5 μg) were ligated as described in 2.5.7. The 
ligation mixture was made in 100 μl aliquots in a 96 well microplate format and 
incubated overnight at 16°C. This was purified using Roche High pure PCR 
product purification kit (#11 732 676 001). 
 
The purified phagemids (~12 μg) were transformed into freshly made EC E. coli 
TG1 cells (as described in 2.5.8) using a standard protocol for making EC E. coli 
TG1 cells in a cold room. The ratio used for electroporation was 3 μg plasmid 
(~50 μl) in 300 μl EC E. coli per electroporation cuvette. 
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Two controls, vector backbone only and pUC vector (Chan, Dreolini, Flintoff, 
Lloyd, & Mattenley, 2002) were transformed as negative and positive controls 
respectively. The transformed library cells were recovered by plating dilutions on 
small (for counting) and large (for harvesting) 2xYT (with carbenicillin, C100) 
plates grown overnight at 30°C. The transformation efficiency of the AM library 
(~107 cfu/μg) and the two controls were calculated using the formula  
 
𝑡𝑟𝑎𝑛𝑠𝑓𝑜𝑟𝑚𝑎𝑡𝑖𝑜𝑛 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 (𝑖𝑛 𝑐𝑓𝑢/𝜇𝑔)  
=  𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠/𝜇𝑔 𝐷𝑁𝐴/𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 
 
The transformed library cells were scraped from large plates with 2xYT (with 
17% glycerol) and stored in aliquots at -80°C. 
2.6.1.4 Phage rescue of library members 
 The transformed (phage) library cells equivalent to OD600= 0.1 was grown in 
2xYT (with C100 and 1% glucose) to an OD600= 0.5 and super-infected with 
helper phage (KM13) using the formula  
 
𝑡𝑜𝑡𝑎𝑙 𝑎𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 ℎ𝑒𝑙𝑝𝑒𝑟 𝑝ℎ𝑎𝑔𝑒 
=  𝑂𝐷600 ∗  (5 𝑥 108) ∗  𝑣𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑐𝑢𝑙𝑡𝑢𝑟𝑒 ∗  𝑀𝑂𝐼 
 
where MOI is Multiplicity of Infection. It is the amount of phage that infects one 
E. coli cell (KM13 = 10). The amount of phage required to infect 1 ml of E. coli 
TG1 at OD600 = 1 is experimentally determined to be 5 x 10
9 cfu for KM13.  
The super-infected culture was incubated at 37 °C for an hour with gentle shaking 
(150 rpm). The phagemid (pOB2) contains an ampicillin resistance gene (AmpR) 
whereas KM13 has a kanamycin resistance gene (KanR). The culture was 
centrifuged at 3300g for 10 mins and supernatant removed and the resulting pellet 
re-suspended with 2xYT (with C100 and kanamycin, K50) and incubated at 25°C 
overnight (200 rpm) for 18 hours, to facilitate survival and reproduction of 
superinfected E. Coli TG1 containing both antibiotic markers and production of 
OBody displaying phages. 
2.6.1.5 PEG precipitation of library members 
The protocol for PEG precipitation of rescued phage (library) was as follows: 
- The culture was centrifuged at 3300g for 30 minutes (4 °C) to recover 
supernatant (containing phage). The supernatant was incubated with 100 
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ml PEG/NaCl (20% Polyethylene glycol 6000, 2.5 M NaCl) for an hour on 
ice (in sterile conditions). All steps were done on ice unless mentioned 
elsewhere 
- The PEG/NaCl solution precipitates phage. This mixture was re-
centrifuged and supernatant (containing PEG/NaCl) was discarded this 
time. The PEG precipitated phage was resuspended with 8 ml PBS with 2 
ml PEG/NaCl for 20 minutes and re-centrifuged again. 
- The supernatant was discarded and phage pellet re-suspended with 5 ml 
PBS. This was re-centrifuged (at max G to remove cell debris) and the 
supernatant (containing phage) was filtered using 0.45 μl filter and stored 
in aliquots (with 15% glycerol) at -80°C. 
- Phage titre determination was done by diluting PEG precipitated phage 106 
times in 2xYT and infecting 1ml freshly grown E. coli TG1 (at OD600 
=0.5, 37°C, 1 hour, 150rpm as in 2.6.1.4.). A fraction of the infected E. 
coli TG1 cells were diluted and plated (C100, 2% glucose) at 30°C 
overnight and colonies counted. The formula for phage titre determination 
is: 
 
𝑝ℎ𝑎𝑔𝑒 𝑡𝑖𝑡𝑒𝑟 (𝑖𝑛 𝑐𝑓𝑢/𝑚𝑙) =  𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠 ∗  𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 ∗  10  
 
where 10 is the dilution related to volume of infected E. coli TG1 cells 
(0.1ml) used for phage titre determination (AM library = 1013 cfu/ml). 
 
2.6.2 Phage selection of Affinity maturation library 
2.6.2.1 Blocking phage and beads 
A calculated volume of PEG precipitated phage (~1012) was blocked with equal 
volume 3% (w/v) skim milk in PBS (MPBS) to prevent non-specific adhesion and 
to ensure phage-ligand binding (during phage selection) is solely through the 
OBody displayed on the surface of minor coat protein III (pIII) of phage. A 
manufacturer recommended amount (~50 μl) of streptavidin/neutravidin beads 
(Themoscientific Dynabeads M280 #11206D or sera-mag speed beads) to be used 
for binding biotinylated-P4 (bio-P4) was blocked separately with 1ml 3 % MPBS 
and both were incubated on a rotating platform for an hour (at room temperature). 
A magnetic strip was used to isolate the blocked beads from the supernatant. Note 
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that streptavidin/neutravidin binds to biotinylated-P4 which binds to specific 
OBody displaying phage. 
2.6.2.2 Phage de-selection and selection 
A small volume (~50 μl) of blocked streptavidin/neutravidin beads were incubated 
with PEG precipitated phage to encourage non-specific binding of phage to the 
beads and these beads were discarded (with non-specific binding phage) using the 
magnetic strip. 
The OBody ligand (bio-P4, with starting concentrations of 1 μM) was added in 
blocked phage and incubated for 2 hours (at room temperature) to select for strong 
P4 binding OBodies. The (OBody displaying) phage binding to bio-P4 was 
removed using blocked streptavidin/neutravidin beads and washed with PBS 
(0.1 % Tween 20) 10 times using the magnetic strip (to remove non-specific 
phage). 
2.6.2.3 Elution of selected phage and infection of E. coli TG1  
The beads were separated from the bound phage (with trypsin cleavable site) 
using trypsin (1 mg/ml) and vigorously shaken at 37°C for 30 minutes. The 
selected phage (~500 μl, after discarding separated beads using the magnetic strip) 
were used to infect freshly made E. Coli TG1 cells (~4.5 ml) as mentioned in 
2.6.1.4. The resulting infected cells were designated as the output. The PEG 
precipitated phage before selection was also separately used to infect E. Coli TG1 
cells as in 2.6.1.5. These unselected infected cells were designated as the input. 
These E. coli TG1 cells were plated on small (for counting) and large (for 
harvesting) 2xYT (C100, 2% glucose) agar plates as described in 2.6.1.3. The 
total output was calculated using the formula:  
 
𝑇𝑜𝑡𝑎𝑙 𝑂𝑢𝑡𝑝𝑢𝑡 (𝑖𝑛 𝑐𝑓𝑢)  =  𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠 𝑥 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 𝑥 50 
 
where 50 is the dilution related to volume of infected E. coli TG1 cells (0.1ml) 
used for output titre determination same as described in 2.6.1.5. These E. coli TG1 
cells were used as inputs for subsequent rounds of selections or stored in -80°C. 
2.6.2.4 Subsequent rounds of phage selections 
The E. coli TG1 (output) cells was used as input for subsequent phage selections. 
The phage was rescued, and PEG precipitated as described in 2.6.1.4 and 2.6.1.5. 
respectively. Successive selections used lower concentrations of ligand, shorter 
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incubation times and stringent washing conditions (up to 20 times) to select for 
high affinity OBody (phage). After 5 to 7 rounds of selection, the last two rounds 
were used to isolate P4 binding OBodies (by colony picking from small output 
plates) and testing their binding using phage ELISA (with immobilized bio- P4). 
 
2.6.3 Phage ELISA  
2.6.3.1 Phage rescue of selected phage 
The colonies from (small) output plates from last two rounds of phage selections 
were individually picked with sterile pipette tips and incubated independently in 
96 well plates containing 2xYT (C100 and 2% glucose) at 37°C, 150 rpm 
overnight. A plate replicator (in 70% ethanol and flame sterilized) was used to 
inoculate these micro-cultures into 96 deep well plates (containing 2xYT, C100 
and 2% glucose) ensuring no cross-contamination. The micro-cultures are stored 
at -80°C (in 17% glycerol) and the deep well plates are incubated at 37°C, 200 
rpm until solution turns turbid (~5 hours). The turbidity indicates OD600~ 0.5 
followed by super-infection (37°C, 150 rpm, 1 hour) with KM13 as described in 
2.6.1.4 (~1010 cfu/ml). Subsequent centrifugation (3300g), re-suspension (2xYT, 
C100, K50) and incubation (25°C, overnight) was as described in 2.6.1.4. 
 
2.6.3.2 Phage ELISA of selected phage 
Biotinylated-P4 was immobilized in a 96 well streptavidin coated microplate and 
blocked with 3% MPBS as described in 2.4.1.1. The deep well plates (from 
overnight 25°C incubation) are centrifuged at 3300g (10 minutes) and the 
supernatant (~50 μl, containing phage with OBody) is used to detect immobilized 
P4 on the streptavidin microplate. The independently bound phage were detected 
by the antibody (anti-M13 Ab-HRP, at 1:4000 ratio in 3% MPBS, Sigma Aldrich 
#27-9421-01) which detects a coat protein (of M13 phage). The HRP was used for 
the colour forming reaction as described in 2.4.1.1 (Figure 2.7)  
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Figure 2.7 Cartoon of Phage ELISA system 
The individual phage clones (with OBody) are grown in deep (96) well plates (upper left). 
These phage were independently added to an ELISA (96-well) plate with immobilized P4 
(grey circles, upper right). The selected OBody binds to P4 and unbound phage are 
washed away. The bound phage is detected by anti-M13 Ab-HRP (green) which produces 
a colour forming reaction (violet) with TMB (lower right). The well containing a P4 
binding OBody is animated (lower left) and the corresponding deep well (upper left, or 
glycerol stock) is used for large scale expression and characterisation of the specific 
OBody clones. [adapted with permission from (Lee et al., 2007)]. 
 
The phage (with OBody) with Abs450 > 0.25 were sub-cloned into expression 
vector pPROEX-HTb as described in 2.5.1 and confirmed for OBody-ligand (P4) 
binding (2.4.1.1).  The confirmed OBodies were expressed in large scale (2.2) and 
binding affinity determined using SPR (2.4.2). 
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3 Characterisation of anti-progesterone OBody (D7) 
3.1 Introduction 
An OBody designated D7 binds to the small molecule progesterone (P4) and it 
was previously generated from a naïve library using phage display. An OBody 
that can detect P4 has many applications in the dairy industry. D7 is an OBody 
from the second generation Pyrobaculum aerophilum Aspartyl t-RNA synthetase 
(2GPATS) library selected against the small molecule target P4. D7 is soluble and 
expressed in large scale using pET28b in E. coli BL21 strain. A simple ELISA 
using immobilized (biotinylated) P4 confirmed D7 binding to progesterone. 
Biophysical characterization of D7 provides key insights into the structure and 
function of an anti-progesterone OBody, with the further goal of improving 
binding affinity. X-ray crystallography is one such technique which can provide a 
detailed understanding of the D7 structure and its specific interactions with P4 
bound. An analysis similar to that reported for the OBody bound to HEL from the 
first generation naïve library (1GPATS) (Steemson et al., 2014).  
 
3.1.1 Structure of Progesterone (P4) 
P4 is a steroid, is secreted by the corpus luteum and placenta of animals, and acts 
on the female reproductive system. It is secreted in milk and is a good indicator of 
embryo survival after artificial insemination (Stronge et al., 2005). It is a small 
molecule by nature like the female hormone estradiol and both have natural 
binding partners such as their specific receptors outlined in Figure 3.1 
(Tanenbaum, Wang, Williams, & Sigler, 1998).  
 
Figure 3.1 Comparison of Estradiol (E2) and Progesterone(P4) bound by 
their receptors ER and PR  
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Atomic details of (1) the estradiol receptor (ER) binding to estradiol (red oval) and (2) 
the progesterone receptor (PR) binding to progesterone (red oval). Both show 
similarities in the steroid rings (pentagonal or hexagonal shapes) but differences in 
terminal polar groups (O and OH groups). In both instances, the steroid ring of 
phenylalanine (Phe) in the receptors stacks against the steroid ring of their respective 
small molecules (thick arrows) whereas the terminal polar interactions are depicted by 
hydrogen bonds (dashed arrows) including that made with water molecules (W). [used 
with permission from (Tanenbaum et al., 1998)].  
 
Progesterone (P4) and estradiol (E2) are very similar molecules, the main 
difference being carbonyl groups (C=O) at each end of P4, whereas hydroxyl 
groups (OH) occupy similar positions in E2 (Figure 3.1, red circles). Their 
respective receptors (ER and PR) provide hydrogen-bond acceptors from E2 and 
donate hydrogen bonds to P4. This is possible because the OH groups at either 
ends of E2 are hydrogen donors and the carbonyl (O) groups at either ends of P4 
are hydrogen acceptors. Both P4 and E2 share steroid rings which 
hydrophobically interact with the aromatic rings of the receptor amino acids. 
Water mediated hydrogen bonds play a role at the ends of both P4 and E2 in the 
context of their receptors. In both ER and PR, the small molecules (E2 and P4) 
form the structural core of their respective receptors from cooperative 
hydrophobic and hydrogen bonding between the molecules and their receptors. 
(Tanenbaum et al., 1998). This gives an understanding of the context of the 
binding pocket that might be required for an artificially synthesized binding 
partner (D7) to P4. 
 
3.1.2 Differences between periplasmic and cytoplasmic expression 
Protein folding in the cytoplasm is assisted by chaperone systems like trigger 
factor (TF), DnaK-DnaJ-GrpE (Hsp 70), GroEL (Hsp 60), IbpAB (sHsps) and 
ClpB as shown in Fig 3.2. TF is the first chaperone the protein encounters when it 
exists the ribosome. It assists in protein folding along with downstream DnaK. 
The latter is part of Hsp 70 which binds to hydrophobic regions of proteins and 
along with partners DnaJ and GrpE assist folding and release of the protein in an 
ATP dependent manner. This cycle can repeat, the protein may be transferred to 
GroEL, subjected to further folding steps or end up aggregating. Hsp 70 increases 
solubility of proteins (Kolaj, Spada, Robin, & Wall, 2009). 
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Figure 3.2 Protein folding in reducing cytoplasmic environment 
1) The trigger factor (TF) binds to the protein when it exits the ribosome. 2) and 3) refers 
to protein being folded by Hsp 70 (DnaK/ DnaJ/GrpE). When the protein does not fold to 
its native form, it goes through repeated cycles with Hsp 70 (4) or Hsp 60 (GroEL, 5) and 
sHsps (IbpAB). Aggregated proteins tend to use the aid of ClpB to fold to its native form 
(9, 10). [adapted with permission from (Kolaj et al., 2009)] 
 
GroEL is a double heptameric ring structure with a central cavity, which binds to 
hydrophobic parts of a protein and internalises it with a lid made of a single 
heptameric ring called GroES (Hsp 10) providing an environment for the protein 
to fold until there is no exposed hydrophobic protein parts, in a ATP dependent 
manner. Small Hsps like IbpA and IbpB act as reservoirs of unfolded protein 
under stress and help fold proteins with Hsp 70. ClpB is a large star shaped, 
hexameric chaperone with a central channel which assists with disaggregating 
proteins with Hsp 70. 
 
Some proteins are secreted to the periplasm for folding. The general secretory 
system (Sec) consisting of SecB chaperone, SecA motor protein and SecYEG 
pore is commonly used pathway. SecB maintains protein in ATP independent 
unfolded form, SecA translocates protein through SecYEG into the periplasm in 
an ATP dependent manner. SecDF prevent reverse translocation of the protein. 
Signal recognition particle (SRP) based FtsY receptor translocates proteins via 
Sec or YidC pore. Tat pathway consisting of Tat ABC translocates folded proteins 
to the periplasm. The translocation is dependent on signal sequences and assisted 
by chaperones in the cytoplasm as shown in Fig 3.3. 
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Figure 3.3 Protein folding in oxidising periplasmic environment 
1) Hsp 70 (DnaK) or SecB maintain the protein exiting the ribosome in its unfolded form 
while delivering it to Sec translocon for translocation into periplasm. 2) Signal sequence 
dependent co-translational translocation occurs through Sec or YidC translocase via SRP 
(FtsY) receptor. 3) Folded proteins are translocated through Tat translocon as shown in 
Fig 1.20. 4) Proteins in periplasm can aggregate due to formation of non-native 
disulfides, 5) get degraded by proteases, 6) undergo chaperone assisted folding, 7) 
repair its disulfides by oxidoreductases (Dsb) or 8) undergo cis- trans isomerisation 
(PPiases) to fold into its native form. [adapted with permission from (Kolaj et al., 2009)] 
 
The proteins in the periplasm after translocation and signal sequence cleavage, 
can be folded with chaperones (Skp, SurA, FkpA), disulfide catalysts (Dsb), 
isomerases (PPiase), degraded with proteases (DegP) or end up aggregating. 
DsbA and DsbC catalyse disulfide formation and isomerisation respectively. They 
are maintained in their oxidised state via DsbB and DsbD respectively. DsbEG are 
other catalysts. SurA and FkpA are key Peptidyl Prolyl cis/trans isomerases. 
Many of the chaperones have more than one function. 
 
Disulfide bonds are the result of oxidation of thiol groups between two cysteines. 
Disulfide bonds can undergo one of the three states – oxidation, reduction and 
isomerisation. Different compartments of a prokaryotic E.coli cell contribute to 
the above states with the cytoplasm and periplasm providing a reducing and 
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oxidising environment respectively. These reactions are assisted by oxido-
reductases from the thioredoxin and glutathione/glutaredoxin pathways 
contributing to the lack of oxidation in the cytoplasm and Disulfide bond (Dsb) 
system contributing to oxidation and isomerisation of thiol groups in the 
periplasm respectively. This is illustrated in Fig 3.4 (Berkmen, 2012). 
 
 
Figure 3.4 Illustration of redox reactions 
1) Oxidation involves the enzyme in oxidised state (DsbA) to form a transient disulfide 
bridge prior to transferring its oxidised state to the reduced substrate (-SH). 2) Similarly, 
an enzyme (TrxA) in reduced state transfers its reduced state to the oxidised substrate 
(S-S). 3) Isomerisation involves similar formation of transient oxidised state between 
enzyme (DsbC) and substrate while the disulfides on the substrate are shuffled resulting 
in formation of native disulfides. [adapted with permission from (Berkmen, 2012)] 
 
These reactions are possible due to the presence of a catalytic site on the oxido-
reductases which has a Cys-X-X-Cys motif which transfers its oxidative state of 
thiol groups to the reduced state of thiol groups of the protein substrate or vice 
versa, (where X is any amino acid). This involves an intermediate short lived 
disulfide formation between the Dsb enzyme and substrate. 
 
Disulfide bonds exist primarily to serve one of the three functions of structure, 
signaling or catalysis of reactions. Structurally speaking, disulphide bonds can 
either produce native folding of the protein or add to the stability of protein. 
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Different compartments of E.coli are required for expressing proteins which 
depend structurally on disulphide bonds. Most proteins that require disulfide 
bonds for native folding are extra-cytoplasmic where proteins may be exposed to 
environmental damage. Disulfide bonds are commonly found in periplasmic 
proteins of prokaryotes like E.coli. The cytoplasm is not capable of oxidising thiol 
groups to produce disulfides for proteins. Signaling disulfide bonds are part of the 
oxidative stress response which responds to reactive oxygen species (ROS). 
Catalytic disulfide bonds are caused by oxido-reductases where the electron 
transfer events of oxidation or reduction are dependent on the amino acids at the 
catalytic site as well as the environment in which the enzyme is expressed. 
 
The OBody D7 was selected against ligand progesterone (P4) using phage display 
with protein assembly occurring in the periplasm of E.coli TG1. This hints at the 
possibility of a structural contribution of disulfides to this OBody. DsbA is a 
strong oxidase that has been shown to oxidise non-native disulfides in proteins. 
The gene coding for the D7 OBody was sub-cloned into an expression vector 
pET28b and produced in the cytoplasm in E.coli BL21. The reducing environment 
of cytoplasm contributed by the two pathways is shown in Fig 3.5. 
 
 
Figure 3.5 Reducing environment in cytoplasm 
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The reducing environment of the cytoplasm is maintained primarily by two pathways: 1) 
Glutathione/glutaredoxin pathway with the glutaredoxins (grxABC) maintaining 
substrates in a reduced state. The glutaredoxins maintain their reduced state via 
glutathione which is synthesized by synthetases (gshAB). Glutathione is maintained in its 
reduced state via glutathione oxido-reductase (gor). 2) Thioredoxin pathway with the 
thioredoxins (trxAC) maintaining substrates in a reduced state. The thioredoxins 
maintain their reduced state via thioredoxin reductase (trxB). Both the pathways receive 
their reducing potential from NADPH. [adapted with permission from (Stewart, Aslund, 
& Beckwith, 1998)] 
 
The reductases, thioredoxins (trxA,C) and glutaredoxins (grxA,B,C) are 
maintained in a reduced state by thioredoxin reductase (trxB) and glutathione 
respectively, which ultimately receive their reducing potential from NADPH. 
(Stewart et al., 1998). 
 
3.1.3 Structure of an OB-fold 
OB-folds are single stranded nucleic acid binding proteins using similar binding 
surfaces for protein-ligand interactions. OB-folds vary from 70 to 150 amino acids 
in length with variability determined by loops with a conserved β-barrel (1.4). The 
binding interface in most OB-folds is adjacent to β2 and β3. The loops involved in 
this interaction contribute to this binding via hydrophobic aromatic interactions, 
hydrogen bonds and electrostatic interactions (Theobald, Mitton-Fry, & Wuttke, 
2003). 
 
 
Figure 3.6 Model of OB-fold showing active side 
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The model of an ‘open’ β-barrel with the β-sheets (numbered) laid out side to side 
shows three layers stabilizing it (top, middle and bottom) with each layer contributed by 
one amino acid per β-sheet (solid black circles). The active side is formed by one side of 
the β-barrel (dashed box) bound by loop-1 (L1) at the bottom and loop-4 (L4) at the top 
[adapted with permission from from (Murzin, 1993)]. 
 
The binding (active) side of an OB-fold is shown in figure 3.6. The β-sheets 
arrange themselves in three layers to stabilise the scaffold internally, contributing 
one amino acid per sheet per layer (Murzin, 1993). The top layer varies with 
respect to residues, but the middle and bottom layer are dominated by 
hydrophobic residues that point into the interior of the barrel. The α-helices are 
usually perpendicular to the barrel axis. The twisting of the β-sheets brings loops 
1 and 4 onto the same side of the barrel, and the shallow groove created between 
them acts as a binding site for elongated ligands (Murzin, 1993). Modifying this 
(binding) surface is the strategy for designing OBodies to P4.  
 
3.1.4 Preliminary OBodies work 
The OB-fold (anticodon recognition domain) of Aspartyl t-RNA synthetase from 
Pyrobaculum aerophilum was engineered using phage display to bind a different 
ligand, hen egg-white lysozyme (HEL) with a binding affinity of 3 nM (Kd) and 
this work was done by a previous PhD student in the lab (Steemson et al., 2014). 
This OBody has high thermal stability, is soluble and lacks disulfide bonds.  
 
The binding affinity (Kd) tells us a lot about the interaction between a protein and 
its ligand and higher affinity translates into superior results and applications. The 
Kd was calculated for the Anti-HEL OBody named native_library_8 (NL8) to be 
35 μM using surface plasmon resonance (SPR). The crystal structure showed a 
1600Å2 buried surface area between the OBody NL8 and the protein ligand HEL 
with hydrophobic residues in the center surrounded by polar and charged residues. 
NL8 inserts its L1 into the substrate binding groove (of HEL) and a residue R35 
of NL8 binds to the HEL active site similar to residue H60 of the HEL inhibitor 
YkfE (Figure 3.7). Acidic residues in the active side of NL8 are bound to 
complementary basic residues on HEL (Steemson et al., 2014). 
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Figure 3.7 Model showing OBody NL8 interacting with HEL in comparison 
to YkfE (HEL inhibitor) 
A cartoon model from crystal structure of NL8 (blue structure) bound to HEL (green 
structure) shown in comparison to similar interaction of HEL inhibitor (YkfE, pink 
structure) with HEL. The inset shows a magnified image of L1 residue R35 of NL8 
interacting with active site of HEL. Similarly, residue H60 of YkfE interacts with active site 
of HEL [used with permission from (Steemson et al., 2014)]. 
 
The OBody NL8 was further randomised by Steemson at 10 residues to facilitate 
better contact with HEL (including improving L4 contact of NL8 with HEL). The 
resulting stronger binding clones that were selected using phage display had a 
consensus in β-sheet residues indicating the versatility of the binding surface. The 
affinity calculated from SPR for OBody named Affinity Maturation 1st Library 10 
(AM1L10) was Kd = 4.6 µM.  
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To improve affinity further, a wider area of the OBody was randomised using 
Error prone PCR (EP-PCR), which produces random mutations over a large area 
of the protein surface. This resulted in OBody named Affinity Maturation 2nd 
Error Prone Library 6 (AM2EP06) with a Kd = 250 nM. The crystal structure of 
AM2EP06 with HEL showed a similar binding surface as NL8 and AM1L10 but 
with the L4 making contact with HEL and having improved buried surface area 
by ~100Å.  
 
A third affinity maturation library was made where mutation was focused on L4 
making contact with HEL. A stop codon was inserted on L4 to prevent re-
selection of existing OBodies and to ensure selection of L4 randomised clones 
(using NNS codons where S= C or G). The resulting strong affinity clones showed 
a common selective pressure towards hydrophobic or small hydrophilic residues 
in L4. The highest affinity recorded by SPR was for OBody named Affinity 
Maturation 3rd Library 9 (AM3L09) (Kd = 3nM). The buried surface area is 1800 
Å2. Electrostatic (charged) interactions were present in two complementary 
(loops) areas of the OBody-HEL complex, one on L1 (R35) and the other on L4 
(D91) (Figure 3.8). A similar pattern was observed with regards to intermolecular 
water hydrogen bonding networks (not shown here). To summarize, the common 
binding site of the OB-fold is used in binding to HEL in all the anti-HEL 
OBodies, with a central hydrophobic patch surrounded by complementary charged 
interactions with HEL. OBody AM3L09 (Kd = 3nM) differs from OBody NL8 (Kd 
= 35uM) as it has more polar and charged interactions with HEL.  
 
Figure 3.8 Animated electrostatic models of HEL and AM3L09 
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Complementary electrostatic interactions between (a) active site (AS) of HEL which 
interacts with (b) loop (L1) residue R35 of OBody AM3L09. Similarly, loop (L4) residue 
D91 of NL8 interacts in a complementary fashion with HEL (red area – negatively 
charged, blue area – positively charged) [used with permission from (Steemson et al., 
2014)].  
 
3.1.5 Re-design of OBody library for P4 
A second generation naïve (2GPATS) OBody library was created by Dr. Mark 
Liddament to be able to select for OBodies with better binding qualities, with 
randomisation (of charged or hydrophobic residues not involved in binding) at the 
periphery of active side of wild type OB-fold (Figure 3.9) to try to eliminate steric 
hindrance. The naïve library was created by designing a library with mutations 
targeting 15 residues coding for the binding surface of 1GPATS library. The 
library was produced such that 2x1010 individually diverse clones were generated 
compared to 108 for 1GPATS (Figure 3.10). 
Chapter Three 
 
83 
 
Figure 3.9 Comparison of OBodies from 1GPATS with 2GPATS model 
Cartoon model of an OBody from the first generation OBody library (1GPATS, A) in 
comparison to 2GPATS (B) showing randomized residues as blue stick figures with new 
residues added for randomization at the periphery of the active side (green arrow) and 
residues which have been omitted from randomisation (red arrow) in 2GPATS. The β-
sheets are shown in yellow, coils in green, α-helices and retained mutations in red.  
  
 
8
4
 
 
Figure 3.10 Gene sequence of 2GPATS naïve library 
Insilico construction of naïve library (using geneious sequencing software) showing protein sequence of a typical OBody (with DNA sequence on top of it) with 
green circles indicating randomised areas specific to 2GPATS (referring to light pink arrows). On top of the protein sequence, bright pink cylinders refer to 
α-helices, wavy lines refer to coils, thin arrows refer to β-strands and orange arrows adjacent to light pink arrows below the protein sequence refers to retained 
(fixed) mutations from 1GPATS. PelB signal (leader) sequence and OBody (scaffold) sequence are annotated (yellow) and randomised mutations are accompanied 
by NNK codons with (?) referring to random amino acids. 
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A sequence comparison between P4 binding OBody (D7, 2GPATS, 7.2.1) and the 
HEL binding OBody (AM3L15, 1GPATS) shows the conservation of core 
structural features such as β-strands forming the barrel and high variability at the 
loop region (L4) (Figure 3.11). There is overall 75% sequence similarity between 
D7 and AM3L15. 
 
Figure 3.11 Comparison of D7 (2GPATS) with AM3L15 (1GPATS) 
Protein sequence comparison (generated using SWISS-MODEL) of D7 (2GPATS) with 
AM3L15 (1GPATS) showing conserved residues as part of the core β-barrel with 
modified residues in β2 and β3 (red boxes) and modified residues in L4 (green box). 
 
My work started with the confirmation of OBody D7 in cytoplasmic expression 
plasmid pET28b in the absence of foreign fragment (YscC) by DNA sequencing. 
OBody D7 was then expressed and purified in large scale using protein 
purification techniques and characterised functionally to assess P4 binding. 
 
3.2 Results 
3.2.1 Large scale expression and purification of D7 
D7 was sub-cloned into expression vector pET28B (7.2.2) and expressed in E. 
coli BL21 strain using standard bacterial media (2xYT, LB) and purified by 
Immobilized metal affinity Chromatography (IMAC, Figure 3.8) using standard 
buffers (TBS, PBS) containing imidazole. Initial purification showed that there 
were two distinct bands, one between 10 -15 kDa and another between 20 - 25 
kDa on a 16.5% SDS-PAGE gel. The OBody (D7) has a theoretical molecular 
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weight of 12.7 kDa possibly indicating that the band at around 25 kDa 
corresponds to an SDS resistant dimer. The SDS-PAGE image also showed the 
possibility of higher order oligomers (Figure 3.12).  
 
 
Figure 3.12 UV elution profile and SDS-PAGE image of IMAC purified D7  
The top image shows the UV absorbance curve (blue, 280nm) in mAU (left y-axis) 
showing the elution of D7 over an imidazole gradient (red) in percentage (right y-axis) 
during Histrap (IMAC) purification. The blue peak indicates maximum D7 elution. The 
x-axis refers to the flow of IMAC buffers (7.1.3.2) containing imidazole. IMAC is 
explained in detail in 2.2.2.1. The bottom image is 16.5% SDS-PAGE showing IMAC 
fractions containing purified D7 with reference to a protein ladder (left) showing 
possible sizes of proteins. D7 elutes as a monomer (12.7kDa) and dimer (25kDA) both 
indicated by arrows. There is also trace oligomerisation at ~37 kDa. Note that each lane 
in SDS-PAGE corresponds to the elution fractions of two UV peaks in IMAC.  
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The fractions containing D7 were pooled and concentrated to further purify using 
an S200 10/300 GL or an S75 16/600 column for size exclusion chromatography 
(SEC). D7 eluted as a single peak corresponding approximately to the monomer 
(Figure 3.13). However, SDS-PAGE showed no separation of monomer and 
dimer species (Figure 3.14). 
 
Figure 3.13 Purification of D7 on S75 16/600 column 
Elution profile of D7 on S75 16/60 shows a single peak (arrow) corresponding to the 
monomer (12.7kDa). Y-axis is the intensity of absorbance by aromatic rings of protein at 
280nm in milli-Absorbance Units (mAU). X-axis is the volume (ml) of buffer (7.1.3.2) the 
protein elutes at and is inversely proportional to the size (MW) of the protein in solution 
(Hong, Koza, & Bouvier, 2012).  
 
 
 
Figure 3.14 SDS-PAGE image of S75 16/600 purified D7 
16.5% SDS-PAGE image showing S75 16/60 (SEC) fractions containing purified D7 with 
reference to a protein ladder (left) showing possible sizes of proteins. D7 still elutes as a 
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monomer (12.7kDa) and dimer (25kDA) both indicated by arrows. There is also trace 
oligomerisation at ~37 kDa. Note that the lane with strong dimer in SDS-PAGE 
corresponds to the UV peak (arrow) in SEC. 
 
Samples were sent to the University of Otago for analysis. An interesting 
observation is that SEC done at University of Otago was sensitive enough to 
separate the monomer from the dimer (Figure 3.15). The other interesting 
observation is the dimer to monomer concentration is low at low concentrations of 
D7 as shown in SDS-PAGE (Figure 3.16). 
 
Figure 3.15 SEC analysis of D7 
Elution profile of D7 on SEC (top) shows two peaks (numbered) corresponding to the 
dimer (12.62ml) and monomer (14.66ml) with relation to the standards (bottom) 
provided by Biorad. Y-axis is the intensity of absorbance by aromatic rings of protein at 
280nm in milli-Absorbance Units (mAU). X-axis is the volume (ml) of buffer the protein 
elutes at and is inversely proportional to the size (MW) of the protein in solution. This 
was carried out in collaboration with University of Otago. 
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Figure 3.16 SDS-PAGE image of low yield D7  
D7 fractions from S200 10/300 GL (SEC) showing low dimerization at low concentration. 
Upper arrow shows the position of (low quantity) dimer. Protein ladder is shown in left 
and monomer (D7) band is shown by lower arrow. Note that each lane in SDS-PAGE 
corresponds to different elution fractions. 
 
Pure D7 was concentrated up to 10 mg/ml and crystal trials were laid out using 
four custom screens (Hampton Research). There was no crystal growth in any of 
the screens and the protein precipitated beyond this concentration in most wells. It 
was hypothesized that a lack of homogeneity (Dale, Oefner, & D’Arcy, 2003) or 
decreased protein stability (leading to protein aggregation) (Gosavi, Mueser, & 
Schall, 2008) may be a factor in lack of crystals. The possible contribution from 
intermolecular disulphide bonds was also considered a possible reason for 
inhomogeneity.  
 
3.2.2 Strategies to improve protein stability 
The factors contributing to protein stability can be divided into protein (intrinsic) 
or buffer (external) causes (Trivedi, Laurence, & Siahaan, 2009). Basic strategies 
to improve protein stability and homogeneity with different buffer conditions 
were tested first (Gosavi et al., 2008). Different types of buffers (TBS, PBS, 
Hepes), pH (4-9) conditions and increasing salt (Gotte & Libonati, 2014) did not 
have any positive effect on the stability of D7. The stability was assessed by 
concentrating the purified protein by centrifugation (2.2.2) and higher stability 
was reflected by achievement of higher concentrations without protein 
precipitation. Addition of 5% glycerol did improve the protein stability as D7 
could be concentrated further than 10 mg/ml. D7 stability was confirmed by 
protein concentration estimation (using nanodrop) and lack of visible protein 
precipitation at high concentration. However, this did not lead to formation of 
crystals and most crystal screens showed precipitation (aggregation).  
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My hypothesis is that oxidation of one or more of the four cysteines is responsible 
for the formation of intermolecular disulphide based dimers (Benvenuti & 
Mangani, 2007). Treatment with reducing agents like dithiothreitol (upto 10 mM 
DTT) or β-mercaptoethanol (upto 20 mM BME) can eliminate intermolecular 
disulfides (Bondos & Bicknell, 2003). Treatment with DTT (Figure 3.17) in gel 
purification buffer resulted in the partial elimination of the dimer band on SDS-
PAGE and crystal trials were laid down using 5 mM DTT or 10 mM BME.  
 
Figure 3.17 SDS-PAGE image of D7 with DTT  
D7 was incubated with 5mM DTT and run on SDS-PAGE with untreated D7 control. The 
dimer band (upper arrow) has disappeared in D7 fractions treated with DTT. The protein 
ladder is on the left and the monomer (D7) band is shown by the lower arrow. Note that 
each lane in SDS-PAGE corresponds to different SEC elution fractions treated with and 
without DTT. 
 
Using DTT or BME was not as effective on a large scale reflected by protein 
aggregation at high concentrations possibly from oligomerisation (Wang, 2005). 
OBodies have been previously concentrated up to 40 mg/ml and crystallized with 
equimolar ligand (Steemson et al., 2014). 
 
D7 was selected against progesterone (P4) by phage display and P4 was added as 
a stabilizing ligand (which decreases the free energy of the complex and 
theoretically improves the chances of crystal lattice formation). The (P4) 
progesterone (1mM, from steraloids) stored in ethanol was incubated with 
concentrated D7 at room temperature for 30 minutes and centrifuged to recover 
the supernatant containing the D7:P4 complex and crystals trials were laid out. 
There were still no protein crystals.  
 
Chapter Three 
 
91 
3.2.3 Construction of D7 mutants  
The next step to try to eliminate dimerization (and the contributions to 
oligomerisation and inhomogeneity) by replacing cysteines with serines with the 
goal to prevent disulphide bonds. The four cysteines are at amino acid positions 
35, 48, 81 and 85. Cysteines 35 (c35) and 48 (c48) are on β2 and β3 respectively. 
Cysteines 81 (c81) and 85 (c85) are both on the loop L4 (Figure 3.18). 
 
Figure 3.18 D7 model showing position of cysteines 
A cartoon representation (created with Pymol) of OBody D7 (cyan) indicating the 
location of four cysteines (green) is shown. The proximal binding face (pF) consists of β-
sheets 2 and 3 (including C35 and C48 as labelled) and loop-4 (L4) includes C81 and C85 
as shown.  
 
Four mutants were created with single point mutations (cysteine to serine) at these 
positions to produce c35s, c48s, c81s and c85s. This was achieved using overlap-
extension PCR (OE-PCR) and this technique has been described in 2.5.4.2. 
Complementary overlap primers were designed for each mutant with the 
nucleotide sequence that replaces cysteine with serine and overlap fragments were 
generated with flanking primers for pOB2 (or YscC). The overlap fragments for 
C35S are 606 bp and 378 bp and for C48S are 640 bp and 334 bp. The overlap 
fragments for C81S are 743 bp and 240 bp and for C85S are 758 bp and 231 bp. 
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The flanking primers were used in the extension step of OE-PCR to fuse the 
overlap fragments to generate D7 mutants which are of the same length (944 bp) 
and was confirmed by DNA sequencing (Figure 3.19). The double mutant (DM, 
C35S:C48S) was similarly designed by using C35S as a template for OE-PCR 
using overlap primers for C48S. The fused overlap fragments were sub-cloned 
without the YscC fragment (483 bp) into the expression vector pPROEX HTb and 
confirmed using appropriate primers. 
 
Figure 3.19 DNA sequencing of D7 mutants  
The DNA sequencing results (courtesy of Massey Genome Sequencing) of fused overlap 
fragments for D7 mutants sub-cloned into expression vector pPROEX HTb are shown. In 
the image (Geneious), the labelled D7 mutants (left) show the relevant mutations (red 
boxes) with amino acids.   
 
3.2.4 Purification of D7 mutants 
Replacement of cysteines with serines on the β2 and β3 showed decreased 
dimerization in reducing (SDS-PAGE) gel image (Figure 3.20). Replacement of 
L4 cysteines did not affect dimerization. 
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Figure 3.20 SDS-PAGE images of D7 mutants 
16.5% SDS-PAGE image showing IMAC fractions containing purified D7 (cysteine) 
mutants with reference to a protein ladder (left) showing possible sizes of proteins. D7 
mutants elute both as a monomer (12.7kDa) and dimer (25kDA) in both L4 mutants c81s 
and c85s (top) indicated by appropriate arrows. β-sheet mutants c35s (top) and c48s 
(bottom) are visible only as monomers. Note that upper arrow refers to dimer and lower 
arrow refers to monomer of D7 mutant. Each lane in SDS-PAGE corresponds to different 
elution fractions per D7 mutant (7.1.3.1, 10 mM BME). 
 
c35s and c48s point mutants were purified using SEC and concentrated with P4 
and crystal trials were laid down. There were no crystals, probably from the 
persistence of oligomerisation at high concentrations (Figure 3.21).  
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Figure 3.21 SDS-PAGE image of β-sheet mutants 
16.5% SDS-PAGE image showing (concentrated) D7 mutants c35s and c48s (right) 
treated with P4 in comparison to untreated D7 used as a control (center) with protein 
ladder (left) showing possible sizes of proteins. The black arrows refer to established D7 
monomer and dimer sizes. c48s lacked the dimer band but showed some kind of 
oligomerisation (red arrow). 
 
It was decided to make a double mutant (DM) with both cysteines at positions 35 
and 48 replaced with serines to eliminate the dimerization seen at high 
concentrations. DM was produced using a new vector pPROEX-HTb as part of 
the optimisation for expression in E. coli. Creating a DM however did not 
eliminate the dimer (Figure 3.22). An alternative strategy of modifying β-sheet 
mutants from serines to alanines (c35a, c48a) did not have satisfactory results at 
higher concentrations either (Figure 3.23). 
 
 
Figure 3.22 SDS-PAGE image of DM at high concentrations 
Chapter Three 
 
95 
16.5% SDS-PAGE image showing (concentrated) DM at different concentrations with 
protein ladder (left) showing possible sizes of proteins. The black arrows refer to 
established D7 monomer and dimer sizes. Note that there are two bands in the 
monomer and dimers bands which is the result of DM with and without a cleaved histag 
(from pPROEX, 7.1.3.1, 10 mM BME). 
 
 
Figure 3.23 SDS-PAGE image of D7 (β-sheet) alanine mutants 
16.5% SDS-PAGE image showing (SEC purified) D7 mutants c35a and c48a with protein 
ladder (left) showing possible sizes of proteins. The black arrows refer to established D7 
monomer and dimer sizes. Each lane in SDS-PAGE corresponds to different elution 
fractions per D7 mutant (7.1.3.1, 10 mM BME). 
 
Replacement of remaining cysteines (L4) with serines was pursued as a last 
attempt to eliminate oligomerisation but the binding affinity for P4 was 
compromised as assessed by ELISA (3.2.6). 
 
3.2.5 Functional characterisation of D7 mutants: FTSA 
Protein stability of D7 and the cysteine mutants was assessed using Fluorescent 
Thermal Shift Assays (FTSA) (Boivin et al., 2013). D7 and the mutants were 
subjected to thermal shift assays using SYPRO-orange dye in Rotor-gene Q-PCR 
machine. The principle of a thermal shift assay is that when the protein is heated 
to high temperatures, it unfolds and the dye binds to the hydrophobic residues and 
fluoresces (Niesen et al., 2007). The melting temperature (Tm) which is the 
temperature at which half of the protein completely unfolds (reflected by midpoint 
of maximum fluorescence) is used to gauge the stability of a protein. This is easily 
visualized by δF/δT which is the change in fluorescence (δF) with change in 
temperature (δT) (Bohling et al., 1999). Thermal shifts showed that all D7 
mutants were stable, reflected by Tm values similar to that of D7 (65.8°C, Figure 
3.24) (Gandham et al., 2015). 
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The δF/δT (Y-axis) 
during a thermal shift 
assay at increasing 
temperatures (X-axis) 
has been shown for D7 
and mutants (c35s, c48s, 
c81s and c85s). The Tm 
for all four mutants are 
similar (63°- 68°C) to 
that of OBody D7 
reflecting their stability. 
Replicates were not 
used. However, this 
experiment was 
repeated independently 
at least two times (7.3). 
 
Figure 3.24 Fluorescent Thermal Shift Assays of D7 and mutants 
Chapter Three 
 
97 
3.2.6 Functional characterisation of D7 mutants: ELISA 
Binding affinity of D7 and mutants were assessed using Enzyme Linked 
Immunosorbent Assay (ELISA) (Friguet et al., 1985, 1995; Hardy et al., 1997; 
Isobe & Nakao, 2003). To establish the sensitivity and specificity of D7 binding 
to P4, an ELISA (Bodmer et al., 1989) was performed with immobilized 
biotinylated P4 (on a streptavidin 96 well microplate) using D7 in different pH 
buffers (pH 4-7), and the specificity of D7 (to P4) was tested with the same buffer 
range but with immobilized biotinylated E2. 
3.2.6.1 Binding of D7 to P4 
The binding of D7 to P4 varied along pH 4-7 in a linear fashion assessed by 
equilibrium binding curves for different pH values (Figure 3.25). The binding 
curve (for a certain pH value) was generated by incubating varying concentrations 
of protein (D7) with constant concentrations of the ligand (P4) and the 
concentration of D7 in complex with P4 is directly reflected by the absorbance at 
450nm (Abs450) from the ELISA colorimetric reaction (Pollard, 2010). The 
equilibrium binding curve (for a certain pH) is then used to calculate the 
equilibrium dissociation constant (Kd) which is reflective of the affinity of protein 
for the ligand (at that certain pH). The lower the Kd (nM) the higher the binding 
affinity between protein and ligand (Heinrich, Tissot, Hartmann, & Cohen, 2010). 
This is seen in increasing affinity of D7 to P4 with decrease in pH; Kd = 133 nM 
(pH 4), 145 nM (pH 5), 312 nM (pH 6) and 405 nM (pH 7). There was complete 
loss of D7 binding to P4 at pH 9. The calculated parameters for non-linear 
regression model of the experimental data is summarized in Table 1. 
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Figure 3.25 Equilibrium binding curves of D7 to P4 from pH 4 to 9 
The binding curves at equilibrium from ELISA of D7 with immobilized P4 is shown for 
different pH with their calculated binding affinity (Kd) using Graphpad Prism for non-
linear regression (right). Absorbance at 450nm (Y-axis) and D7 concentration in nM 
(X-axis) for the binding curves from ELISA colorimetric reaction is shown. Raw ELISA data 
is provided in appendix (7.4.1).  
 
Table 3.1 ELISA of OBody D7 at different pH 
The table shows Graphpad prism generated values for non- linear regression from ELISA 
data for OBody D7 binding to P4 at different pH. The standard error and 95% confidence 
intervals (nM) refer to the binding affinity (Kd). R square is an important parameter 
indicating goodness of fit of the binding curve to experimental data. The values closer to 
1 indicate a good fit.  
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Non-linear fit pH 4 pH 5 pH 6 pH 7 pH 9 
Bmax 
(Abs450) 
3.11 2.48 2.21 2.54 Very 
low 
Kd (nM) 133.8 145.3 312.3 502.6 No 
binding 
Std. Error 
(nM) 
27.39 24.36 45.95 214.1 N/A 
95% conf. int 
(nM) 
77.52 – 
190.1 
95.21 – 
195.4 
217.8 – 
406.7 
62.44 – 
942.7 
N/A 
R square 0.97 0.98 0.99 0.93 N/A 
 
3.2.6.2 Specificity testing of D7 to P4 and E2 
The specificity of D7 to P4 was tested by replacing P4 with a similar small 
molecule E2 under the same pH conditions. At lower pH values (pH 4) there was 
a loss of specificity as D7 bound to both immobilized P4 and E2 but at a higher 
pH (pH 7) specificity was restored to P4 (Figure 3.25) and binding to E2 was lost 
(Figure 3.26). Binding of D7 irrespective of the ligands was strongest at lower pH 
values.  
 
Figure 3.26 Equilibrium binding curves of D7 to E2  
The binding curves (per pH) at equilibrium from ELISA of D7 with immobilized E2 is 
shown at pH 4 and pH 7 with the calculated binding affinity (Kd) using Graphpad Prism 
for non-linear regression (right). Absorbance at 450nm (Y-axis) and D7 concentration in 
nM (X-axis) for the binding curves from ELISA colorimetric reaction is shown (left) and Kd 
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values (right) are 143.6 nM (pH 4) for E2. Note loss* of D7 binding affinity to E2 at pH 7. 
Raw ELISA data is provided in appendix (7.4.2). * The binding curve for D7 binding to E2 
shows no saturation.  
 
P4 and E2 are predominantly hydrophobic molecules and it is highly likely that 
OBody D7 has predominantly hydrophobic interactions with P4 and E2. This is 
observed by strong binding of D7 to both P4 and E2 at pH 4. However, at pH 7 
binding of P4 to D7 is maintained but binding of E2 to D7 is lost. This is possibly 
due to the loss of a favourable electrostatic interaction with increase in pH of 
buffer, possibly due to the titration of an acidic or basic amino acid. The possible 
acidic amino acids for the range pH 4 to pH 7 are aspartic acid and glutamic acid 
and one basic amino acid histidine. The only non- hydrophobic parts of P4 and E2 
are the different polar groups at their end positions (3.1.1). The binding of P4 and 
E2 to D7 was tested with salt (500 mM NaCl) at pH 4 and pH 7 to shield charged 
interactions between these small molecules and OBody D7 (Figure 3.27). The 
binding of P4 to D7 from pH 4 to pH 7 is minimally disrupted by salt (500 mM 
NaCl, Figure 3.27) as expected (3.2.6.1) unlike loss of binding of E2 to D7 at pH 
4 (E2 does not bind to D7 at pH 7) confirming that there is a significant charged 
interaction involved in the binding of E2 to D7. It is important to note that at pH 
4, the acidic amino acids are not charged and histidine is positively charged (pKa 
of histidine side chain = 6.04). This suggests that the involved amino acid is 
histidine due to salt disruption of D7 binding to E2 at pH 4 (Jifeng Zhang 2012). 
 
Figure 3.27 Equilibrium binding curves of D7 to P4 and E2 with high salt 
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The binding curve (per pH) at equilibrium from ELISA of D7 with immobilized P4 and E2 
are shown at pH 7 + 500 mM NaCl and pH 4 + 500 mM NaCl (left) and calculated binding 
affinity (Kd) using Graphpad Prism for non-linear regression are shown (right). 
Absorbance at 450nm (Y-axis) and D7 concentration in nM (X-axis) for the binding curves 
from ELISA colorimetric reaction is shown (left) and Kd values (right) show 369.3 nM 
(pH4 + 500 mM NaCl) and 405.2 nM (pH 7 + 500 mM NaCl) for P4 and no* binding (pH 4 
+ 500 mM NaCl) for E2. Raw ELISA data is provided in appendix (7.4.2). * The binding 
curve for D7 binding to E2 shows no saturation.  
 
My hypothesis was confirmed by D7 binding to P4 being relatively unaffected 
(pH 4 + 500 mM NaCl, pH 7 + 500 mM NaCl) (Figure 3.27) whereas loss of D7 
affinity to E2 was observed at pH with highest binding affinity (pH 4 + 500 mM 
NaCl). No ELISA was done for D7 binding to E2 at pH 7 since there is no affinity 
between them. The calculated parameters for non-linear regression model of the 
experimental data is summarized in Table 2.  
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Table 3.2 ELISA of OBody D7 with different targets 
The table shows Graphpad prism generated values for non- linear regression from ELISA data for OBody D7 binding to P4 and E2 at different pH and salt 
(500 mM NaCl). The standard error and 95% confidence intervals (nM) refer to the binding affinity (Kd). R square is an important parameter indicating 
goodness of fit of the binding curve to experimental data. The values closer to 1 indicate a good fit.  
 
Non-linear fit Progesterone (P4) Estradiol (E2) 
 pH 4 pH 4 + 500 mM 
NaCl 
pH 7 pH 7 + 500 
mM NaCl 
pH 4 pH 7 pH 4 + 500 
mM NaCl 
Bmax (Abs450) 3.11 3.09 2.54 2.76 2.83 Very low 0.78 
Kd (nM) 133.8 369.3 502.6 405.2 143.6 Not binding Low binding 
Std. Error (nM) 27.39 65.98 214.1 57.02 31.77 N/A N/A 
95% conf. int (nM) 77.52 – 190.1 233.7 – 505 62.44 – 942.7 288 – 522.5 78.28 – 208.9 N/A N/A 
R square 0.97 0.99 0.93 0.99 0.97 0.82 0.99 
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3.2.6.3 ELISA with D7 mutants 
Therefore pH 7 was established as the buffer standard for determining the Kd of 
D7 mutants since it had a good balance of sensitivity and specificity to P4. β sheet 
mutations (c35s and c48s) retained affinity to P4 whereas L4 mutant (c81s) lost 
affinity to P4, which was shown by ELISA (Figure 3.28) with Kd = 394 nM (c35s) 
and 1 μM (c48s).  
 
 
Figure 3.28 Equilibrium binding curves of D7 mutants to P4 
The binding curves at equilibrium from ELISA of D7 and mutants (C35S, C48S and C81S) 
with immobilized P4 at pH 7 is shown (left) and calculated binding affinity (Kd) using 
Graphpad Prism for non-linear regression are shown (right). Absorbance at 450nm 
(Y-axis) and D7 or mutant concentration in nM (X-axis) for the binding curves from ELISA 
colorimetric reaction is shown (left) and Kd values (right) show no* affinity with loop (L4) 
mutant (c81s). Raw ELISA data is provided in appendix (7.4.3). * The binding curve for 
c81s binding to P4 shows no saturation. 
 
Interestingly, these experiments were conducted with alanine mutants (C35A and 
C48A) in a ‘reverse’ system where constant concentration of D7 mutants were 
immobilized on the 96 well microplate and varying concentrations of 
(biotinylated) P4 was used to produce colorimetric reaction (Figure 3.29) 
(Bodmer et al., 1989). A double mutant of the same cysteines (DM, C35S: C48S) 
was also compared to D7 mutants with the same system. Both ELISA systems 
confirmed the finding that the loop (L4, C81S) was critical for binding of D7 to 
P4 and extensive modification of the β- sheet cysteines (DM, serine and alanine 
mutants) retained binding to P4. 
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Figure 3.29 Equilibrium binding curves of D7 mutants to P4 (reverse ELISA) 
The binding curves at equilibrium from ELISA of immobilized D7 mutants (C35A, C35S, 
C48A, C48S and DM) with increasing concentrations of P4 at pH 7 is shown with legend 
(top land bottom) and calculated binding affinity (Kd) using Graphpad Prism for non-
linear regression are shown (box). Absorbance at 450nm (Y-axis) and P4 concentration in 
μM (X-axis) for the binding curves from ELISA colorimetric reaction are shown (top and 
bottom). Raw ELISA data is provided in appendix (7.4.3). The calculated parameters for 
non-linear regression model of the experimental data is summarized in Table 3. 
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Table 3.3 ELISA of OBody D7 mutants to P4 
The table shows Graphpad prism generated values for non- linear regression from ELISA data for OBody D7 or mutant binding to P4. The standard error and 
95% confidence intervals (nM) refer to the binding affinity (Kd). R square is an important parameter indicating goodness of fit of the binding curve to 
experimental data. The values closer to 1 indicate a good fit. The values in parenthesis refer to the reverse ELISA statistics. 
 
Non-linear fit D7 C35S  C48S  C81S DM C35A C48A 
Bmax (Abs450) 3.66  2.15 (2.92) 2.96 (2.95) 1.52 (1.09) (2.78) (2.79) 
Kd (nM) 589.1  394.3 (716.3) 1040 (434.2) low binding (2436) (806) (700) 
Std. Error (nM) 98.04 85.76 (81.72) 240.8 (34.62) N/A (499) (91.34) (64.92) 
95% conf. int (nM) 387.5 – 790.6  218 – 570.7 
(549.6 – 882.9) 
544.9 – 1535 
(363.6 – 504.8) 
N/A (1422 – 3450) (619.7 – 992.2) (567.7 – 832.6) 
R square 0.99   0.98 (0.9584) 0.99 (0.98) 0.90 (0.9) (0.96) (0.97) 
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3.2.6.4 Comparison with anti-P4 antibody (Ab) 
An ELISA was designed where varying concentrations of a commercial anti-P4 
antibody (Ab) was used instead of an OBody (D7), with a constant concentration 
of immobilized P4 to validate the ELISA system and compare an anti-P4 antibody 
(Figure 3.30) with the anti-P4 OBody (D7) at a favourable pH for the antibody 
(pH 7) (Reverberi & Reverberi, 2007).  The Ab had a Kd (=59 nM) two-fold 
stronger than the best value obtained for D7 at low pH (Kd=133.8 nM at pH 4, 
Figure 3.25). 
 
 
Figure 3.30 Equilibrium binding curve of anti-P4 antibody (Ab) to P4 
The binding curve at equilibrium from ELISA of Ab with immobilized P4 at pH 7 is shown 
with legend (left) and calculated parameters using Graphpad Prism for non-linear 
regression are shown (right). Absorbance at 450nm (Y-axis) and Ab concentration in nM 
(X-axis) for the binding curve from ELISA colorimetric reaction is shown (left) and Kd is 
59.6 nM (right). Raw ELISA data is provided in appendix (7.4.4). 
 
3.2.7 MBP fusion to D7 for crystallization 
The next strategy for crystallization was fusion of D7 to affinity tags such as MBP 
which is a 40 kDa protein (Smyth, Mrozkiewicz, McGrath, Listwan, & Kobe, 
2003) and has been successful in crystallizing difficult proteins in the past (Costa, 
Almeida, Castro, & Domingues, 2014; Hayhurst, 2000; Kapust & Waugh, 1999; 
Moon, Mueller, Zhong, & Pedersen, 2010; Nallamsetty & Waugh, 2006; Waugh, 
2016). Therefore the pOPIN system was employed for fusing MBP to D7 (7.2.3) 
with the goal of increasing solubility further and improving crystallization 
properties (Berrow et al., 2007). The molecular weight (MW) of the hybrid 
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protein was calculated to be ~54 kDa (MBP-D7, including non-cleavable histag). 
However, the SDS-PAGE gel image showed the protein band at a lower level at 
50 kDa (Figure 3.31, B) but a second band was seen at double the size (~100 kDa) 
indicating the (intermolecular disulfide based) dimeric nature of D7. MBP without 
fusion OBody showed a similar lower band midway between 37 and 50 kDa 
(Figure 3.31, C) confirming that the success of fusion of MBP and Obody D7.  
MBP-D7 was purified first using IMAC (Histrap, Figure 3.31) and then by SEC 
(S75 16/600, Figure 3.32) similar to previously employed protein purification 
protocol, the latter indicating the oligomerisation nature of D7 (third band at ~ 
200 kDa). Crystallization trials did not yield any success and MBP-D7 
precipitated at high concentrations similar to its non-MBP fusion counterpart. 
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Figure 3.31 UV elution profile and SDS-PAGE: IMAC purified MBP-D7 
The top image shows the UV absorbance curve (blue, 280nm) in mAU (left y-axis) 
showing the elution of MBP-D7 over an imidazole gradient (red) in percentage (right y-
axis) during Histrap (IMAC) purification. The blue peak indicates maximum MBP-D7 
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elution. The x-axis refers to the flow of IMAC buffers (7.1.3.1, 10mM BME) containing 
imidazole. IMAC is explained in detail in 2.2.2.1. The middle (B) image is 16.5% SDS-PAGE 
showing IMAC fractions containing purified MBP-D7 with reference to a protein ladder 
(left) showing possible sizes of proteins and D7 as a second reference (right) with 
numbered protein sizes of interest. MBP-D7 (arrows) elutes as a monomer (54kDa, 2) 
and dimer (110kDA, 1) similar to its non-MBP counterpart D7 (monomer,12.7kDa, 4 and 
dimer, 25kDa, 3). The bottom image (C) shows only purified MBP similar to (B). Note 
that the lanes of MBP-D7 with strong dimer in SDS-PAGE (B) correspond to the elution 
fractions of UV peak in IMAC. 
 
 
Figure 3.32 UV elution profile and SDS-PAGE: SEC purified MBP-D7 
The elution profile of MBP-D7 (top image) on S75 16/600 column shows a single peak 
corresponding to the monomer (54 kDa). Y-axis is the intensity of absorbance by 
aromatic rings of protein at 280nm in milli-Absorbance Units (mAU). X-axis is the volume 
(ml) of buffer (7.1.3.1, 10 mM BME) the protein elutes at and is inversely proportional to 
the size (MW) of the protein in solution (Hong et al., 2012). A 16.5% SDS-PAGE (bottom 
image) is showing S75 16/600 (SEC) fractions containing purified MBP-D7 with reference 
Chapter Three 
 
110 
 
to a protein ladder (left) showing possible sizes of proteins. MBP-D7 still elutes as a 
monomer (54kDa) and dimer (110kDA) both indicated by arrows similar to its non-MBP 
fusion counterpart D7 (not shown here). Note a possible oligomer band at ~ 200 kDa. 
Note that the lanes in SDS-PAGE correspond to the elution fractions of UV peak in SEC. 
 
3.3 Discussion 
Structural characterisation of OBody (D7) with ligand progesterone (P4) involves 
growing protein crystals. One of the key requirements for crystallization is protein 
solubility (Gosavi et al., 2008) and monodispersity (Dale et al., 2003). 
Crystallization trials showed that D7 aggregated at high concentrations and was a 
mixture of monomers, dimers and possibly higher oligomers (as seen in 
SDS-PAGE). This is most likely due to mixed intermolecular disulphide bonds. 
This was interesting since the OBody D7 which was assembled in the oxidising 
periplasmic environment of E.coli TG1 (which favours formation of disulfides), 
expressed as a dimer in the reducing cytoplasmic expression strain of E.coli BL21. 
However, reduction of OBody D7 with reducing agents did not affect P4 binding. 
 
Intra-molecular disulfide bonds have been known to be thermodynamically 
favourable for protein folding as it minimizes the search for lowest free energy 
conformation state (Chuang, Chen, Yang, Lyu, & Hwang, 2003). Disulfide bonds 
are only formed in the oxidizing environment of the periplasm in E.coli and their 
correct formation is catalyzed by two enzymes DsbA and DsbC oxidoreductases 
(Figure 3.33)(Trivedi et al., 2009). Proteins with disulfides are possible only if it 
is beneficial for proper folding, and are formed with the help of chaperone DsbA 
(Baneyx & Mujacic, 2004). Non-native disulfides are eliminated or repaired by 
chaperone DsbC (Qin, Wang, & Thirumalai, 2015). 
 
Figure 3.33 Protein folding in the periplasm 
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An illustration of proteins (brown thread like structure) translocating through the inner 
membrane (IM) into the periplasm via SecYEG (unfolded protein) and TatABC (folded 
protein) pathways (explained in detail in Figure 1.20) is shown. The unfolded protein 
(containing cysteines) enters the periplasm via SecYEG (Sec Pathway) and chooses the 
following routes: 1) form abnormal disulfides and aggregate 2) form normal disulfides 
with chaperone DsbA and 3) repair of abnormal disulfides with DsbC. DsbB and DsbD 
recharging the chaperones DsbA and DsbC are also shown (S- disulphide, SH- free 
cysteine) [adapted from (Baneyx & Mujacic, 2004)]. 
 
Since OB-folds are highly stable (Zhao, Schmitt, & Fisk, 2016) it is likely that 
disulfides in D7 (Obody) are inter-molecular (dimeric) in nature (Szilágyi, 
Kardos, Osváth, Barna, & Závodszky, 2007). This phenomenon is seen in GFP 
which is a stable protein domain but forms intermolecular (non-native and 
disulphide based) oligomers in the periplasm of E. coli (Aronson, Costantini, & 
Snapp, 2011; Dammeyer & Tinnefeld, 2012).  
 
A conservative approach of in vitro reduction was tried first to improve solubility 
and monodispersity. This included reducing inter-molecular disulfides with DTT 
and BME (reducing agents). Addition of stabilizing ligand (P4) was also tried 
since the binding of a ligand may promote crystallization (Böhm, 2005; Celej, 
Montich, & Fidelio, 2003; Vodnik, Zager, Strukelj, & Lunder, 2011).  
 
ELISA of OBody D7 at different pH values showed a decrease in binding affinity 
for P4 at higher pH and loss of specificity (E2) at lower pH possibly due to loss of 
positively charged interaction. This may be unfavourable with regards to binding 
affinity but favourable with regards to specificity to P4. There are at least six 
histidines in OBody D7 excluding the hexahistidine tag that may be responsible 
for this phenomenon. 
 
When in vitro reduction did not yield satisfactory results, replacement of cysteines 
(mutations) and functional assessment (FTSA, ELISA) of their role in binding to 
P4 were chosen as the next strategy with the goal to improve crystallizability. OE-
PCR has been successful in mutating cysteines (35, 48, 81 and 85) to serines in 
the OBody D7. This led to the assessment of contribution of cysteines to 
dimerization of D7 and its binding to P4.  
 
Removal of all cysteines was not possible as this also deleted P4 binding. A 
protein tag which has been used as a crystallization chaperone – MBP was fused 
to D7 and concentrated. This did improve solubility dramatically as D7 was 
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concentrated up to 70mg/ml. The mono-dispersity was unaffected and did not 
produce any crystals.  
 
The final strategy was to completely eliminate the cysteines but retaining the 
binding affinity to P4. An improvement in D7 affinity to P4 was also desired from 
its comparison with anti-P4 Ab affinity to P4. This can be achieved by a D7 
affinity maturation (phage) library to randomize those regions which have 
cysteines i.e. β2 (c35), β3 (c48) and L4 (c81, c85) to select for cysteine deficient 
OBodies that bind to P4, by phage display (Clementi et al., 2012; Dufner, 
Jermutus, & Minter, 2006). The possible outcome from phage selections with this 
new library will be isolation of clones that are stronger (P4) binding and the 
OBodies that lack cysteines will improve chances of crystallization due to 
improvement in protein solubility (from lack of aberrant intermolecular 
disulfides) (Bondos & Bicknell, 2003) and monodispersity (due to elimination of 
oligomerisation) (Benvenuti & Mangani, 2007).  
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4 Structural and functional characterisation of 
improved anti-progesterone (P4) OBodies  
4.1 Introduction 
There are three techniques to engineer a high affinity binding protein: 1) rational 
mutagenesis based on design 2) computational protein design and 3) directed 
evolution (Tobin, Richards, Callender, & Wilson, 2014). Rational mutagenesis 
refers to using prior biochemical knowledge to improve the structure or function 
of a protein of interest (POI). Computational protein design uses molecular 
simulations based on existing knowledge of related proteins to design POI with 
improved structure or function. There is a lack of prior knowledge of binding 
between an OBody (D7) and the small molecule (P4) and no existing model to 
simulate a stronger P4 binding OBody. This leaves us with directed evolution as 
the optimum strategy to improve on the structure and binding function of this P4-
binding OBody. Directed evolution is a random mutational approach with limited 
knowledge of the (binding surface of) POI to artificially select for high affinity 
binding proteins to specific targets (similar to natural selection). This can be 
achieved by random mutagenesis, focused mutagenesis or DNA recombination 
(Packer & Liu, 2015). The crystal structure of an OBody with its ligand P4 would 
enable detailed analysis of the binding interface and enhance optimisation of P4 
binding OBodies. 
 
4.1.1 Directed evolution with phage display 
Phage display is a protein engineering technique which relies on making gene 
libraries of mutants of binding proteins and creating a phenotype-genotype link 
via packaging the gene in phage particles and displaying the translated protein on 
the surface of the phage (Binz et al., 2005; Carmen & Jermutus, 2002; Dufner et 
al., 2006; Hoogenboom, 2005; Packer & Liu, 2015; Rothe, Hosse, & Power, 
2006; Sidhu & Koide, 2007). An artificial selective pressure is introduced to 
isolate mutants that bind to a specific target. These mutants can be recovered, 
amplified and subjected to multiple rounds of selection (or phage selection) to 
select for high affinity binding proteins to the target. When multiple rounds of 
phage selections no longer produce any further stronger binding proteins to the 
specific target (due to isolation of best possible mutants for the particular library 
gene design), the best phage clone representing the highest affinity-binding to the 
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target is sequenced and analysed for further improvement of protein – ligand 
binding. 
 
4.1.2 Affinity maturation with focused mutagenesis and phage display 
Affinity maturation (AM) is a two-step process which consists of somatic 
hypermutation of B-cell receptors (BCR, antibodies) and selection of these B-cells 
with target antigen during the immune response in animals (Weiser et al., 2011). 
This can be artificially replicated by focused mutagenesis via PCR for 
hypermutation and phage display for selection. The best mutant is used as a 
template for the construction of new gene libraries by various strategies of 
randomization based on previous understanding of the binding surface of the 
protein, ranging from random mutagenesis using error-prone PCR (McCullum, 
Williams, Zhang, & Chaput, 2010) to combinatorial mutagenesis focused on 
specific stretches of gene sequences (Hawkins, Russell, & Winter, 1992; Parker, 
Griswold, & Bailey-Kellogg, 2011; Steemson et al., 2014; Verma, Grigoryan, & 
Bailey-Kellogg, 2015) and the gene libraries are used for new rounds of phage 
selection to obtain stronger binding mutants to the target.  
 
OBodies have been characterized to use a specific binding surface for binding 
(Arcus, 2002; Murzin, 1993; Steemson et al., 2014). The P4 binding OBody D7 
has been found to have cysteines on this surface (β-sheets 2 and 3 and loop 4) and 
ELISA of cysteine mutants further indicate their involvement in OBody function 
(Table 3.3). Affinity maturation was planned for optimization of OBody D7 to 
improve its binding affinity to progesterone (P4) and eliminate cysteines to 
improve crystallizability.  
 
4.1.3 Construction of pF and L4 based (AM) libraries  
The OBody D7 was selected from a naïve library using directed evolution via 
phage display. D7 was mutated at the cysteines (C35, C48, C81 and C85) based 
on the prior knowledge of cysteines being responsible for intra or inter-molecular 
disulphide bonds as discussed in chapter 3. Functional characterization of D7 
indicated that cysteines in loop 4 (L4) were critical in P4 binding but did not yield 
crystals possibly due to presence of cysteines and resulting intermolecular 
disulfides. The presence of cysteines in loop four (L4) may be a limiting factor in 
crystallization (due to heterogeneity from dimerisation or instability at high 
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concentrations). Alternatively, the cysteines on L4 may be crucial for P4 binding. 
Thus, construction of AM libraries by focused mutagenesis of loop (L4) and 
another sparing the loop but involving the β-sheets i.e. proximal binding face 
(pF), and selection via phage display were chosen as strategies to improve the 
binding affinity of D7 (Figure 3.14) to P4 and make it more amenable for 
crystallization. 
 
The best mutant was a double cysteine to serine mutant (DM, C35S:C48S) where 
the altered cysteines occurred at positions on the β2 and β3 strands. This OBody 
(DM) was randomized at the loop (L4) for the construction of an AM library 
(L4_DM) with the goal of selecting for higher affinity P4-binding OBodies 
without any cysteines via phage display and to improve crystallizability. Since the 
cysteines in this loop may be critical for binding function, the parallel 
conservative library (pF_35) was designed by eliminating only the cysteines on 
the β- sheets by randomisation of β3 (pF, centered around C48) on another high 
affinity D7 mutant (C35S, 3.2.6.3) leaving the loop intact. 
 
4.2 Results 
4.2.1 Construction of AM library 
4.2.1.1 Point mutations for construction of AM libraries 
Affinity maturation (AM) libraries (pF_35 and L4_DM) were designed to 
improve the binding affinity and crystallizability of D7 (with P4) and is described 
in 2.6. The AM libraries were designed in steps. To prevent ‘carry-over’ of the 
original OBody (D7) in the AM libraries, stop codons were strategically inserted 
into positions 48 and 83 of D7 by OE-PCR to generate pF_stop and L4_stop 
respectively (Figure 4.1). 
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Figure 4.1 DNA sequencing of stop codon insertion into D7 for AM library 
construction   
The DNA sequencing of fused overlap fragments of D7 containing stop codons (pF_stop 
and L4_stop) at position 48 and 83 respectively are shown. The labelled D7 stop mutants 
(left) show the stop codon (TAA) indicated by blue tab. 
 
Point mutations were made in these mutants (pF_stop and L4_stop) using overlap 
primers for C35S thus producing pF_35_stop and L4_35_stop mutants 
respectively using OE-PCR. A point mutation was made in L4_35_stop using 
overlap primers for C48S thus producing L4_DM_stop mutant using OE-PCR. 
 
4.2.1.2 Randomization of AM libraries 
pF_35_stop and L4_DM_stop DNA sequences were used as templates to generate 
overlapping fragments using randomization primers for construction of the 
respective libraries. The primer sets used are pF_forward (or reverse) and 
L4_forward (or reverse) for the appropriate libraries (Figure 4.2). Only the reverse 
(rev) primers had NNK codons where N=G, A, T or C and K= G or T. This 
arrangement allows elimination of stop codons TAA and TGA  in an amber 
(TAG) suppressed E.coli TG1 leading to the possibility of all 20 amino acids 
(Mena & Daugherty, 2005) in the randomized positions. The PCR trials consisted 
of temperature optimisation (50 °C to 57 °C) to generate randomized overlap 
fragments (pF_35_rand_A and L4_DM_rand_A). The annealing temperatures of 
the PCR which gave the best results was 54.6 °C to 56.4 °C for pF_35_rand_A 
and 50.1 °C to 50.8 °C for L4_DM_rand_A. These randomized overlap fragments 
were generated in large quantities to create diversity of DNA sequences.
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The sequence of β-sheet 3 (top) and 
loop 4 (bottom) from pF_35 and 
L4_DM libraries respectively are 
shown as part of larger sequence of 
OBody D7 mutants (labelled). The 
complementary primers (green, for 
OE-PCR) show randomized areas 
(grey, NNK) also highlighted in red. 
The overlapping fragments are 
generated separately with Forward 
primers (left arrows, sequence not 
shown) and pF/L4 reverse (green) for 
forward fragments, and Reverse 
primers (right arrows, sequence not 
shown) and pF/L4 forward (green) 
for reverse fragments. The numbers 
48 and 83 refer to the stop codon 
residues for pF_35 and L4_DM 
respectively shown as TAA (*). The 
extension step (OE-PCR) follows 
using only flanking primers (arrows, 
sequence not shown) to generate 
single randomized pF_35 and L4_DM 
fragments. 
 
 
Figure 4.2 Sequence of randomisation scheme for β-sheet 3 (pF_35) and loop (L4_DM) on D7 stop mutants 
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The non-randomized overlap fragments (pF_35_B and L4_DM_B) were 
generated and fused with the randomized overlap fragments with OE-PCR and 
confirmed (Figure 4.3).  
 
Figure 4.3 DNA sequencing of pF_35 and L4_DM 
The DNA sequencing of fusion of the appropriate overlap fragments with OE-PCR are 
shown with randomized residues shown in red boxes with relation to numbered amino 
acid (E.g. 48) using naïve library OBody D7 as a reference.  
 
These randomized fusion products (insert) were restriction enzyme digested with 
Sac2 and Not1-HF (NEB) as described in 2.5.6. The YscC phagemid (vector, 
from D7) was restriction enzyme digested with the same set of enzymes. The AM 
inserts and YscC phagemid were ligated as described in 2.5.7 and transformed 
into electro-competent E. coli TG1 cells as described in 2.5.8. 
 
4.2.2 Phage selections of AM libraries 
The transformed AM libraries (pF_35 and L4_DM) were pooled and grown as 
explained in 2.6.1.4. The purified rescued phage was precipitated using PEG 
(2.6.1.5) and used for bio-panning against target P4 as explained in 2.6.2. The 
library panning are summarized in Table 4. Hyperphage (M13K07δIII, which 
lacks wild type gIII) was used to rescue phage in early rounds of selections to 
enhance phage display of moderate affinity P4 binding OBodies (Rondot et al., 
2001). The phagemid particles isolated from successive library panning rounds 
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were used for successive phage selections. Streptavidin and neutravidin beads 
were used in alternative selections (to isolate phage via biotinylated P4) to prevent 
selection of non-specific streptavidin binding OBodies (Vodnik et al., 2011). The 
antigen concentration and duration of selection was reduced from round 2 
onwards to facilitate stringent selection conditions for high affinity P4 binding 
OBodies. There is low phage yield after round 4 which possibly indicates loss of 
P4 binding OBodies in subsequent library panning rounds (illustrated in Figure 
4.4). 
  
1
2
0
 
Table 4.1 summary of AM library affinity-screening 
The table summarizes the conditions of phage selection rounds (R1 to R7). Phage from selections are used in successive rounds as shown under input library. 
The phage library volume after blocking with 3%MPBS (ml) and target antigen (biotinylated-P4, uM) is mentioned. The selection beads (streptavidin or 
neutravidin) to isolate phage via biotinylated-P4 and helper phage used for phage rescue are shown. The total input titre (cfu) and output titre (cfu/ml) shown 
are used to calculate the yield (%).  
 
Selection 
round 
(R) 
Input 
library 
Library 
volume 
Antigen 
biotin P4  
Selection 
beads 
Selection 
duration 
(hours) 
Helper phage 
type 
Total input 
titer(cfu) 
 
Output 
titre 
(cfu/ml) 
yield 
R1 AM 0.3 ml 1 uM Streptavidin 2 KM13 1.0E+12 
 
1.9E+04 
 
<0.01 % 
R2 R1 1 ml 4 uM Neutravidin 3.5 M13K07δIII 1.5E+11 
 
5.4E+07 
 
3.6% 
R3 R2 1 ml 2.5 uM Streptavidin 3 M13K07δIII 8.5E+11 
 
1.2E+08 
 
1.4% 
R4 R3 1 ml 2.5 uM Neutravidin 2 KM13 1.8E+13 
 
2.4E+08 
 
0.13% 
R5 R4 1 ml 1.5 uM Streptavidin 1.5 KM13 2.5E+13 
 
1.5E+07 
 
<0.01% 
R6 R5 1 ml 1 uM Neutravidin 1 KM13 4.1E+14 1.8E+07 
 
<0.01% 
R7 R6 1 ml 0.5 uM Neutravidin 0.45 KM13 9.5E+14 1.8E+07 
 
<0.01% 
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Figure 4.4 summarizes the output from phage selections in colony forming units 
(cfu/ml) and shows that there was enrichment of possible P4-binding OBodies 
until round 4 (R4) followed by a significant drop in phage output. This is in 
agreement with the selection pressure where the antigen concentration (μM) and 
duration of incubation (hrs) have been decreased in subsequent selection rounds 
and is reflected by most P4 binding OBodies isolated from R4 and R5 (Table 4.1) 
beyond which there was low recovery of P4 binding OBodies.  
 
Figure 4.4 Bar graph showing phage selection of AM library 
The phage selection rounds (R1-R7, x-axis) of OBodies to P4 are shown as bar charts with 
relation to phage output (cfu/ml, left x-axis). The right x- axis shows both antigen 
concentration (μM, red line) and duration of incubation (hrs, green line) with reference 
to selection rounds. The increase in phage output up to R4 indicates enrichment of 
possible P4 binding OBodies followed by a decrease in phage output indicating loss of 
possible P4 binding OBodies.   
 
4.2.2.1 Phage ELISA and isolation of P4 binding OBodies 
The phagemid particles from library panning rounds were clonally isolated in agar 
plates (C100, 2.6.2.4) and assayed by phage ELISA for binding to P4 as described 
in 2.6.3. The P4 binding OBodies were isolated from three rounds (R4, R5 and 
R7) as illustrated in Figure 4.5. However, R5 showed the highest number of 
Individual OBody clones with high signal in ELISA (~10 times higher than 
background) which indicates selection of specific P4 binding OBodies compared 
to round 4 with the highest phage output (Figure 4.4). It is important to note that 
most of the isolated OBody clones were non-specific in binding and the 
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magnitude of absorbance has no correlation with binding affinity (Bodmer et al., 
1989). 
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Figure 4.5 Phage ELISA of selections 
An illustration of phage ELISA of labelled selection rounds showing Abs450nm (y-axis) 
and individual OBody clones (x-axis and legend). The individual OBody clones are tested 
for p4 binding in duplicates (one with P4 immobilized as test and the other with PBS as 
control). The individual OBody clones are in 96-well format (12x8).  The first three wells 
in column 12 is the positive control (anti-P4 antibody). The positive P4 binding OBodies 
and positive control show high Abs450nm values. 
 
The distinct P4 binding OBodies were confirmed by sequencing using flanking 
primers by PCR as shown in Figure 4.6 (7.2.7). These OBodies have been 
functionally characterised in 4.2.4. 
 
 
Figure 4.6 DNA sequencing of P4 binding OBodies from AM library  
The DNA sequences of P4 binding OBody clones from round 4 (R4) to round 7 (R7) are 
shown (left label) with randomized loops (L4, red box) in relation to numbered amino 
acids (E.g. 83). The best P4 binding OBody B7 is highlighted in green. 
 
4.2.3 Analysis of P4 binding OBodies 
The strong P4-binding OBodies were screened by phage ELISA and confirmed by 
large scale expression and surface plasmon resonance (SPR) analysis. The P4 
binding OBodies screened from phage ELISA mostly consisted of L4 randomized 
OBodies. The amino acid sequence alignment (Figure 4.7) of the selected 
OBodies from the AM libraries shows an L4 with both polar and hydrophobic 
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amino acids with preference towards hydrophobic amino acids especially tyrosine 
(Y) and tryptophan (W) at the periphery, and polar (or charged) amino acids 
especially glutamine (Q) at the center of L4. The OBody B7 is an exception as it 
has charged amino acids in the periphery i.e. histidine (H), glutamic acid (E) and 
aspartic acid (D), and hydrophobic amino acids i.e. tryptophan (W) and proline 
(P) in the center of L4. Overall, there is no consensus in amino acid sequence in 
L4 of selected OBodies from AM library. 
 
 
Figure 4.7 Amino acid alignment of P4 binding OBodies (AM library) 
The amino acid sequence of D7 centered around L4 is shown in comparison to the P4 
binding OBodies selected from AM library. The OBodies are labelled (right) in red. This 
alignment is generated using geneious software showing common amino acid sequences 
(green bar, non-coloured) around L4 (black line). The sequences in L4 are coloured 
based on lack of consensus (blue=polar or charged, red= hydrophobic). 
 
The OBodies selected from AM library were sub-cloned into pPROEX-HTb and 
expressed in E. coli DH5α strain and purified as described in 3.2.1. These P4 
binding OBodies (without cysteines) were purified with IMAC which confirmed 
the correlation between the presence of cysteines and dimerization (4.2.5). They 
purified only as a monomer unlike D7 (which contained cysteines and shows 
dimer and multimer bands on the SDS-PAGE gel). 
 
4.2.4 Surface Plasmon Resonance (SPR) analysis of P4-binding OBodies 
These OBodies were tested for binding affinity (Kd) using SPR due to the ease of 
use and high accuracy at the same time (Van Der Merwe, 2001). D7 and its 
mutant (DM) were analyzed using SPR to establish a standard (Figure 4.8) and 
their Kd values were  within 5-fold of magnitude of ELISA results in Chapter 3 
(Friguet et al., 1995; Hardy et al., 1997; Heinrich et al., 2010). 
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Figure 4.8 Equilibrium binding curves of naïve library OBodies (SPR) 
The binding curves at equilibrium from SPR generated sensorgrams are shown for 
different concentrations of D7 or mutant (DM) binding to biotinylated P4 (ligand) 
immobilized on a SA chip. The y-axis shows the change in refractive index at equilibrium 
(Req, in RU) and the x-axis shows the concentration of analyte (OBody, in μM). The 
relevant statistics are summarized in Table 4. SPR is explained in detail in 2.4.2 and raw 
data provided in appendix (7.5). 
 
It is important to note that it is the difference in magnitude of Req (RU) at varying 
concentrations of analyte that is indicative of binding at equilibrium (not the 
absolute magnitude) similar to Abs 450nm of ELISA (Bodmer et al., 1989). The 
SPR analysis (Figure 4.9) showed that most of the OBodies from AM library had 
a Kd in the same range of D7 (in low μM).  
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Figure 4.9 Equilibrium binding curves of AM library OBodies (SPR) 
The binding curves at equilibrium from SPR generated sensorgrams are shown for 
different concentrations of affinity maturation (AM) library OBodies binding to 
biotinylated P4 (ligand) immobilized on a SA chip. The y-axis shows the change in 
refractive index at equilibrium (Req, in RU) and the x-axis shows the concentration of 
analyte (OBody, in μM). The binding affinity (Kd) of the OBodies is indicated. The 
relevant statistics are summarized in Table 4. SPR is explained in detail in 2.4.2. and raw 
data provided in appendix (7.5). 
 
The analyzed OBodies from the AM library have been summarized with relation 
to D7 and two of its mutants (C35S, DM) in Table 5. All selected OBodies lack 
cysteines except clone G5 from round 7 (R7) which has the same L4 sequence as 
G10 and shows a re-selection of cysteines on β2 and β3. However, there was an 
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increase in binding affinity in G5 (Kd ~ 2.7 μM) as compared to G10 (Kd ~ 7.3 
μM) thus indicating a contributory role of cysteines (in β-sheets) in binding of 
OBodies to P4. 
 
Table 4.2 SPR of P4 binding OBodies 
The table shows Graphpad prism generated values for non- linear regression from SPR 
data for AM OBody binding to P4. The standard error and 95% confidence intervals (μM) 
refer to the binding affinity (Kd). R square is an important parameter indicating 
goodness of fit of the binding curve to experimental data. The values closer to 1 indicate 
a good fit. The values of another independent SPR analysis of OBody B7 is provided in 
parenthesis. 
 
Non-linear 
fit 
D7 DM B7 G10 G5 E1 
Bmax 
(Abs450) 
66.8 24.19 259.4 
(230.6) 
246.6 310.5 125.4 
Kd (μM) 2.69 2.71 3.86 
(2.68) 
7.32 2.73 3.05 
Std. Error 
(μM) 
0.21 0.46 0.54 
(0.35) 
0.40 0.25 0.4 
95% conf. 
int (μM) 
2.24 – 
3.14 
1.73 – 3.7 2.67 – 
5.05 
(1.91 – 
3.44) 
6.45 – 
8.2 
2.19 – 3.28 3.31 – 
5.05 
R square 0.99 0.97 0.98 
(0.9831) 
1 0.99 1 
 
4.2.5 Large scale expression and purification of B7   
The OBody B7 (7.2.4) from L4 based AM library expressed in high yield and 
lacked cysteines with binding affinity comparable to D7 (Kd = 2.7 μM, SPR). 
Therefore, B7 was chosen for crystallization trials and expressed in E. coli BL21 
(DE3, pPROEX, 7.2.5) strain using standard bacterial media (2xYT, LB) and 
purified by Immobilized metal affinity Chromatography (IMAC, Figure 4.10 and 
4.11) and size exclusion chromatography (SEC, Figure 4.12 and 4.13) using 
standard buffers (TBS, PBS) similar to 3.2.1.  
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Figure 4.10 Purification of B7 on Histrap column 
The UV absorbance curve (blue, 280nm) in mAU (left y-axis) shows the elution of B7 
over an imidazole gradient (red) in percentage (right y-axis) during Histrap (IMAC) 
purification. The blue peak indicates maximum B7 elution. The x-axis refers to the flow 
of IMAC buffers (in ml, first 15ml of binding buffer followed by elution buffer containing 
imidazole, 7.1.3.1). IMAC is explained in detail in 2.2.2.1. 
 
 
Figure 4.11 SDS-PAGE image of Histrap purified B7 
16.5% SDS-PAGE image showing Histrap (IMAC) fractions containing purified B7 with 
reference to a protein ladder (left) showing possible sizes of proteins. B7 elutes as a 
monomer (14.5 kDa, arrow). Note that each lane in SDS-PAGE containing OBody B7 
corresponds to elution fractions of UV peak in IMAC. 
 
The OBody B7 was expressed in large amounts and was highly stable compared 
to its predecessor OBody D7 presumably due to lack of cysteines. Purification 
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confirmed loss of dimerization (as compared to D7) with 16.5% SDS-PAGE 
(Figure 4.11 and 4.13) and confirmed the size of the monomer (B7 = 14.5kDa).  
 
 
Figure 4.12 Purification of B7 on S75 16/60 column 
The UV absorbance curve (blue, 280nm) in mAU (y-axis) shows the elution of B7 during 
S75 16/600 (SEC) purification. The x-axis refers to the flow of SEC buffer (in ml, 7.1.3.1). 
The blue peak indicates maximum B7 elution and corresponds to the size of monomer 
(14.5 kDA). SEC is explained in detail in 2.2.2.2.  
 
 
Figure 4.13 SDS-PAGE image of S75 16/600 purified B7 
16.5% SDS-PAGE image showing S75 16/600 (SEC) fractions containing purified B7 with 
reference to a protein ladder (left) showing possible sizes of proteins. B7 elutes as a 
monomer (14.5 kDa) indicated by an arrow between 10 and 15 kDa. Note that each lane 
in SDS-PAGE containing OBody B7 corresponds to elution fractions of UV peak in SEC 
with the exception of IMAC (Ni) fractions. 
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The OBody B7 was concentrated and incubated with P4 (as described in 2.2.4) 
and crystal trials were put down with PEGRx HT - HR2-086, Crystal Screen HT - 
HR2-130, Index HT - HR2-134, and SaltRx HT - HR2-136 as described in 2.3.1. 
The crystals from these trials were grown in larger volumes by varying the pH and 
concentration of precipitant of the mother liquor. The larger crystals tested on 
X-ray diffractometer did not diffract or were salt crystals (2.3.2). Crystallization 
attempts included removal of N-terminal histag using recombinant tobacco etch 
virus protease (rTEV) and expression with short C-terminal histag using pET28b 
plasmid. This did not lead to growth of protein crystals and fusion to 
crystallization chaperone (MBP) was undertaken with the hopes of crystallization 
of this P4 binding OBody. 
 
4.2.6 Fusion of crystallization chaperone MBP to OBody B7 (MBP-B7) 
The OBody B7 was fused to MBP (7.2.6) successfully using the pOPIN system as 
described in 3.2.7.  It was purified with IMAC (Figure 4.14) and SEC (Figure 
4.15) similar to 4.2.5. 
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Figure 4.14 Purification of MBP-B7 on Histrap column 
The top image shows the UV absorbance curve (blue, 280nm) in mAU (left y-axis) 
showing the elution of MBP-B7 over an imidazole gradient (red) in percentage (right 
y-axis) during Histrap (IMAC) purification. The blue peak indicates maximum MBP-B7 
elution. The x-axis refers to the flow of IMAC buffers containing imidazole (7.1.3.1). 
IMAC is explained in detail in 2.2.2.1. The bottom image is 16.5% SDS-PAGE showing 
Histrap (IMAC) fractions containing purified MBP-B7 with reference to a protein ladder 
(left) showing possible sizes of proteins. The arrow indicates the size of this hybrid 
protein (~54 kDa). Note that two lanes in SDS-PAGE containing MBP B7 correspond to 
elution fractions of UV peak in IMAC. 
 
The SEC elution of MBP-B7 showed two peaks and as there are no cysteines 
(Figure 4.15) this is possibly due to non-covalent association/oligomerisation 
(Gotte & Libonati, 2014; Hashimoto & Panchenko, 2010; Nishi, Hashimoto, 
Madej, & Panchenko, 2013). The SDS-PAGE analysis of the OBody fused to 
MBP showed an extra band (high MW peak, red arrow) above the 75 kDa level 
but most of the MBP-B7 eluted as monomer (black arrow, 54 kDa). Both peaks 
were separately subjected to crystallization trials (as described in 2.3).  
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Figure 4.15 Purification of MBP-B7 on S75 16/60 column 
The top image shows UV absorbance curve (blue, 280nm) in mAU (y-axis) showing the 
elution of MBP-B7 during S75 16/600 (SEC) purification. The low MW peak indicates 
maximum MBP-B7 elution (black arrow). The x-axis refers to the flow of SEC buffer (in 
ml, 7.1.3.1). The UV curve did produce two peaks with trace oligomerisation (non-
covalent) possibly producing the high MW peak (red arrow). SEC is explained in detail in 
2.2.2.2. The bottom image is 15% SDS-PAGE showing S75 16/600 (SEC) fractions 
containing purified MBP-B7 (black arrow) with reference to a protein ladder (left) 
showing possible sizes of proteins. The fractions represent MBP-B7 with relation to SEC 
elution (high and low MW peaks). MBP-B7 elutes as a monomer (54 kDa) indicated by a 
black arrow between 50 and 75 kDa. Note extra band above 75 kDa (high MW peak, red 
arrow) which is possibly due to non- covalent oligomerisation of MBP-B7.  
 
The MBP-B7 from the low MW peak (Figure 4.15) produced protein crystals for 
the first time (after incubation with P4) that diffracted to a resolution of ~8 Å 
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using the sealed source X-ray diffractometer (XRD) at the University of Waikato. 
These crystals were then sent to the Australian Synchrotron to collect diffraction 
data to solve the crystal structure of MBP-B7 with P4. The MBP-B7 crystals from 
the low MW peak (~54 kDa) were tested for retention of binding (via B7) to P4 
using SPR. Interestingly, SPR showed the Kd of MBP- B7 (688 nM, Figure 4.16) 
to be 4.3 times higher than B7 alone. (Kd = 2.7 μM).  
  
 
Figure 4.16 Equilibrium binding curve of MBP-B7 using SPR 
The binding curve at equilibrium from SPR generated sensorgram is shown for different 
concentrations of MBP-B7 binding to biotinylated P4 (ligand) immobilized on a SA chip. 
The y-axis shows the change in refractive index at equilibrium (Req, in RU) and the x-axis 
shows the concentration of analyte (OBody, in μM). The relevant statistics are 
summarized in the right. SPR is explained in detail in 2.4.2.  
 
4.2.7 Crystal structure of fusion protein (MBP-B7) with progesterone (P4) 
4.2.7.1 Crystal conditions 
MBP-B7 was incubated with P4 (in a ratio of 1:1 as described in 2.2.4) and 
concentrated to ~65 mg/ml and crystallization screens were put down in drops of a 
1:1 ratio as described in 2.3.1. PEG 24 (30% w/v PEG monomethyl ether 2000, 
0.1M Tris pH 8, Figure 4.17B) and PEG 33 (28% w/v PEG 4000, 0.1M Tris pH 8, 
Figure 4.17A) are conditions from PEGRx HT (HR2- 086) screen that produced 
diffracting protein crystals (Smyth et al., 2003). These conditions were refined 
using a grid format in 6x4 large well plates with the precipitant (PEG 4000 or 
PEG monomethyl ether 2000) ranging from 24 to 34% w/v and pH values ranging 
from 7.9 to 8.2.  
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Figure 4.17 Crystals of MBP-B7 (with P4) under X-ray diffraction 
An image of MBP-B7 (left, with P4) crystals under an optical microscope (Nikon SMZ800) 
shows crystals of different sizes in the 2 μl crystal drop (1:1) containing protein with PEG 
33 (A) or PEG 24 (B)(# HR2-086). A X-ray diffraction image from the best diffracting 
crystal for each condition are also shown (right) i.e. 2.5 Å dataset (A) and 1.9 Å dataset 
(B) collected at the Australian Synchrotron.  
 
4.2.7.2 Data processing 
The raw diffraction data (collected at the Australian synchrotron, 7.6) were 
indexed using iMOSFLM (2.3.3.1) and integrated using aimless software 
(2.3.3.2). The data collection statistics (Table 6) showed that both crystal 
conditions PEG 24 (30% w/v PEG monomethyl ether 2000, 0.1M Tris pH 8) and 
PEG 33 (28% w/v PEG 4000, 0.1M Tris pH 8) from PEGRx HT (HR2- 086) 
screen produced crystals that belonged to P21 space group (2.3.3.1). The best 
condition to solve the crystal structure of B7 with P4 was PEG 24 (30 % w/v PEG 
MME 2000, 0.1M Tris pH 8) due to two reasons i.e. the dataset was of higher 
resolution (1.9 Å) and does not have significant crystal pathology like twinning 
(PEG 33). This 1.9 Å dataset (PEG 24) was processed to a resolution of 2.5 Å and 
showed data completeness of 94.3 % in its highest resolution shell (2.3.3.2). The 
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Rmerge which reflects data quality and the signal to noise (I/sigI) ratio was overall 
within acceptable range ~0.2 (less than 0.8) and 3.9 (greater than 2) respectively 
(Karplus & Diederichs, 2012). The CC ½ was 0.844 at 2.5 Å (i.e. greater than 
0.4)(P. R. Evans & Murshudov, 2013). The phases were estimated using 
molecular replacement with MBP as a model (PDB: 1OMP) (Sharff, Rodseth, 
Spurlino, & Quiocho, 1992) using Phaser (Phenix suite, 2.3.3.3) (P. Evans & 
McCoy, 2008). Similarly, other datasets (belonging to PEG 24 and PEG 33) were 
solved with molecular replacement ranging in resolution from 1.9 Å to 3.5 Å.  
This MR solution from Phaser (which contains the experimentally derived 
intensities and computationally derived phases with relation to the MBP model) 
was used to build an electron density map and model of B7 with model building 
software Auto-build from Phenix suite (2.3.3.4). The solution contained 4 
molecules of MBP-B7 in the asymmetric unit (ASU) consistent with the 
calculated Matthews co-efficient (Matthews, 1968).  
 
Table 4.3 Data collection statistics of OBody B7 
The values in brackets are indicative of highest resolution shell. 
  
Crystal condition PEG 33 (PEG 4000) PEG 24 (PEG MME 
2000) 
Crystal pathology twinning translational NCS 
Space group P 1 21 1 P 1 21 1 
Unit cell (Å) 61.8, 142.8, 109.5 65.9, 193.9, 82.4 
Unit cell (°) 90, 90.37, 90 90, 97.7, 90 
Resolution (Å) 47.59– 2.70 97.11–2.50 
Rmerge 0.153 (1.177) 0.204 (0.518) 
Rpim 0.059 (0.455) 0.100 (0.258) 
Completeness (%) 92.8 (93.8) 98.6 (94.3) 
No. of observations 368459 (33369) 350581 (21103) 
Unique reflections 48648 (4485) 70181 (4303) 
Multiplicity 7.6 (7.4) 5.0 (4.9) 
Average mosaicity 0.36 1.29 
Mean I/sigI 13.3 (2.0) 3.9 (1.9) 
Mean (I) CC (1/2) 0.997 (0.613) 0.978 (0.844) 
No. of molecules in 
asymmetric unit (ASU) 
4 4 
Wavelength (Å) 0.9537 0.95373 
Chapter Four 
 
136 
4.2.7.3 Crystal pathology 
The PEG 24 data had translational NCS (tNCS) which occurs when two or more 
molecules have a symmetry function locally but not as a crystal in the 
translational direction (Dauter & Jaskólski, 2016). Phaser (Phenix) uses maximum 
likelihood approaches for molecular replacement which takes into consideration 
deviations of translation and orientation and assigns it to the same asymmetric 
unit to produce a successful structure solution  (Sliwiak, Jaskolski, Dauter, 
McCoy, & Read, 2014). Refmac5 (CCP4) uses local and global based NCS 
restraints which compensates for local differences in NCS related chains during 
refinement. In this way, the tNCS data was used for final data refinement. 
 
The PEG 33 data had twinning which is a pathology where the diffraction spots 
result from the crystals being in two different orientations (Parsons, 2003; Zwart, 
Grosse-Kunstleve, Lebedev, Murshudov, & Adams, 2008). The intensities of 
diffraction spots in twinned crystals are the result of overlap of diffraction from 
the two orientations and was also resolved using Phaser and refined with intensity 
based twin refinement Refmac5.  This data was used only for initial model 
building and was not included in structure analysis. 
 
4.2.7.4 Data refinement 
The data from PEG 24 was used for solving the structure of OBody B7 bound to 
P4. The refinement of this data was challenging due to tNCS and thus model 
building was initially done with PEG 33 (twinned) data using Auto-build (Phenix 
suite, 2.3.3.4) (Read, Adams, & McCoy, 2013). Auto-build generated only parts 
of OBody B7 with trace skeletal outline of the β-sheets of the β-barrel and parts of 
the α-helix. A previous OBody structure (PDB: 4GLV) was mutated in silico to 
resemble B7 with Wincoot and positioned (and merged) with the model of B7 
(from Auto-build) using Pymol. This hybrid model was used to build the rest of 
B7 by rounds of model building and refinement with Refine from the Phenix 
suite. Small parts of the B7 model could not be built (e.g. flexible loops (L4) and 
the linker adjoining MBP and B7) and were deleted from the hybrid model. The 
partially refined MBP-B7 structure revealed the electron density for the position 
of P4 bound to OBody. Wincoot was used to fit this ligand and refined.  
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The model from this twinned data (PEG 33) was used to construct a final model 
for tNCS (PEG 24) data using refinement with Refmac5 (CCP4 suite, 2.3.3.5). 
The MBP part of the model refined perfectly with tNCS data whereas residues of 
the OBody did not match the electron density. These poorly fitting residues were 
removed and refined in cycles with Refmac5 (CCP4) and Refine (Phenix). This 
led to improvement in overall model and poorly fitting residues were added to 
match the electron density. This resulted in building of the OBody and Rfree was 
26% (lower than 30%) for the final model (Kleywegt & Brünger, 1996; Wlodawer 
et al., 2008). The refinement statistics from the PEG 24 data used to solve the 
MBP-B7 structure with progesterone (P4) has been summarized in Table 7.  
 
Table 4.4 Data refinement statistics of OBody B7 
The table lists out important parameters indicating refinement and summary of best 
dataset.  
 
Crystal condition 
PEG 24 (PEG MME 
2000) MBP-B7 
MBP only 
Rwork 0.22 0.25 
Rfree 0.26 0.29 
Bond length (rms) 0.01 0.01 
Bond angle (rms) 1.66 1.38 
Total no. of atoms 14261 12093 
Total no. of protein atoms 13791 11818 
No. of waters 378 275 
Average B-factors (protein) 32.50 30.8 
Average B-factors (water) 33.59 36.08 
Ramachandran plot    
amino acids in favored 
regions (%) 
89 % 
95.6 % 
amino acids in allowed 
regions (%) 
10.7 % 
4.27 % 
amino acids in disallowed 
regions (%) 
0.3% 
0.13 % 
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4.2.8 Structure of OBody B7 and interaction with P4 
4.2.8.1 Comparison of AM library OBody (B7) to naïve library OBody (D7)  
The affinity maturation (AM) library OBody B7 (4.2.5) is similar in structure to 
naïve library OBody (D7, Figure 3.14) and differs only in six amino acids in the 
loop (L4, Figure 4.18) and lack of cysteines (including proximal binding face, 
pF). The naïve library OBody D7 has a different loop (L4, with cysteines at 
positions 81 and 85) and cysteines at two positions in pF (35 and 48). The 
progesterone (P4) packs against tryptophan (W472) on the opposite side of the 
proximal binding face on the β-barrel of the OBody B7. This OBody-P4 binding 
is expected to be the same for OBody D7 due to same sequence of amino acids at 
the progesterone (P4) binding site. 
 
Figure 4.18 Model of AM OBody (B7) with progesterone (P4) 
A cartoon representation of OBody B7 (green) indicating the mutated loop (L4) with 
residues (yellow), location of eliminated cysteines in β-sheets 2 and 3 (orange) and 
P4 binding site on the other side of β- barrel with the residues binding P4 (cyan) 
constructed using Pymol is shown. The residue numbers are indicated and * refers to 
numbering without MBP (Lys 451 and Trp 472). ** refers to a random mutation during 
phage selection of AM library (S35G). 
 
The 2GPATS OBodies are also similar to 1GPATS OBodies engineered to bind 
HEL by phage display. The models generated from solved structures of OBodies 
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from both generations (B7 and AM3L15) have been superimposed in figure 4.19 
to show the similarities and differences. The r.m.s.d of the backbone atoms 
between the two OBodies is 0.61 Å. The β-barrel and -helix overlap well 
without any change in overall structure. The loops show major differences with 
2GPATS OBody possessing a smaller loop 2 (L2) and a larger loop 1 (L1) and 
loop 4 (L4) when compared to 1GPATS OBody. The design of 2GPATS library 
involved shortening of L2 by two amino acids (removal of GA spacer, figure 3.7) 
and elongation of L4 by addition of two amino acids. This was done due to 
non-involvement of L2 in the binding interface whereas L4 lies in the periphery of 
the binding interface and elongation was hypothesized to contribute in ligand 
binding. However, elongation of L1 was not planned during library design and is 
the result of different amino acids at the intersection of L1 with the β1 and β2 
strands. 
 
 
Figure 4.19 Overlap of 2GPATS OBody (B7) and 1GPATS Obody (AM3L15) 
A cartoon representation of OBody B7 (green) overlapping OBody AM3L15 (red) 
showing the agreement with the overall β-barrel structure and the -helix. The 
differences between these two models lie in the labelled loops indicated by boxes. The 
coloured arrows indicate the loops of the appropriate OBodies.  
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4.2.8.2 Crystal packing of MBP-B7 
MBP-B7 packs as four copies in the asymmetric unit (ASU) of the crystal. The 
ASU is the smallest indivisible part of the crystal which can be used to form a unit 
cell of the crystal by rotation or translation under crystal symmetry (Krissinel & 
Henrick, 2007). The unit cell is required to construct the entire crystal by 
translation in all three dimensions. There is a long flexible linker between MBP 
and OBody B7 allowing MBP molecules to pack together with the B7 occupying 
the space in the cleft between MBP molecules as shown in Figure 4.20. This also 
allows two B7 molecules to form a non-covalent dimer as hypothesized from SEC 
purification of MBP-B7 (Figure 4.15). This is possible via a hydrophobic pocket 
between the B7 monomers which allows for P4 binding and is discussed in 
4.2.8.4. 
 
The arrangement of MBP-OBody fusion proteins leads to formation of 
intermolecular polar bond interactions in two interesting ways. Firstly, there is a 
complementary interaction involving alanine (A379) and glutamine (Q375) of the 
two opposing MBP-B7 linkers as shown in the Figure 4.20. Amino acid 378 is the 
first amino acid of the OBody with methionine (M378) interacting with glycine 
(G376) of the opposing MBP molecule in the MBP-OBody linkers. Secondly the 
alpha helices of the MBP molecules form intermolecular polar bond interactions 
with adjacent opposing OBody molecules (threonine T345-histidine H418 and 
serine S367-tryptophan W400). Most of these interactions are of moderate affinity 
based on the intermolecular distances (~ 2.5 Å) and result in robust crystal 
packing of these molecules. The amino acids that are completely missing from 
any of the four MBP-B7 in the ASU are Y422, S437, P471 and D473. 
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Figure 4.20 Crystal packing of MBP and OBody B7 
 
 A cartoon representation of 
the crystal packing between 
two MBP- OBody fusion 
proteins created with pymol 
is shown. The MBP OBody 
pairs (yellow – cyan and 
brown - green) and the bound 
P4 molecules (pink and blue) 
with colour appropriate labels 
(amino acid and residue 
number) and intermolecular 
polar bond distances are 
indicated. The interaction of 
L474 of two OBodies via a 
water molecule is highlighted 
in red. This is an aerial view of 
the two OBodies (looking 
down the β-barrels, green 
and cyan) stacked against 
each other supported by two 
α-helices of adjacent MBP 
molecules (C- terminal, 
yellow and orange) with the 
adjoining MBP -B7 linkers 
between the two OBodies.   
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Other amino acid residues potentially contributing to the intermolecular 
interaction were assessed by using the PDBePISA tool (Table 4.5). It confirms the 
amino acids already established to interact with P4 (hydrogen bonds) but also 
indicates the binding surface area (BSA) to be dominated by hydrophobic amino 
acids (Phe 374, Trp 382 and Trp 400). Buried surface area is a stronger indicator 
of intermolecular interaction than hydrophobicity (Chen, Sawyer, & Regan, 
2013).   
 
Table 4.5 Interactions between MBP and Obody B7 
The amino acid residues contributing to the intermolecular interaction between two 
MBP-OBody molecules (A and B) and relevant values are shown. ASA and BSA refer to 
accessible surface area and buried surface area respectively (in Å). ΔiG refers to 
solvation energy effect (in kcal/mol). The OBody residues are highlighted in bold. 
 
Interfacing 
residues 
H-bond  ASA BSA ΔiG 
A: Asp 363  72.56 27.72 0.07 
A: Thr 366  101.20 48.94 0.73 
A: Ser 367  63.82 22.03 -0.15 
A: Leu 370  109.32 58.48 0.94 
A: Val 372  132.50 17.25 0.28 
A: Leu 373  113.27 84.44 1.13 
A: Phe 374  163.01 112.59 1.74 
A: Gln 375 H 155.26 32.78 0.21 
A: Gly 376  61.26 37.56 -0.23 
A: Thr 377  95.51 22.93 0.37 
A: Met 378 H  127.89 71.43 1.63 
A: Ala 379 H 43.81 42.13 0.06 
A: Thr 380  97.86 22.09 - 0.12 
A: Trp 382  142.49 116.34 1.27 
A: Ala 398  23.84 21.50 0.22 
A: Trp 400 H  127.58 104.12 1.20 
A: Asp 417  41.99 20.42 -0.09 
A: His 418 H 118.14 89.45 0.01 
A: Gly 420  61.44 24.33 -0.14 
A: Val 447   74.18 39.42 0.63 
A: Ile 473  59.92 10.95 -0.02 
A: Leu 474  129.21 60.70 0.44 
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Interfacing 
residues 
H-bond  ASA BSA ΔiG 
B: Tyr 341  124.64 54.42 0.76 
B: Thr 345 H 80.15 50.09 0.49 
B: Asn 349  37.05 10.05 -0.11 
B: Asp 363  75.25 31.96 0.15 
B: Thr 366  100.33 52.65 0.78 
B: Ser 367 H 57.25 48.12 0.01 
B: Leu 370  92.93 60.00 0.96 
B: Leu 373 H 123.64 93.53 1.21 
B: Phe 374  155.55 107.98 1.63 
B: Gln 375 H 152.31 45.27 0.32 
B: Gly 376  H 54.05 33.01 -0.16 
B: Thr 377  92.60 24.58 0.03 
B: Met 378  107.99 57.91 1.31 
B: Ala 379 H 42.88 39.86 0.08 
B: Thr 380  70.86 21.99 -0.11 
B: Trp 382   198.84 72.30 0.73 
B: Ala 398  43.72 17.70 0.22 
B: Gly 399  32.31 11.92 0.18 
B: Trp 400 H 177.09 114.26 1.17 
B: Glu 445  74.93 10.21 0.16 
B: Val 447   62.69 33.58 0.54 
B: Leu 474  103.30 53.59 0.37 
B: Asn 475  144.59 23.23 -0.17 
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4.2.8.3 Interactions between MBP molecules 
The MBP molecules interact with each other with at least three molecules 
involved in intermolecular polar bonds of moderate affinity (~ 2.5 Å, figure 4.21). 
There is a complementary interaction between glutamic acid (E309) and lysine 
(K305) between two MBP molecules. The other notable interactions are between 
asparagine (N124) and lysine (K127) between the same molecules and between 
glutamic acid (E172) and lysine (K219) with the third MBP molecule. This 
combined with strong interactions between MBP and OBody (B7, 4.2.8.2) result 
in strong crystal packing of these molecules.  
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Figure 4.21 Crystal packing of MBP molecules 
A cartoon representation of the crystal packing between MBP molecules created with pymol is shown. The three interacting MBP molecules 
(grey, pink, yellow) with colour appropriate labels (amino acid and residue number) and intermolecular polar bond distances are indicated.  
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4.2.8.4 Binding between OBody B7 and progesterone (P4) 
Surprisingly, the P4 molecule fits in a hydrophobic pocket created between two 
OBodies with the steroid rings of P4 packed against the aromatic rings of 
tryptophan W472 of one OBody (Figure 4.22). This hydrophobic pocket is 
fortified by valine (V449) and methionine (M378) of the adjacent OBody 
molecule, the latter amino acid forming a part of the MBP-OBody linker which 
forms the majority of the wall of the hydrophobic pocket with charged glutamic 
acid (E371). The rest of the hydrophobic pocket is supported in one direction with 
valine (V396) and a charged lysine (K451) of the adjacent OBody (with the 
carbonyl end of P4 forming a hydrogen bond with a water molecule in the 
vicinity) and in another direction by asparagine (N475) and leucine (L474) of the 
opposite OBody. Similarly, another P4 molecule is found in the hydrophobic 
pocket supported by tryptophan W472 of the opposite OBody with two-fold 
symmetry as shown in figure 4.20. 
 
 
Chapter Four 
 
147 
 
Figure 4.22 Interaction surface between OBody B7 and P4 
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The atomic detail image of P4 (A, magenta) in the hydrophobic pocket between two 
OBodies (B7) is shown as a model (a) and with electron density (b). This Pymol 
generated image also shows P4 packed against tryptophan 472 of B7 (green) surrounded 
by adjoining MBP linker (yellow) and opposite OBody (cyan). The colour appropriate 
labels (charge, amino acid and residue number) and hydrogen bond with water is 
indicated. Note the change in orientation of electron density image (b) from the 
direction of the hydrogen bond. 
 
The amino acid residues potentially contributing to the intermolecular interaction 
were assessed by using the PDBePISA tool (Table 4.6). The majority of the 
buried surface area is formed by leucines (amino acids 370, 373 and 474 of both 
OBodies). The hydrophobic amino acids W472 (involved in packing against P4 
molecule), M378 (first amino acid of OBody) and a charged amino acid E371 
(MBP) contribute to the rest of the buried surface area. The overall buried solvent 
accessible surface area between the two Obodies is 1320 Å. 
 
Table 4.6 Interactions at binding interface of Obody B7 
The amino acid residues contributing to the binding interface between two MBP-OBody 
molecules (A and B) and P4 with relevant values are shown. ASA and BSA refer to 
accessible surface area and buried surface area respectively (in Å). ΔiG refers to 
solvation energy effect (in kcal/mol). The OBody residues are highlighted in bold. 
 
Interfacing 
residues 
H-bond  ASA BSA ΔiG 
A: Leu 370  109.32 23.93 0.38 
A: Glu 371  112.98 26.91 -0.02 
A: Val 372  132.50 15.58 -0.18 
A: Leu 373  113.27 28.83 0.46 
A: Gly 376  61.26 17.85 0.29 
A: Thr 377  95.51 15.99 -0.14 
A: Met 378  127.89 16.20 0.23 
A: Val 449  16.05 14.36 0.23 
A: Lys 451  81.54 17.84 -0.55 
A: Trp 472  82.36 54.37 0.85 
A: Leu 474  129.21 16.91 0.27 
     
P4: A  487.98 341.37 -4.46 
P4: B   105.56 -1.10 
     
B: Met 378  107.99 28.96 1.04 
B: Val 447  62.69 17.57 0.28 
B: Leu 474  103.30 33.49 0.54 
 
The surface representation of the model from Figure 4.20 and 4.22 is shown with 
P4 (Figure 4.23) to better visualise the P4 molecule with relation to the two MBP 
fused OBodies (B7). The binding interface is in the form of a hollow tube lined 
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with hydrophobic amino acids with either ends lined by charged amino acids 
(positively charged area towards K451 of adjacent OBody and negatively charged 
area towards N475 of the opposite Obody). The P4 molecule fits in this pocket 
with its hydrophobic steroid rings via aromatic stacking, and the polar ends of the 
P4 molecule are exposed towards the charged ends. Most of the hydrophobic 
pocket is supported by the two opposing OBodies and adjacent MBP-B7 linker 
with two charged ends contributed by the two Obodies (centered around K451 of 
adjacent OBody and N475 of the opposite OBody). Similarly, another P4 
molecule shows a two-fold rotation with the two B7 molecules. 
 
In chapter 3, it was established that there was a pH dependent change in binding 
affinity (Kd) and specificity to P4 (3.2.6.1 and 3.2.6.2). Histidine was 
hypothesized as the amino acid (pKa ~ 6) to contribute to this phenomenon. 
However, since the binding interface is the same for OBody D7 and B7, there are 
no histidines in the vicinity of the binding interface (Figure 4.20 and 4.22) to 
explain this pH dependency or specificity and may be the result of indirect effects 
on protein stability and disruption of OBody dimers required for P4 binding.
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Figure 4.23 Surface representation of B7 with P4 
The cartoon model of two OBodies forming the binding interface with P4 with reference to surface is shown from the side (blue – positive charged, red – negative 
charged, yellow - hydrophobic) with the top view in inset.  The P4 molecules (green and cyan) can be seen in the hydrophobic channels created by the two 
OBodies and their MBP linkers (black arrow) with two-fold symmetry. The positively charged area centered around K451 (white arrow) is also indicated.
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4.3 Discussion 
4.3.1 Affinity maturation of OBodies 
It was hypothesized that the cysteines in OBody D7 may be an impediment to 
crystallization due to formation of intermolecular disulfides. Therefore, affinity 
maturation (AM) libraries were designed from the functional mutants of D7. DM 
(C35S:C48S) was chosen as the OBody template for a loop 4 (L4) based AM 
library which lacked cysteines in the β-sheets (β2 and β3) and the cysteines in the 
loop were randomized to eliminate them. C35S was chosen as the OBody 
template for proximal binding face (pF) based AM library where only β3 
(centered around C48) was randomized as a conservative approach to improve 
binding function if the cysteines on L4 proved to be critical for P4 binding.  
 
OE-PCR was used to insert stop codons into D7 mutants to prevent re-selection 
during phage display and to create PCR fragments for randomization of 
nucleotide sequences coding for the binding surfaces. This PCR based 
randomization of the nucleotide sequences for the binding surfaces using 
randomization primers and temperature optimization resulted in the construction 
of two AM libraries (pF_35 and L4_DM) based on D7 mutants C35S and DM 
respectively. 
 
The P4 binding OBodies were phage selected from the L4 based AM library 
which was designed based on the rationale that L4 is critical in binding between 
D7 and P4 as described in 3.2.6. The conservative randomization of pF based AM 
library possibly did not offer enough selective advantage for P4 binding compared 
to L4 based AM library thus explaining lack of OBodies from pF based AM 
library.  
 
4.3.2 Randomization of loop (L4) and P4 binding 
The OBodies from the L4 based AM library were confirmed by sequencing to 
vary only in L4 residues (randomized) in most P4 binding OBodies. These 
OBodies did not have a consensus in loop (L4) sequence thus indicating poor 
involvement in P4 binding. These OBodies were tested for binding affinity using 
SPR which showed no improvement in binding affinity with Kd in low 
micromolar values as naïve OBody D7 (4.2.4). Most OBodies lacked cysteines 
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and the best candidate B7 was subjected to crystallization trials as described in 
4.2.5 and 4.2.6. 
 
The isolation of these OBodies however reflected the selection pressure of 
decreasing amounts of target (P4) and duration of incubation leading to OBody 
output drastically dropping after round 4 (R4) with most P4 binding OBodies 
isolated from R4 and R5. The solved structure of B7 with P4 explains the lack of 
improvement in OBody affinity to P4 possibly due to recruitment of a novel 
binding interface not seen in OB-folds found in nature (Arcus, 2002; Murzin, 
1993) instead of randomized L4 as shown in 4.2.3. This novel binding interface 
was common to all OBodies from the second generation (Pyrobaculum 
aerophilum Aspartyl t-RNA synthetase) naïve OBody library (2GPATS) library 
and the AM library. The crystal condition (containing PEG MME 2000) used to 
solve this structure (of B7) showed retention of the novel P4 binding interface and 
(non-covalent) dimerization of the OBody required for P4 binding.  
 
Previous studies of OB-fold (OBody) binding to ligands show binding at the 
‘Oligomer binding site’ (Figure 1.7) (Arcus, 2002; Murzin, 1993; Steemson et al., 
2014; Theobald et al., 2003) whereas this P4 binding OBody represents a novel 
dimeric arrangement and binding interface for small molecule ligands. However, 
the sequence of loops has a strong influence on protein stability (Hashimoto & 
Panchenko, 2010). Therefore, variations in binding affinity of OBodies to P4 from 
both libraries probably reflected the stability provided by the cysteines in 
2GPATS library OBodies (in the form of D7) or stability provided by L4 residues 
(in the form of OBodies selected from AM library) with regards to dimeric 
arrangement required for formation of hydrophobic pocket for P4 binding. OBody 
B7 fused to MBP may have improved affinity to P4 over OBody D7 indirectly 
due to same stabilizing effect and not due to stronger interaction with P4 as the 
binding interface is theoretically the same (Trivedi et al., 2009). However, the AM 
library did contribute to elimination of cysteines from OBodies resulting in 
crystallization with P4. 
 
4.3.3 Structure of OBody bound to P4 
Crystallization was challenging with pure B7 probably due to inherent tendency to 
dimerize thus affecting homogeneity (similar to D7). Crystallization was 
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successful with fusion to MBP and the crystals diffracted to 1.9 Å resolution with 
PEG based conditions though they had pathologies like twinning or translational 
non-crystallographic symmetry (tNCS). The highest resolution, non-twinned data 
was used for structure solution using Phaser and refinement with Refmac5. The 
diffraction data used to solve the MBP-B7 structure with P4 does indicate that 
there is a propensity for the OBodies to dimerize (forming a hydrophobic pocket 
to contain P4) though selected P4 binding OBodies were randomized on the 
conventional binding surface not used for P4 binding. 
 
The binding between B7 and P4 is an interesting pattern where two OBodies (B7) 
come together via a novel binding interface, forming hydrophobic pockets (Figure 
4.23) to house two P4 molecules (supported on adjacent tryptophans W472) with 
two-fold symmetry. This is supported by their MBP counterparts via interactions 
with -helices and linkers (4.2.8.2). The end result is the formation of two 
hydrophobic channels able to accommodate a P4 molecule each with the polar 
ends free to make interactions with possibly charged amino acids exterior to the 
hydrophobic channels. The P4 binding to OBody is similar to P4 binding with P4 
receptor by aromatic stacking as mentioned in 3.1.1 (Tanenbaum et al., 1998) 
except that this results in two OBodies forming a non-covalent dimer to bind P4 
molecule in a manner not documented before.  
 
Comparison of the solved structure (PEG MME 2000) and the one used for initial 
model building (PEG 4000) showed different positions of OBody B7 with respect 
to MBP due to the flexible MBP-B7 linker. However, the position of P4 and 
packing of the adjacent OBodies was similar and both belong to p21 space group. 
 
4.3.4 Future experiments 
The binding affinity of P4 binding OBodies has plenty of room for improvement 
as the hydrophobic pockets between the two OBodies can be made more compact 
by modifying residues on the novel binding interface such that hydrophobic 
amino acids can be added and charged amino acids removed in such a way as to 
improve hydrophobicity between the OBodies and for P4. However, charged 
residues can be placed outside the hydrophobic pocket or existing charged (or 
polar) amino acids can be brought closer (figure of 8, Figure 4.24) to the carbonyl 
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groups of the P4 molecule to form strong hydrogen bonds to contribute to overall 
binding.  
 
 
Figure 4.24 Improved binding model of B7 with P4 
The schematic ‘figure of 8’ binding pattern (top) of B7 to P4 is shown with coloured 
labelling (with relevance to the Pymol generated cartoon model of B7 binding to P4 
from solved crystal structure of MBP-B7 with P4, bottom). The schematic shows a side 
view of the OBody β-barrels (B7 A, green and B7 B, cyan from MBP-B7 A and MBP-B7 B 
respectively) and the arrangement of P4 molecules (P4 A, purple and P4 B, blue with 
labelled rings) between them. The steroid rings of the P4 molecules are packed against 
aromatic rings of tryptophan 472 of MBP-B7 from nearest B7. The orientation of P4 
molecules is also shown with the end containing pentagonal ring (ring D) towards the 
bottom and the end containing hexagonal ring (ring A) towards the top. The model 
(bottom) follows the schematic where both P4 pack against W472 (dashed circles) of 
adjacent B7. P4 (A) forms hydrogen bonds with K451 of B7 (A) and N475 of B7 (B) 
denoted by dashed lines. P4 (B) makes similar interactions with B7 (A) and B7 (B).  
 
W472 involved in aromatic stacking of P4 can be mutated to alanine to analyse its 
contribution to P4 binding. The amino acids around W472 can be replaced with 
larger hydrophobic amino acids and tested for P4 binding by SPR. Similarly, the 
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amino acids near the charged ends of the hydrophobic channel (centered around 
K451 and N475) can be mutated into serines and analysed for specificity of P4 
binding with pH dependence since the difference between P4 and E2 is with 
respect to their polar groups. Rational design and randomization of this novel 
binding interface can be used to optimize P4 binding. A radical approach is to add 
cysteines peripheral to the novel binding interface to form intermolecular 
disulfides to covalently strengthen the dimerization and resulting trapping of P4 
molecules. 
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5 Characterisation of YscC for phage display  
5.1 Introduction 
5.1.1 The YscC fragment and phage display 
The signal sequence of PelB (Pectate Lyase B) (Bergquist & Gibbs, 2007; 
Hayhurst, 2000; Singh et al., 2013; Speck, Arndt, & Muller, 2011; Thie, 
Schirrmann, Paschke, Dubel, & Hust, 2008; Velappan et al., 2010; Wilson & 
Finlay, 1998; Zhao et al., 2016) is the preferred signal sequence used to 
translocate proteins using the conventional SecB route and is produced as a fusion 
with N-terminal end of POI (and pIII) from the encoding phagemid. Similarly, the 
second generation Pyrobaculum aerophilum Aspartyl t-RNA synthetase 
(2GPATS) naïve library was designed with PelB as a signal sequence at the N-
terminal end of the OBody. D7 which was selected against the target progesterone 
(P4) had a foreign insertion in its open reading frame (ORF) of the encoding 
phagemid (at the Nco1 cut site) as shown in Figure 5.1 (7.2.1). 
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Figure 5.1 Insertion of foreign YscC fragment in (D7) phagemid 
Illustration of insertion of foreign YscC fragment between signal sequence PelB (exteme top left, grey) and OBody (D7, extreme bottom right, green) generated by 
Geneious software. The YscC fragment (pink and orange) shows the short end sequence of YscU domain (non-functional, left pink) and N0 domain of YscC (orange) 
with signal sequence (right pink) in frame with the OBody (D7). The restriction enzyme cut site (nco1, C^CATGG) where the foreign insertion occurs is also shown 
(red, top left and bottom right). Note that signal sequence PelB is not in frame with D7 (due to insertion of YscC fragment).  
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The foreign genomic fragment is from Achromobacter xylosoxidans (UniprotKb: 
A0A179TE40) and was inserted in the phagemid (pOB2) Nco1 restriction site 
between the 3’ end of the PelB signal sequence and the 5’ end of the OBody (D7). 
This foreign fragment has a 3’end partial remnant of the sequence coding for 
YscU (Yops protein translocation protein U) and a 5’end sequence coding for N0 
domain of a type 3 secretin family protein called YscC (InvG/EscC/MxiD)(Zheng 
et al., 2007). The PelB signal sequence is non-functional since it is out of frame 
with the sequence coding for D7 (OBody) whereas YscC signal sequence and N0 
domain is in frame with D7. YscU is highly unlikely to be functional as it is short 
and truncated.  
 
D7 was the only OBody from 2GPATS library which was soluble and well 
expressed in E. coli. It was hypothesized that this foreign signal sequence 
(refererred as ssYscC in this chapter) or the N0 domain of YscC had a positive 
effect in phage display of D7 due to an alternative route for translocation of stable 
OBodies (like D7) or efficient translocation of the OBody (Hueck, 1998; 
Korotkov, Gonen, & Hol, 2011; Kostakioti, Newman, Thanassi, & Stathopoulos, 
2005). 
 
5.1.2 The phagemid (YscC) for AM library construction  
The phagemid used for construction of a second generation Pyrobaculum 
aerophilum Aspartyl t-RNA synthetase naïve OBody library (2GPATS) is called 
pOB2. When OBody D7 was selected with P4 as the target antigen, D7 was over-
represented in phage selections (screened by phage ELISA and confirmed by 
DNA sequencing). DNA sequencing of the phagemid revealed an insertion of a 
foreign segment between the signal sequence (PelB) and the the OBody (D7), 
consisting of a signal sequence and the N0 domain from secretins, a close 
homologue of YscC) from Yersinia. The secretin (YscC) is a component of the 
type 3 secretory system (T3SS) and has sequence homology with other 
gram-negative bacteria, EscC of Entero Pathogenic E. coli (EPEC) and InvG of 
Salmonella (Burkinshaw & Strynadka, 2014; Hueck, 1998; Zheng et al., 2007). It 
was hypothesized that the foreign segment may have enhanced the display of D7 
on the surface of phage due to improved transport via the inner membrane due to 
the signal sequence (Steiner et al., 2006) or the protein domain (Zheng et al., 
2007). This may be due to either maintenance of the unfolded form of OBody in 
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the cytoplasm during delivery to the inner membrane (Baneyx & Mujacic, 2004) 
or enhancing OBody folding in the oxidising environment of the periplasm 
(Trivedi et al., 2009). Thus, the AM libraries (pF_35 and L4_DM) were designed 
with the foreign segment retained in phagemid pOB2 and the phagemid was 
renamed YscC (based on the T3SS component of Yersinia). 
 
The (N0) periplasmic domain of outer membrane (OM) secretin YscC 
(EscC/InvG) that belongs to type III secretion system (T3SS) of gram-negative 
bacteria is also called an injectisome and injects virulent proteins into eukaryotic 
host cells. The injectisome consists of ring structures and a protruding needle. 
Secretins form one ring and are common to bacterial export pathways like T2SS, 
T3SS, T4 pilus and filamentous phage extrusion. They consist of 12 – 14 subunits 
forming a ring structure used to translocate proteins across the outer membrane. 
The secretin consists of a N-terminal periplasmic domain and conserved protease 
resistant C-terminal region (secretin homology region) in the outer membrane (Fig 
5.2) (Spreter et al., 2009).  
 
Figure 5.2 Structure of foreign YscC fragment in (D7) phagemid 
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a) The YscC (InvG/EscC) is shown with its three domains (N0, N1 and C) as part of T3SS. 
IM components (EscJ and PrgH) are also shown. b) structure of N-terminal domains (21- 
174) of YscC (EscC) is shown with flexible linker at position 105. Note that EscC and its 
domains are shown in comparison with the IM components of T3SS. 
 
The crystal structures of N-terminal part of YscC (InvG/EscC) show two domains 
connected by a flexible linker (105) forming a hydrophobic interface between two 
domains which makes it possible for the subunits to form a ring structure. The 
residues in the core of the domains, the linker and the interface are conserved 
across T3SS species and the modular architecture of InvG overlaps with inner 
membrane (IM) ring subunits PrgH and PrgK (EscJ).  
 
The N-terminal part of YscC (InvG) has a wedge-shaped structure made up of two 
α-helices folding against a β-sheet. This conserved feature along with the linker 
allows subunits of three membrane proteins (InvG, PrgH and PrgK) to form the 
ring structures of T3SS. The filamentous phage pIV protein is homologous to 
InvG. 
 
This N-terminal fragment of YscC (InvG) was hypothesized to improve phage 
display of OBody D7 due to the isolation of single P4 binding OBody. This 
fragment also contains a unique signal sequence in frame with periplasmic 
domain (InvG) and OBody D7. Extra-cytoplasmic proteins like InvG contain 
signal sequences which facilitate translocation across IM and maybe useful for 
phage display of stable proteins. Phage assembly involves incorporation of minor 
coat proteins (e.g. pIII) in the inner membrane followed by incorporation into 
phage. Extra-cytoplasmic proteins in gram-negative bacteria can have either of the 
following fates after translocation: stay attached to OM, assemble to flagella/pili, 
injected to host cells or released extra-cellularly (Gagic, Ciric, Wen, Ng, & 
Rakonjac, 2016).  
 
Phage display involves translocation of pIII fused protein in unfolded form across 
the IM to successfully display protein due to the requirement of functional 
disulfide formation in the periplasm. Most pIII based phage display is via its Type 
I signal sequence that translocates sandwiched proteins using the general secretory 
(Sec) pathway. Transmembrane α-helices have also shown successful 
translocation of phage display proteins across the IM. A few proteins have been 
displayed with (Type 2 and 4) and without signal sequences (Ciric et al., 2014). 
This was possible due to extra-cytoplasmic proteins with their native targeting 
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factors cloned in frame with pIII lacking a signal sequence. Most of these 
targeting factors have a conserved structure but are sequence independent and 
target proteins to the appropriate chaperones of the translocation systems. Most 
secreted proteins have signal sequences and transmembrane proteins have 
hydrophobic transmembrane α-helices. Most of the signal sequences are cleaved 
by corresponding membrane associated signal peptidases (I, II and IV) after 
translocation. pVIII has a Type 1 signal sequence whereas pVI, pVII and pIX 
have only transmembrane α-helices. 
  
5.1.3 Phage display and inner membrane translocation pathways 
M13 bacteriophage reproduce in E. coli and are released without lysis of the host 
bacterial cell. This requires that the proteins translated on the ribosome (in the 
cytoplasm) are translocated to the periplasm through the inner membrane through 
special export channels as described in 1.7.2. Phage display requires that the 
protein of interest (POI) to be displayed on the surface of phage are exported 
through the same export channels. The most important channels are SecYEG 
translocase belonging to the general secretory (Sec) pathway (which specializes in 
translocation of unfolded proteins and co-translational translocation via SRP) and 
Tat translocase belonging to twin arginine translocation pathway (which 
specializes in export of folded proteins) as shown in Figure 1.20 (Holland, 2004; 
Natale et al., 2008; Paschke & Hohne, 2005; Saier, 2006; Thie et al., 2008; Valent 
et al., 1998). 
 
The Sec pathway is generally used for protein translocation in phage display as 
the display protein pIII has to be maintained in unfolded form in the cytoplasm for 
translocation into the periplasm for proper folding (due to cysteines in pIII that 
require native formation of disulfides in the oxidizing environment of periplasm 
catalyzed by Dsb oxidoreductases)(Baneyx & Mujacic, 2004; Trivedi et al., 2009) 
and several attempts to translocate pIII using the Tat pathway have been 
unsuccessful due to pIII misfolding (Nangola et al., 2010). However, the Sec 
pathway is not a good candidate for translocation of highly stable or fast folding 
cytoplasmic proteins (e.g. GFP, DARPin) since these proteins will fold after 
exiting the ribosome (post translation) and prior to binding of SecB chaperone and 
delivery to Sec translocase (Aronson et al., 2011; Dammeyer & Tinnefeld, 2012; 
Dinh & Bernhardt, 2011; Fisher & DeLisa, 2008; Huber & Beckwith, 2006). The 
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Tat pathway intuitively is the best option for these proteins but display protein 
(pIII) is functional only if translocated in an unfolded form via Sec pathway.  
 
5.1.4 Strategies for highly stable protein translocation 
Several research groups have found strategies (Figure 5.3)  to enhance export and 
folding in the periplasm, one being SRP phage display which uses the co-
translational branch of Sec pathway (Steiner, Forrer, & Pluckthun, 2008; Steiner 
et al., 2006) and a second being Tat-mediated phage display (TDP) (Paschke, 
2006; Paschke & Hohne, 2005). In these scenarios, SRP bypasses the SecB 
chaperone and fusion protein is threaded directly into Sec translocase whereas 
with TDP, c-terminal pIII and the POI are separately translocated through Sec and 
Tat translocases respectively (via independent expression and appropriate signal 
sequences, Fig 5.3B) and fuse in the periplasm via respective cysteine-based 
leucine zippers (Jun and Fos). 
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Figure 5.3 Alternative strategies for stable protein translocation 
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Illustrations for protein translocation strategies are shown. (A) Sec based translocation 
compares conventional (SecB, post-translational, left) phage display with SRP phage 
display (co-translational, right) where SecB (not shown here) is incapable of 
translocating fast folding (DARPin) proteins whereas SRP manages to thread the stable 
protein directly into Sec translocase. (B) Tat-mediated phage display (TDP) shows 
separate genes (on plasmid) for POI and c- terminal domain of pIII (CT) which are 
independently translated (with POI fused to Fos linker and pIII fused to Jun linker) and 
translocated through Tat and Sec pathways respectively followed by fusion at the 
periplasm via cysteine based (Fos- Jun) leucine zippers. (Huber & Beckwith, 2006; 
Paschke, 2006)  
 
In this scenario N0 domain of YscC which has homologs in other species 
(YscC/InvG/MxiD/EscC; UniprotKb: A0A179TE40) (Burkinshaw & Strynadka, 
2014; Diepold & Wagner, 2014; Gaytan, Martinez-Santos, Soto, & Gonzalez-
Pedrajo, 2016; Kimbrough & Miller, 2002; Schuch & Maurelli, 2001)  is 
translocated through Sec translocase  and is capable of exporting a highly stable 
protein like the OB-fold (OBody) with pIII circumventing the need to use cysteine 
based leucine zippers (as in Tat phage display). This also provides a niche where 
SRP phage display is problematic when highly stable proteins require cofactors to 
bind them in cytoplasm before translocation into periplasm (Steiner et al., 2006). 
 
This led us to test the hypothesis that the phage selection had fortuitously 
provided us with a signal sequence that was very efficient at delivering fast 
folding and stable POIs to the periplasm along with pIII and without the need for 
parallel export through SEC and TAT pathways. 
 
5.2 Results 
5.2.1 Characterisation of YscC fragment 
5.2.1.1 Testing YscC for better phage display 
This phagemid (named YscC) was compared with the phagemid (pOB2) from 
2GPATS library by comparing phage display of the best P4 binding OBody B7 in 
both phagemid constructs. pOB2-B7 (Figure 5.4) was constructed by removing 
the YscC fragment (425 bp) from the original B7 phagemid using Nco1 restriction 
enzyme. Both the constructs were confirmed by DNA sequencing using flanking 
primers. 
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Figure 5.4 DNA sequencing of B7 gene without YscC fragment  
The DNA sequence of pOB2 B7 with signal sequence (pink with red borders) of PelB 
fused to 5’- end of gene for OBody (B7, green) is shown. The restriction enzyme cut sites 
(blue) are also indicated.  
 
The resulting constructs named YscC-B7 and pOB2-B7 were tested by phage 
ELISA to compare the performance of phage display from these two constructs. 
The phage ELISA was performed as described in 2.6.3 and confirmed that the 
YscC did provide a significant advantage in display of B7 as shown by increased 
absorbance at 450nm (Figure 5.5) 
 
 
Figure 5.5 Comparison of YscC and pOB2 for phage display of B7  
The bar graph shows the phage ELISA of B7 expressed from three different phagemid 
constructs: pOB2, MBP and YscC. Biotinylated-P4 was immobilized as the target. Anti-P4 
antibody was used as the positive control. YscC-B7 was used in an empty well as a 
negative control. The y-axis shows the absorbance (Abs450) at 450nm which is a 
function of the display level of B7 on the surface of phage. Note that pOB2 and MBP 
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share the same signal sequence (PelB) and YscC has its own signal sequence (ssYscC). 
The experiment was performed in triplicates. 
 
The phage ELISA of B7 with the two constructs shows that YscC produces 
significantly higher absorbance (Abs450) than pOB2 and positive control 
confirming that the YscC produces a significant improvement in phage display of 
OBodies. B7 is known to be well expressed and free of cysteines, thus indicating a 
possible translocation difference between the two phagemids, with and without 
YscC. This experiment was performed using KM13 helper phage for infection 
which has low display of foreign protein fusion to pIII (Carmen & Jermutus, 
2002; Paschke, 2006; Rondot et al., 2001) and the results have been replicated 
many times independently. The next step was to determine whether the signal 
sequence (ssYscC) or mature domain (of YscC) was responsible for the enhanced 
phage display of OBody B7 (5.1.1). 
 
Phage display with longer fusion proteins have been shown to be better 
translocated via the Sec translocase probably due to efficient chaperoning by 
SecB (Dinh & Bernhardt, 2011). MBP is one such protein which is a naturally 
occurring periplasmic protein and does not contain cysteines. To test the theory 
whether YscC was providing the same benefit of a longer fusion protein, a large 
protein MBP was fused to B7 (in a pOB2 phagemid with PelB as the signal 
sequence) and compared to YscC-B7. The (pOB2) MBP-B7 construct was 
confirmed by DNA sequencing. Having MBP at the N-terminus of B7 does not 
improve display of this protein on the surface of phage (as detected by phage 
ELISA). The lack of access of B7 for P4 binding in MBP B7 has been ruled out 
previously with SPR studies in 4.2.4. 
 
5.2.1.2 Testing of signal sequence (ssYscC) for better phage display 
A B7 construct ssYscC B7 was made using YscC-B7 to test if the signal sequence 
(ssYscC) or mature domain of YscC was responsible for better phage display 
(reflected by strong absorbance at 450nm as in Figure 5.4). The YscC gene coding 
for mature domain (N0, Figure 5.1) was removed from YscC-B7 using custom 
order primers leaving only the short signal sequence (ssYscC B7, 21 amino acids) 
with a non-functional intergenic fragment of 19 amino acids (Figure 5.6).  
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Figure 5.6 Phage display of B7 with signal sequence- ssYscC 
The bar graph shows the phage ELISA (top) of B7 expressed on ssYscC B7 which contains 
only the signal sequence of foreign insertion YscC (ssYscC) fused to B7. Anti-P4 antibody 
was used as the positive control to detect P4. ssYscC B7 was used in an empty well as a 
negative control. The y-axis shows the absorbance (Abs450) at 450nm which is a 
function of the display level of B7 on the surface of phage. The DNA sequence (bottom) 
of ssYscC B7 showing signal sequence (pink with red borders) of YscC fused to 5’- end of 
gene for OBody (B7, green) separated by non-functional intergenic fragment (19 amino 
acids). The restriction enzyme cut site used (Pst1) for removing majority of YscC (yellow) 
is also indicated. The experiment was performed in triplicates. 
 
The phage ELISA results show that the signal sequence (ssYscC) is responsible 
for better phage display of OBody B7 reflected by high Abs450nm levels as that 
of YscC B7 (Figure 5.4) thus ruling out the involvement of N0 domain (YscC) in 
better phage display. 
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5.2.1.3 The structure of signal sequence ssYscC 
The cleavage site of the signal sequence was predicted using two signal sequence 
web servers Phobius and Signal-blast as shown in Figure 5.7. The tripartite 
structure (Figure 1.21) of this signal sequence from Phobius shows no large 
hydrophobic amino acids in the H-region which would have been indicative of a 
SRP dependent signal sequence. The presence of two positively charged amino 
acids in the N-region is highly suggestive of post-translational Sec dependent 
signal sequence. The lack of twin arginines in the N-region rules out a Tat 
dependent signal sequence. A few signal sequences have been shown for 
comparison (Natale et al., 2008) 
 
 
Figure 5.7 Structure and comparison of ssYscC   
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The tripartite structure of signal sequence of YscC is shown in different colours (top) and 
compared to conventional signal sequences (bottom). The non-cytoplasmic part (mature 
domain) and signal peptidase cleavage site is indicated (top). Signal sequences (ss) for 
Sec and SRP pathway dependent phage display is shown in relation to POI and C-
terminal of display protein p3 (bottom). The signal sequence was analysed using Phobius 
(Stockholm Bioinformatics Centre) and signal-blast (University of Salzburg). The image is 
used with permission from  (Steiner et al., 2006). 
 
5.2.2 Testing YscC for better phage display of other stable (or fast folding) 
proteins  
5.2.2.1 Phage display of highly stable and fast folding GFP with YscC  
The signal sequence of YscC (ssYscC) was further explored to characterize the 
compatibility of phage display with other fast folding or stable proteins that are 
generally refractory to phage display. Green Fluorescent Protein (GFP) is one 
such protein which has an E. Coli optimized variant (GFPuv) which fluoresces 
under UV light (Crameri, Whitehorn, Tate, & Stemmer, 1996; Dammeyer & 
Tinnefeld, 2012; Fukuda, Arai, & Kuwajima, 2000; Paschke & Hohne, 2005) and 
an engineered fast folding variant (sfGFP)(Aronson et al., 2011; Dinh & 
Bernhardt, 2011; Fisher & DeLisa, 2008; Speck et al., 2011; Velappan et al., 
2010). GFPuv (also called cycle 3 variant) emits green light (508 nm) when 
excited by UV light (395 nm) forms a stable protein and cannot be translocated to 
the periplasm with signal sequence pelB of pOB2 (i.e. via the conventional Sec 
pathway), with minimal translocation by signal sequences of gene III (Linton, 
Walsh, Sims, & Miller, 2012) and MBP (Feilmeier, Iseminger, Schroeder, 
Webber, & Phillips, 2000). Thus, constructs pOB2-GFPuv-B7 and YscC-GFPuv-
B7 were constructed (Figure 5.8) to test for better phage display with the YscC 
fragment. These constructs were confirmed by DNA sequencing.  
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Figure 5.8 Phage display of GFPuv with YscC fragment 
The bar graph (top) shows the phage ELISA of GFPuv (with B7* to detect P4) expressed 
on two different phagemid constructs (pOB2 and YscC) and YscC-sfGFP-B7. Anti-P4 
antibody was used as the positive control to detect P4. YscC-B7 was used in an empty 
well as a negative control. The y-axis shows the absorbance (Abs450) at 450nm which is 
a function of the display level of B7 on the surface of phage. Note that pOB2 has its own 
signal sequence (PelB) and YscC has its own signal sequence (ssYscC). The DNA sequence 
(p.170) of YscC GFP showing previously annotated YscC (yellow, as in Figure 5.1) fused to 
5’- end of gene for GFP (green). The restriction enzyme cut sites (Nco1 and Sac2) are 
also indicated. This experiment was performed in triplicates. 
 
The phage ELISA of GFPuv with the two constructs shows that YscC produces 
up to 5 times higher absorbance (Abs450) than pOB2 confirming that the YscC 
produces a significant improvement in phage display of GFPuv.  
 
However GFPuv has cysteines and is non-fluorescent if folding occurs in the 
periplasm due to formation of intermolecular disulfide bonds (similar to the 
OBody D7)(Aronson et al., 2011). The fast folding mutant super-folder GFP 
(sfGFP) folds fast enough to prevent cysteines from forming intermolecular 
disulfide bonds and is fluorescent in the periplasm. Thus, similar constructs were 
made with sfGFP as GFPuv (Figure 5.7) and efforts for phage display produced 
only marginally improved display with the YscC fragment. This was probably due 
to the incompatibility of the Sec system with folded proteins. 
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5.2.2.2 Phage display of highly stable but not fast folding DARPin with 
YscC  
Further exploration of the signal sequence of YscC was limited to highly stable 
proteins like DARPins (with the exclusion of fast folding variants like sfGFP) 
(Binz et al., 2004; Stumpp et al., 2008; Wetzel, Settanni, Kenig, Binz, & 
Pluckthun, 2008). Designed Ankyrin Repeat Proteins (DARPins) are non-
immunoglobulin based scaffolds that do not contain cysteines (Binz et al., 2005; 
Jost & Pluckthun, 2014) and are refractory to conventional (post-translational) 
Sec based translocation (Huber & Beckwith, 2006; Steiner et al., 2008; Steiner et 
al., 2006). Thus, a YscC based construct was designed similar to the GFP 
constructs (5.2.2.1, GFPuv and sfGFP) and phage ELISA was performed to assess 
phage display of the highly stable DARPin (E_01) with B7 as a detecting epitope 
(to P4, Figure 5.9). These constructs were confirmed by DNA sequencing using 
flanking primers. It is important to note that cloning of solely the signal sequence 
(ssYscC) was not achieved with GFP and DARPin, thus resorting to use of the 
entire YscC N-terminal fragment to these constructs. 
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Figure 5.9 Phage display of DARPin with YscC 
The bar graph (top) shows the phage ELISA of DARPin (with B7 to detect P4) expressed 
on phagemid construct YscC B7. Anti-P4 antibody was used as the positive control to 
detect P4. ssYscC B7 was used in an empty well as a negative control. The y-axis shows 
the absorbance (Abs450) at 450nm which is a function of the display level of B7 on the 
surface of phage. This experiment was performed in triplicates. The DNA sequence 
(p.173) of YscC DARPin showing annotated DARPin (green with black borders) fused at 5’ 
end to YscC and 3’ end to OBody B7. The restriction enzyme cut sites (Nco1 and Sac2, 
orange) are also indicated. Note that the location of restriction sites is different as 
compared to GFP. 
 
Phage display of DARPin with YscC fragment did show moderate levels of 
display but needs to be repeated using only the signal sequence (ssYscC) since the 
functionless mature domain (N0) may interfere with Sec based translocation 
across the inner membrane. 
 
5.3 Discussion 
The original P4 binding OBody D7 was used as a template for the design of AM 
libraries. The YscC fragment was retained in the construction of AM libraries 
because it was hypothesized to aid phage display of OBodies. Phage selections 
using these libraries led to the isolation of a significant number of P4 binding 
OBodies possibly due to better phage display due to YscC fragment and 
predominantly from L4_DM due to larger nucleotide randomization (though not 
directly involved in P4 binding).  
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The influence of the YscC fragment was further characterized by constructing 
OBody B7 constructs with only the ssYscC and this was confirmed by 
experimentation: the signal sequence was responsible for the enhanced phage 
display of OBodies compared to the conventional pelB signal sequence, probably 
owing to efficient translocation of highly stable OBodies via the post-translational 
Sec pathway. The co-translational route of Sec pathway was ruled out as the 
signal sequence is not sufficiently hydrophobic to be recognized by the SRP 
(Fekkes & Driessen, 1999). This idea of efficient display of OBodies was further 
tested with other highly stable proteins such as GFP and DARPin which proved 
that ssYscC holds promise to efficiently display stable proteins other than 
OBodies. However, these experiments need to be repeated without the YscC 
fragment to explore the potential of the signal sequence in displaying stable 
proteins other than OBodies. 
 
There are at least two other technologies that can efficiently display stable or fast 
folding proteins, SRP phage display and Tat phage display. SRP phage display 
uses the co-translational route of the Sec pathway and is not ideal for proteins that 
require cofactors prior folding (in the cytoplasm). Similarly Tat phage display 
exploits separate translocation of C- terminal pIII via the Sec pathway and POI 
via the Tat pathway followed by fusion in the periplasm via cysteine-based 
leucine zippers. However, this is incompatible with proteins containing cysteines 
due to risk of aberrant inter-molecular disulfide bonds. Thus, ssYscC which uses 
the conventional post-translational Sec pathway creates a niche which can 
overcome both the above limitations as it translocates unfolded proteins and also 
exports pIII fused to the POI without the requirement of cysteines. 
 
The signal sequences can be modified to improve efficiency of translocation via 
the Sec pathway or stability of POI (Martoglio & Dobberstein, 1998; Singh et al., 
2013). The signal sequences are in the folded form prior to translocation and 
α- helices are translocation competent (Knyazev, Kuttner, Zimmermann, 
Sobakinskaya, & Pohl, 2018). β-strand based proteins are poorly translocated via 
the bacterial Sec pathway unless they are preceded by an α- helix (Gonsberg et al., 
2017). The next step would be to create an affinity maturation library where the 
signal sequence of YscC is randomized based on mRNA secondary structure, 
H-region and cleavage site (Jeiranikhameneh, Moshiri, Keyhan Falasafi, & 
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Zomorodipour, 2017). The fused stable protein that is refractory to phage display 
is used as a quality control to isolate ssYscC variants that efficiently translocate 
these proteins via Sec pathway and bind to established targets (Feilmeier et al., 
2000; Heggeset et al., 2013). 
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6 Discussion 
Protein based bio-sensors generally have higher sensitivity and specificity 
compared to small molecules sensors (A. J. Smith, 2015). Antibodies are the 
dominant proteins used for diagnostics and therapeutics in this context. They are 
expensive to produce and often require expensive storage and transport 
conditions. Their expensive production arises as there is a requirement for 
mammalian cell lines to facilitate correct folding and correct post- translational 
modifications (Li, Vijayasankaran, Shen, Kiss, & Amanullah, 2010). Different 
formats of antibodies and alternatives to antibodies from naturally occurring 
binding proteins have been engineered to get around these limitations (Gebauer & 
Skerra, 2009; Jost & Pluckthun, 2014; Nygren & Skerra, 2004). OBodies, based 
on the OB-fold, are a possible non-immunoglobulin scaffold as they fold into a 
stable β- barrel with high melting temperature (Tm) and can be produced in E. coli 
with an adaptive binding surface leading to the ability to produce bio-sensors that 
can be stored and transported at room temperature and produced in large amounts 
in bacteria thus reducing the costs of production. 
 
OBodies (~13 kDa) also have a size advantage over antibodies (150 kDa) making 
it more applicable for intracellular applications like carrying a chemical payload 
or probe for radioimaging. Small molecule targets are mostly hydrophobic or 
polar and have to rely on limited interactions for binding to sensors unlike large 
protein targets (Cooper, 2000). A smaller biosensor like OBodies will be an 
advantage over a large biosensor like antibodies due to lower steric clashes (Du et 
al., 2016).  
 
Progesterone (P4) is a ligand for an extra-cellular receptor and is similar to the 
environment of P4 binding OBodies displayed on the surface of phagemid 
particles during phage selections (Tanenbaum et al., 1998). Anti-P4 antibodies are 
ubiquitous in diagnostic testing but they are expensive to manufacture and require 
cold storage to prevent the antibody from aggregation/denaturation (Isobe & 
Nakao, 2003). Non-immunoglobulin scaffolds are good alternatives to produce 
low cost and thermostable bio-sensors with anticalins based on the lipocalin fold 
the only known non-immunoglobulin scaffold to bind small molecules (Arne 
Skerra, 2001; A. Skerra, 2008).  
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The OBody is another similar scaffold which has shown potential in being a 
non-immunoglobulin based small molecule bio-sensor with thermostability and 
ease of manufacturing. Aptamers based on single stranded oligonucleotides (DNA 
or RNA) are other alternatives to antibodies and non-immunoglobulin scaffolds as 
small molecule binding agents (Ruscito & DeRosa, 2016). However, aptamers are 
negatively charged, targeted by nucleases and are heat labile positioning 
non-immunoglobulin protein-based scaffolds as ideal small molecule bio-sensors. 
 
Low levels of P4 in cow’s milk, days 5 to 7 after artificial insemination has been 
shown to be correlated with low fertility (Stronge et al., 2005). Enzyme 
immunoassay (EIA) is the gold standard for testing P4 levels in cow’s plasma or 
milk over radioimmunoassays (Isobe & Nakao, 2003). P4 binding OBodies are 
compatible with a similar system (ELISA) to detect P4 and can be a powerful 
alternative to EIA based on cumbersome antibodies. 
  
6.1 Characterisation of OBody D7 from naïve library 
An OBody (D7) was previously engineered to detect the small molecule 
progesterone (P4). Structural studies of this OBody with P4 would show the 
nature of binding and a rationale to improve binding affinity (Kd) by rational 
design. X-ray crystallography was planned to visualise protein crystals to obtain 
an atomic resolution model of the protein and binding characteristics in atomic 
detail. However, the OBody D7 failed to crystallize possibly owing to cysteines 
forming inter-molecular disulfide bonds and aggregation at high concentrations 
(Dale et al., 2003; Gosavi et al., 2008; Szilágyi et al., 2007). Therefore, mutants of 
the OBody D7 were designed to test the contribution of cysteines to binding with 
the hope of eliminating cysteines and increasing crystallizability. The loop (L4) 
mutants where cysteines were replaced with uncharged serines showed loss of 
binding to P4 in binding ELISA whereas similar β- sheet mutants did not affect 
binding but did show a relative decrease in dimerization when visualised by SDS-
PAGE and size exclusion chromatography. Crystallization trials with these serine 
D7 mutants and MBP fused variants to increase crystallizability were not 
successful and it was planned to construct new OBody libraries from D7 to 
eliminate cysteines or increase binding affinity by directed evolution using phage 
display. Since D7 (Kd ~ 600 nM – 2.7 μM) shows at best 10 times weaker binding 
to P4 than an anti-P4 antibody (Kd ~ 60 nM), the construction of affinity 
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maturation libraries was considered the next step to make P4 binding OBodies 
competitive (Benvenuti & Mangani, 2007; Bondos & Bicknell, 2003; Clementi et 
al., 2012; Dufner et al., 2006).  
 
The presence of cysteines in the P4 binding OBody D7 and the oxidising 
environment of the periplasm where it was assembled during phage display can be 
tested further by expressing large scale in an E.coli strain like AD494 (lacking 
trxB) or origami (lacking trxB and gor) from Novagen with an oxidising 
cytoplasm or signal sequence-based periplasmic targeting and expression, to test 
for retention of solubility and P4 binding from oxidation of cysteines unlike the 
reducing environment of cytoplasm. 
 
6.2 Construction of AM libraries and characterisation of OBody 
B7  
Construction of two affinity maturation libraries, each focusing on two locations 
containing cysteines on the hypothesized binding surface of OBody D7, one on β- 
sheets (pF) and the other on loop L4 were carried out (Arcus, 2002; Murzin, 1993; 
Steemson et al., 2014; Theobald et al., 2003). These libraries used appropriate D7 
mutants as templates for randomisation of binding residues as a balanced strategy 
to improve binding affinity to P4 or eliminate cysteines without loss of binding 
affinity respectively. Phage display of these library clones and selected for P4 
binding, isolated L4 based OBodies that were in the same range of binding 
affinity as OBody D7. Crystallization trials with the best P4 binding OBody from 
AM library (L4_DM), B7 which had similar binding affinity range as naïve 
OBody D7 (Kd ~ 700 nM when fused to MBP, standalone Kd ~ 2.6 – 3.8 μM, 
4.2.6 and 4.2.4) and expressed well without cysteines showed that the OBodies 
bound to P4 in a novel way with a different binding surface. The formation of 
dimer during binding to P4 explains the possible tendency for dimerization of 
OBody D7 and lack of increase in binding affinity of OBodies from AM libraries. 
There was no consensus in the loop (L4) sequences of isolated OBodies from AM 
libraries confirming the lack of role of the conventional binding surface of the 
OB-fold in P4 binding. The lack of OBodies not binding to P4 (with the same P4 
binding surface) may indicate the stability provided by certain loop sequences for 
OBody dimerization to bind P4 (Hashimoto & Panchenko, 2010). There was a 
correlation between solubility of protein and P4 binding as observed with D7 
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mutants (C81S, C85S) and AM Obodies that bound weakly, as they did not 
express well in E. Coli. However, this does not explain the loss of P4 binding with 
removal of loop 4 cysteines or the presence of cysteines in the opposite side of the 
P4 binding interface in OBody D7.  
 
The AM bodies were tested for binding with SPR and interestingly the MBP 
fusion of B7 (which crystallized) showed a significant improvement in P4 binding 
possibly due to contributions from MBP- B7 linker to the hydrophobic packing of 
P4 molecules (Figure 4.20). This observation along with improvement of OBody 
D7 binding to P4 with decreasing pH shows that the unique binding surface has 
the potential to be improved further for strengthening binding affinity to P4. The 
OBody can be made as competitive as an antibody by construction of second 
generation (2nd) AM libraries focused on randomisation of this unique P4 binding 
surface such that the figure of 8 model can be completed by binding of two P4 
molecules between two OBodies. This can be achieved by improving hydrophobic 
packing of P4 molecules between the two OBodies and enhancing charged 
interactions between the carbonyl groups of P4 with that of nearby residues of 
participating OBodies.  
 
The crystal packing of OBody B7 forming a dimer with the unique P4 binding 
surface can be confirmed by point mutations of the novel binding surface and 
testing retention of P4 binding and change in position of P4 in the crystal 
structure. The crystal packing of two OBodies is a possibility in its real 
environment on the end of each phagemid particle as it has five copies of pIII able 
to display atleast two adjacent pIII fusions with OBodies. 
 
6.3 Characterisation of YscC 
The selection of OBody D7 to ligand progesterone (P4) introduced a foreign gene 
insertion (the YscC fragment) from Yersinia encoding Ysc proteins required for 
assembly of Sec independent type III secretion system (Burkinshaw & Strynadka, 
2014; Hueck, 1998; Zheng et al., 2007). This was incorporated into the 
construction of new affinity maturation libraries with sufficient diversity (pF_35 
and L4_DM, 1012 members) using OE- PCR. The YscC fragment significantly 
improved the display of OBodies (~ 108 members/ml) compared to conventional 
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Sec based PelB signal sequence, where only one OBody (D7 with YscC fragment) 
was selected from naïve library selections.  
 
Further exploration of the effects of the YscC fragment showed that it was the 
YscC signal sequence which enhanced phage display of stable proteins like 
OBodies possibly by improved translocation through the inner membrane using 
the same Sec system as PelB (Burkinshaw & Strynadka, 2014). This was further 
confirmed with improved phage display of other stable proteins such as GFP and 
DARPins, indicating a competitive technology to display cysteine-based proteins 
or rival Tat phage display and SRP display of stable proteins. 
 
The improved phage display of OBodies by the signal sequence of YscC 
(InvG/EscC) can be explored further by improving the experimental conditions of 
phage ELISA. CsCl purification of rescued phagemid particles displaying the 
OBody can eliminate false positive results from fragments of E.coli containing 
OBody and virion proteins (like pVIII), formed from potential toxicity (Barbas, 
Burton, & Silverman, 2004). It is also important to titrate the phagemid particles 
displaying OBody with ssYscC and ssPelB to control for equal number of OBody 
displaying phagemid particles with both signal sequences, to rule out propagation 
based advantage in phagemid particle production (Vodnik et al., 2011). 
 
6.4  Future experiments 
The novel binding interface involved in binding to P4 has to be tested rigorously 
before optimising this surface for further improvement in P4 binding. Mutating 
some key amino acids like W472 can further increase our confidence in affecting 
the binding nature of the hydrophobic channels formed between OBodies. Next, 
the dimeric requirement of OBodies for P4 binding can be tested by adding large 
amino acids adjacent to the P4 binding interface to prevent dimerization and 
verify retention of P4 binding. Once the novel binding interface and requirement 
of dimerization for P4 binding can be validated, a second affinity maturation 
library can be designed with OBody B7 as a template. 
 
Further improvement in P4 binding requires randomization of this novel binding 
surface (in B7) and phage selections to isolate stronger P4 binding OBodies. This 
will involve optimising availability of hydrophobic amino acids for aromatic 
packing and removal of charged or polar amino acids from the hydrophobic 
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channels that accommodate P4. Since there are no loops in this side of the OBody, 
most efforts of randomisation will be focused on β-sheet 4 and β-sheet 5. The best 
binding scenario of two OBodies held together by two P4 molecules in a crossed 
(figure of 8) pattern can also be made possible by modifying the residues in the P4 
binding site of the OBodies such that the hydrophobic packing between P4 
molecules and tryptophan 472 is improved with large hydrophobic amino acids 
and two P4 molecules made to bind better to two OBodies (if required) by 
hydrogen bond formation as shown in Figure 4.24. Addition of cysteines to fuse 
two OBodies together at the novel binding interface is also an option. 
 
The inherent tendency of these OBodies to dimerize can be exploited to engineer 
bi-specific OBodies that bind to two different targets or stronger binding OBodies 
that bind to two different epitopes of the same target similar to other non-
immunoglobulin scaffolds like Anticalins (Böhm, 2005; Nygren & Skerra, 2004) 
or DARPins (Boersma, Chao, Steiner, Wittrup, & Pluckthun, 2011; Jost & 
Pluckthun, 2014). Further characterization of these OBodies by SPR and 
crystallization trials will help in realizing OBodies as a robust alternative to 
antibodies to bind small molecules. 
 
The 2GPATS library has not been as successful as 1GPATS library for selection 
of target (P4, LH, Wee1 kinase and MK13) binding OBodies or their 
crystallisation. It will be interesting to conduct phage selections with the 1GPATS 
naïve library against target P4 to determine whether OBodies binding to P4 at the 
conventional HEL binding surface can be isolated and crystallized, as the 
2GPATS based OBodies may have an inherent tendency to dimerize 
hydrophobically. 
 
With regards to the signal sequence of YscC, it is important to assess the massive 
improvement in phage display of only one type of stable protein (OB-folds) over 
other stable proteins (sfGFP, DARPin) with a similar fold called SH3 folds 
(Agrawal & Kishan, 2001).It is important to test other potential stable proteins for 
efficient phage display using this signal sequence. It is important to test different 
signal sequences (including Srp and Tat) with phage display of OBodies as 
translocation across the inner membrane may be a bottleneck preventing efficient 
display on the surface of phagemid particles. 
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Since signal sequences vary in translocation ability using the same translocation 
pathways, it may be possible to randomize the signal sequence and test for 
efficient phage display of a common stable protein (sfGFP) which can be detected 
by increased fluorescence (Feilmeier et al., 2000; Martoglio & Dobberstein, 1998; 
Singh et al., 2013). This affinity maturation of the signal sequence can also be 
combined with affinity maturation of the P4 binding OBody where improved 
display and binding may allow enrichment of stronger P4 binding OBodies. 
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7 Appendices 
7.1 General Molecular Biology 
7.1.1 Media composition 
The recipe for the common media used are as follows: 
7.1.1.1 2xYT (Yeast extract Tryptone) media 
The recipe for this media is (BD-Difco # 244020) 
16 g of pancreatic digest of casein  
10 g of yeast extract 
5 g of NaCl 
pH 7 (in 1L) of UP H2O 
This was sterilized as 500 ml cultures in 2 L baffled flasks at 121°C for 20 
minutes  
7.1.1.2 Luria-Bertani (LB) media 
The recipe for this buffer is as follows: 
10 g bacto-tryptone 
5 g yeast extract 
10 g NaCl 
pH 7 (in 1L) of UP H2O 
This was sterilized in a similar format as 2xYT.  
7.1.1.3 M9 minimal media 
This media was used to grow E. coli TG1 strains (without antibiotic resistance) 
over 36 hours at 37°C. The recipe is: 
1x M9 salts  
7 mM MgSO4  
0.3 mM thiamine  
44 mM glucose  
0.1 mM CaCl2 
Glucose was sterile filtered (0.2 μM, Pall acrodisc) and added separately after heat 
sterilization (autoclave) of the remaining ingredients of the recipe. M9 salts (5x) 
were made separately and autoclaved before use. The recipe for 5xM9 salts is: 
233 mM Na2HPO4  
110 mM KH2PO4  
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42.7 mM NaCl  
9.3 mM NH4Cl 
7.1.1.4 SOC media 
This media was used in recovery of EC E. coli after electroporation. The recipe is: 
20 g/L Tryptone  
5 g/L Yeast extract  
10 mM NaCl  
2.5 mM KCl  
5 mM MgS04  
10 mM MgCl2  
20 mM glucose 
Glucose was sterile filtered and added separately after heat sterilization of the 
remaining ingredients of the recipe. 
7.1.1.5 TSB media 
10 % w/v PEG 8000 
10 mM Mg SO4 
10 mM MgCl2 
This is made up to 95 % final volume in LB media and autoclaved and stored at 
4 °C. DMSO is added to final 5 % v/v before use. 
 
7.1.2 Antibiotics  
The following antibiotics were used at 1/1000 stock concentrations in culture 
media for protein expression and phage selections. The stocks were stored 
at - 20°C. 
1) Ampicillin/Carbenicillin 100 mg/ml (C100, for plasmids pOB2, pOPINM, 
pPROEX-HTb) 
2)  Kanamycin 50 mg/ml (K50, for plasmids pET28B, KM13, M13K07δIII) 
 
7.1.3 Buffer composition 
The recipe for the common buffers used are as follows: 
7.1.3.1 Tris buffered saline (TBS) 
20 mM Tris 
150 mM NaCl 
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0.05% (v/v) Tween-20 (T20) 
pH 7.5 
This buffer was used for size exclusion chromatography (SEC) of OBodies, and 
general storage and incubation with ligand (P4) for crystal trials. 
The following were added for immobilized metal affinity chromatography 
(IMAC) elution 
20 mM Imidazole – binding buffer  
1M imidazole – elution buffer  
7.1.3.2 Phosphate buffered saline (PBS) 
The buffer used for phage selections and occasional protein purification was 
Dulbecco’s PBS (Sigma Aldrich # D5652, pH 7.2 – 7.8) 
The following was added for washing steps in phage display and ELISA 
0.1 % (v/v) T20 
 
7.1.4 SDS-PAGE reagents 
7.1.4.1 Resolving Gel (layer)  
5.55 mL UP H2O  
16.50 mL 30% (w/v) acrylamide  
7.5 mL 1.5 M Tris pH 8.8  
0.3 mL 10% (w/v) SDS  
0.15 ml 10% (w/v) ammonium persulfate (APS) 
15 μL tetramethylethylenediamine (TEMED)  
7.1.4.2 Stacking Gel (layer) 
8.5 mL UP H2O  
2.125 mL 30% Acrylamide  
1.6 mL 1.0 M Tris pH 6.8  
0.125 mL 10% (w/v) SDS  
63 μL 10% (w/v) APS 
6.3 μL TEMED  
7.1.4.3 4x SDS protein loading dye 
10 mL 1 M Tris, pH 6.8  
8 mL glycerol  
16 mL 10% (w/v) SDS  
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4 mL β-mercaptoethanol  
1 mL 1% bromophenol blue 
7.1.4.4 1x Tris-glycine SDS (TGS) running buffer 
25 mM Tris 
250 mM glycine 
1% SDS (w/v) 
7.1.4.5 PAGE staining solution (Fairbanks A) 
0.05 % (w/v) Coomassie Brilliant Blue R-250  
25 % (v/v) IPA  
10 % (v/v) Acetic acid  
7.1.4.6 PAGE de-staining solution  
10% Acetic acid 
 
7.1.5 Agarose gel ingredients 
7.1.5.1 1% agarose gel 
50 ml TAE running buffer 
0.5 g agarose 
5 μl SYBR-safe DNA gel stain 
7.1.5.2 1 x Tris-acetate EDTA (TAE) running buffer 
40 mM Tris-acetate 
1 mM EDTA 
7.1.5.3 10x DNA loading dye 
0.05% (w/v) Bromothymol Blue  
0.25% (w/v) Xylene cyanol  
30% (v/v) glycerol 
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7.1.6 Electrophoresis standards 
7.1.6.1 Precision Plus Protein standards 
 
The protein standards stained by coomassie with numbers of bands indicating size of 
proteins in daltons (Da). 
7.1.6.2 1kb Plus DNA Standards 
 
The DNA standards stained by ethidium bromide with numbers of bands indicating size 
of nucleotides in base pairs (bp). 
 
7.1.7 Bacterial strains 
Name Genotype 
TG1 supE thi-1 Δ(lac-proAB) Δ(mcrB-hsdSM)5 (rK– mK–) [F´ 
traD36 proAB lacIqZΔM15] 
DH5α F- thi-1 endA1 recA1 relA1 gyrA96 Φ80lacZΔM15 
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Δ(lacZYA-argF)U169, hsdR17(rK- mK+), λ– 
Bl21 (DE3) F– ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 [lacI lacUV5-
T7 gene 1 ind1 sam7 nin5]) 
 
7.1.8 Plasmids 
7.1.8.1 pPROEX-HTb 
 
The multiple cloning site (MCS) of pPROEX-HTb indicating compatible restriction enzyme 
cut sites with N-terminal his-tag (grey) is shown. The forward and reverse diagnostic 
primers (green) and pTrc promoter (light brown) are also shown. 
  
2
0
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7.1.8.2 pET28b 
 
The multiple cloning site (MCS) of pET28b lies between N-terminal lac operon (yellow) and C-terminal his-tag (brown, adjacent to TGA stop codon). The N-terminal 
T7 promoter (light green), T7 forward primer (dark green), his-tag (brown) and C-terminal T7 reverse primer (bright green), T7 terminator (red) are also indicated. 
  
2
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7.1.8.3 pOPINM 
 
The multiple cloning site (MCS) of pOPINM (yellow) between restriction enzyme cut sites KpnI and HindIII (grey) are shown. The N-terminal fusion protein 
MBP (red) and C-terminal sequencing primer pTriEx down (green) are also indicated.  
  
2
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7.1.8.4 pOB2 
  
The OB-fold (pAOB3, yellow) is shown between pelB signal sequence (pink) and C-terminal his-tag (yellow). The resulting OBody is marked in orange. The 
N-terminal lac promoter (light green) and C-terminal gene (gIII) are also indicated.  
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7.1.9 Primers 
Name DNA sequence description 
245 AAATACCTGCTGCCGACC Diagnostic forward 
primer – pOB2 
246 TTGTCGTCTTTCCAGACGTT Diagnostic reverse 
primer – pOB2 
D7F CATGCCATGGCCACCCACTGGAC forward cloning primer 
- pPROEX-HTb 
D7R ATAAGAATGCGGCCGCTCAGTCTATTGG reverse cloning primer - 
pPROEX-HTb 
C35S_F GACAACGGGAGCTATAAGAGCGTGGGTGTGAGCGATCATC C35S forward primer  
C35S_R GATGATCGCTCACACCCACGCTCTTATAGCTCCCGTTGTC C35S reverse primer 
C48S_F CAGGGGTTTGTGCTGGTCAGCCTCGTTGCAGGATCAAC C48S forward primer 
C48S_R GTTGATCCTGCAACGAGGCTGACCAGCACAAACCCCTG C48S reverse primer 
C81S_F GGCATTGTTCATGCCAGTAGCAAGCATAAGTGTGGTGTG C81S forward primer 
C81S_R CACACCACACTTATGCTTGCTACTGGCATGAACAATGCC C81S reverse primer 
C85S_F CATGCCAGTTGTAAGCATAAGAGCGGTGTGAGTATTAGTCCCAGC C85S forward primer 
C85S_R GCTGGGACTAATACTCACACCGCTCTTATGCTTACAACTGGCATG C85S reverse primer 
pOPINM_F (KpnI) 
pOPINM_F (LIC) 
AAGTTCTGTTTCAGGGTACCATGGCCACCCACTGG 
AAGTTCTGTTTCAGGGCCCGATGGCCACCCACTGG 
 
  
forward cloning primer 
- pOPINM 
  
2
1
0
 
pOPINM_R ATGGTCTAGAAAGCTTTAGTCTATTGGAAGCGGC reverse cloning primer - 
pOPINM 
pF_rand_F GCAGGATCAACACCAGATC Randomization forward 
primer – pF_35 
pF_rand_R CTGGTGTTGATCCTGCNNKGAGNNKGACNNKCACAAACCCCTGATGATC Randomization reverse 
primer – pF_35 
(randomized -red) 
L4_rand_F GGTGTGAGTATTAGTCCM Randomization forward 
primer – L4_DM  
L4_rand_R GACTAATACTCACACCNNKNNKNNKNNKNNKNNKGGCATGAACAATGCC Randomization reverse 
primer – L4_DM 
(randomized -red) 
ssYscC_PstI AACTGCAGATGGCCACCCACTGGACCGCGG Primer to remove gene 
for YscC N0 domain 
using PstI restriction 
enzyme cut site 
YscC_DARPin GGGCTGCAGATGTCTTCCGGTGATCTGGG Primer to clone 
DARPin E_01 in frame 
with YscC fragment 
GFPuv_F TCCCCGCGGCTAGCAAAGGAGAAGAACTTTTC forward GFPuv cloning 
primer – pOB2 
GFPuv_R TTTTCCTTTTGCGGCCGCTTTGTAGAGCTCATCCATGCCATG reverse GFPuv cloning 
primer – pOB2 
GFPuv_OB_sacI CCCGAGCTCTACAAAGCGGCCACCCACTGGACCGCGG Primer to clone GFPuv 
between signal 
sequence and OBody 
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7.2 OBody sequences 
7.2.1 Naïve library OBody D7 in phagemid (pOB2) 
 
The naïve library OBody D7 (green) is shown with N-terminal YscC fragment (orange). The N-terminal signal sequence ssYscC (light pink) and important restriction 
enzyme cut sites are also indicated (Nco1, Sac2 and Not1). Note the insertion of YscC fragment between two Nco1 restriction sites. 
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7.2.2 Naïve library OBody D7 in cytoplasm expression plasmid (pET28b) 
 
The naïve library OBody D7 (green) is shown without N-terminal YscC fragment. The important restriction enzyme cut sites are also indicated (Nco1 and Not1). 
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7.2.3 MBP fusion of OBody D7 
 
The naive library OBody D7 (green) is indicated showing nucleotide and amino acid sequences with N- terminal MBP (red). An important restriction site is indicated 
(HindIII, grey). Note that this fusion was created using ligation independent cloning (LIC). 
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7.2.4 Affinity maturation (AM) library OBody B7 
 
The AM library OBody B7 (green) is highlighted showing nucleotide and amino acid sequences. 
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7.2.5 AM library OBody B7 in cytoplasm expression plasmid (pPROEX) 
 
The AM library OBody B7 (green) is shown without N-terminal YscC fragment. Note that this plasmid has a N-terminal histag but uses the same restriction cut sites 
as pET28b (Nco1 and Not1, violet) as indicated. 
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7.2.6 MBP fusion of OBody B7 
 
The AM library OBody B7 (green) is indicated showing nucleotide and amino acid sequences with N- terminal MBP (red). The important restriction sites are 
indicated (KpnI and HindIII, grey). 
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7.2.7 AM library clones 
 
The DNA sequence alignment of OBodies from R4 to R7 of (L4_DM) AM library is shown focused on the randomized loop (colored). Note that the non-randomized 
areas of the OBodies have no point mutations. 
 
 
The DNA sequence alignment of pF_35 OBodies from AM library is shown focused on the β-sheet 3 (colored). Note that the non-randomized areas of the OBodies 
have no point mutations. 
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7.3 FTSA of D7 mutants  
 
The raw thermal unfolding data of fluorescent thermal shift assays (FTSA) performed on 
labelled D7 mutants at pH7 is shown. The midpoint of the slope of these curves provide 
the respective melting temperatures (Tm). 
 
7.4 ELISA of D7 and mutants 
7.4.1 P4 immobilized ELISA: pH 
7.4.1.1  pH 6 and pH 5 
 
The raw data of ELISA of decreasing concentrations of OBody D7 with immobilized P4 at 
equilibrium is shown for pH 6 and pH 5. Biotinylated P4 was immobilized at a constant 
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concentration of 4.38 μM. Absorbance at 450nm (Y-axis) and D7 concentration in M (X-
axis, pH) for the ELISA colorimetric reaction is shown. The controls used anti- P4 
antibody to detect immobilized P4 and PBS for positive and negative control 
respectively. The experiment was done in triplicates (A, B and C).  
 
The raw data of ELISA of decreasing concentrations of OBody D7 with immobilized P4 at 
equilibrium is shown for pH 4 and pH 7. Biotinylated P4 was immobilized at a constant 
concentration of 4.38 μM. Absorbance at 450nm (Y-axis) and D7 concentration in M (X-
axis, pH) for the ELISA colorimetric reaction is shown. The controls used anti- P4 
antibody to detect immobilized P4 and PBS for positive and negative control 
respectively. The experiment was done in triplicates (A, B and C). 
7.4.1.2  pH 4 with salt and pH 9 
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The raw data of ELISA of decreasing concentrations of OBody D7 with immobilized P4 at 
equilibrium is shown for pH 4 (with 0.5 M NaCl) and pH 9. Biotinylated P4 was 
immobilized at a constant concentration of 4.38 μM. Absorbance at 450nm (Y-axis) and 
D7 concentration in M (X-axis, pH) for the ELISA colorimetric reaction is shown. The 
controls used anti- P4 antibody to detect immobilized P4 and PBS for positive and 
negative control respectively. The experiment was done in triplicates (A, B and C). 
* refers to 0.5M NaCl being applicable only to pH 4. 
7.4.2 Antigen immobilized ELISA: P4 and E2 
7.4.2.1  E2 (pH 7 vs pH 4) 
 
The raw data of ELISA of decreasing concentrations of OBody D7 with immobilized E2 at 
equilibrium is shown for pH 7 and pH 4. Biotinylated E2 was immobilized at a constant 
concentration of 4.38 μM. Absorbance at 450nm (Y-axis) and D7 concentration in M 
(X-axis, E2) for the ELISA colorimetric reaction is shown. The controls used anti- P4 
antibody to detect immobilized P4 and PBS for positive and negative control 
respectively. The experiment was done in triplicates (A, B and C). 
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7.4.2.2 P4 (pH 7) and E2 (pH 4) both salt 
 
The raw data of ELISA of decreasing concentrations of OBody D7 with immobilized P4 or 
E2 at equilibrium is shown (with 0.5 M NaCl) at pH 7 and pH 4 respectively. Biotinylated 
P4 or E2 was immobilized at a constant concentration of 4.38 μM. Absorbance at 450nm 
(Y-axis) and D7 concentration in M (X-axis, P4 or E2, pH) for the ELISA colorimetric 
reaction is shown. The controls used anti- P4 antibody to detect immobilized P4 and PBS 
for positive and negative control respectively. The experiment was done in triplicates (A, 
B and C).  
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7.4.3 ELISA of D7 mutants 
7.4.3.1 P4 immobilized ELISA 
 
The raw data of ELISA of decreasing concentrations of OBody D7 mutants with 
immobilized P4 at equilibrium is shown for pH 7. Biotinylated P4 was immobilized at a 
constant concentration of 4.38 μM. Absorbance at 450nm (Y-axis) and D7 mutant 
concentration in M (X-axis, mutant) for the ELISA colorimetric reaction is shown. The 
controls used anti- P4 antibody to detect immobilized P4 and PBS for positive and 
negative control respectively. The experiment was done in triplicates (A, B and C). 
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The raw data of ELISA of decreasing concentrations of OBody D7 mutants with 
immobilized P4 at equilibrium is shown for pH 7. Biotinylated P4 was immobilized at a 
constant concentration of 4.38 μM. Absorbance at 450nm (Y-axis) and D7 mutant 
concentration in M (X-axis, mutant) for the ELISA colorimetric reaction is shown. The 
controls used anti- P4 antibody to detect immobilized P4 and PBS for positive and 
negative control respectively. The experiment was done in triplicates (A, B and C). 
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7.4.3.2 OBody immobilized ELISA 
  
The raw data of ELISA of immobilized OBody D7 mutants with decreasing concentrations of P4 at equilibrium is shown for pH 7. D7 mutants were immobilized at a 
constant concentration of 394.32 nM. Absorbance at 450nm (Y-axis) and P4 concentration in M (X-axis, OBody mutant) for the ELISA colorimetric reaction is 
shown. OBodies D7 and TM (C35S:C48S:C81S) were used (to detect immobilized P4) for positive and negative controls respectively. The experiment was done in 
triplicates (A, B and C). Note that TM (C35S:C48S:C81S) or triple mutant involving the loop (L4) has no binding to P4 and was thus used as negative control. 
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7.4.4 Antibody immobilized ELISA 
 
The raw data of ELISA of decreasing concentrations of Anti -P4 antibody with 
immobilized P4 at equilibrium is shown for pH 7. Biotinylated P4 was immobilized at a 
constant concentration of 4.38 μM. Absorbance at 450nm (Y-axis) and anti- P4 Ab 
concentration in nM (X-axis) for the ELISA colorimetric reaction is shown. The 
experiment was done in triplicates (A, B and C). 
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7.5 SPR 
7.5.1 SPR of D7 
 
The SPR generated sensorgram at equilibrium is shown for different concentrations of OBody D7 binding to biotinylated P4 (ligand) immobilized on a SA chip. The 
y-axis shows the change in refractive index at equilibrium (Req, in RU) and the x-axis shows the duration of the experiment (in seconds). The rates of association 
  
2
2
7
 
and dissociation of OBodies to P4 are rapid, therefore Kd was calculated at equilibrium. The different colours of the curves represent the different concentrations 
and duplicates of OBody D7. 
  
7.5.2 SPR of B7 
 
The SPR generated sensorgram at equilibrium is shown for different concentrations of OBody B7 binding to biotinylated P4 (ligand) immobilized on a SA chip. The 
y-axis shows the change in refractive index at equilibrium (Req, in RU) and the x-axis shows the duration of the experiment (in seconds). The rates of association 
  
2
2
8
 
and dissociation of OBodies to P4 are rapid, therefore Kd was calculated at equilibrium. The different colours of the curves represent the different concentrations 
and duplicates of OBody B7. Note that the gap in the sensorgram (100 – 150 RU) is due to omission of intermediate dilution of OBody B7. 
 
 
The SPR generated sensorgram at equilibrium is shown for different concentrations of OBody B7 binding to biotinylated P4 (ligand) immobilized on a SA chip. The 
y-axis shows the change in refractive index at equilibrium (Req, in RU) and the x-axis shows the duration of the experiment (in seconds). The rates of association 
and dissociation of OBodies to P4 are rapid, therefore Kd was calculated at equilibrium. The different colours of the curves represent the different concentrations 
and duplicates of OBody B7.  
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7.5.3 SPR of MBP-B7 
 
 
The SPR generated sensorgram at equilibrium is shown for different concentrations of MBP fusion of OBody B7 binding to biotinylated P4 (ligand) immobilized on 
a SA chip. The y-axis shows the change in refractive index at equilibrium (Req, in RU) and the x-axis shows the duration of the experiment (in seconds). The rates of 
association and dissociation of OBodies to P4 are rapid, therefore Kd was calculated at equilibrium. The different colours of the curves represent the different 
concentrations and duplicates of MBP-B7. 
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7.5.4 SPR of other OBodies 
7.5.4.1 DM (C35S:C48S) 
 
The SPR generated sensorgram at equilibrium is shown for different concentrations of 
D7 mutant DM binding to biotinylated P4 (ligand) immobilized on a SA chip. The y-axis 
shows the change in refractive index at equilibrium (Req, in RU) and the x-axis shows the 
duration of the experiment (in seconds). The rates of association and dissociation of 
OBodies to P4 are rapid, therefore Kd was calculated at equilibrium. The different 
colours of the curves represent the different concentrations and duplicates of D7 
mutant DM. Note that the data was used for analysis after reaching equilibrium (red 
box). 
7.5.4.2 G10 
 
The SPR generated sensorgram at equilibrium is shown for different concentrations of 
OBody G10 binding to biotinylated P4 (ligand) immobilized on a SA chip. The y-axis 
shows the change in refractive index at equilibrium (Req, in RU) and the x-axis shows the 
duration of the experiment (in seconds). The rates of association and dissociation of 
OBodies to P4 are rapid, therefore Kd was calculated at equilibrium. The different 
colours of the curves represent the different concentrations and duplicates of OBody 
G10. 
7.5.4.3 G5 
 
The SPR generated sensorgram at equilibrium is shown for different concentrations of 
OBody G5 binding to biotinylated P4 (ligand) immobilized on a SA chip. The y-axis shows 
the change in refractive index at equilibrium (Req, in RU) and the x-axis shows the 
duration of the experiment (in seconds). The rates of association and dissociation of 
OBodies to P4 are rapid, therefore Kd was calculated at equilibrium. The different 
colours of the curves represent the different concentrations and duplicates of OBody 
G5. Note that G5 has the same loop (L4) sequence of G10 except presence of cysteines 
in the β- sheets. 
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7.5.4.4 E1 
 
The SPR generated sensorgram at equilibrium is shown for different concentrations of 
OBody E1 binding to biotinylated P4 (ligand) immobilized on a SA chip. The y-axis shows 
the change in refractive index at equilibrium (Req, in RU) and the x-axis shows the 
duration of the experiment (in seconds). The rates of association and dissociation of 
OBodies to P4 are rapid, therefore Kd was calculated at equilibrium. The different 
colours of the curves represent the different concentrations and duplicates of OBody E1. 
 
7.6 Diffraction datasets 
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twinned 115_01 2.75 28% w/v 
PEG 4000, 
0.1M Tris 
pH 8 
P1 21 1 62.15, 
109.49, 
149.52, 
90, 
96.79, 90 
87.6 
twinned 115_07 2.82 28% w/v 
PEG 4000, 
0.1M Tris 
pH 8 
P1 21 1 62.38, 
148.6, 
109.7, 
90, 
90.08, 90 
98.4 
twinned 115_12 2.49 28% w/v 
PEG 4000, 
0.1M Tris 
pH 8 
P1 21 1 61.83, 
142.76, 
109.5, 
90, 
90.37, 90 
84.4 
 116_01 3.28 28% w/v 
PEG 4000, 
0.1M Tris 
pH 8 
P1 21 1 62.32, 
150.83, 
109.97, 
90, 
90.39, 90 
99.5 
 116_06 3.47 28% w/v 
PEG 4000, 
0.1M Tris 
pH 8 
P1 21 1 62.75, 
150.73, 
109.75, 
90, 
90.16, 90 
98.6 
tNCS 116_05 1.97 30% w/v 
PEG MME 
2000, 0.1M 
Tris pH 8 
P1 21 1 65.92, 
193.9, 
82.43, 
90, 97.7, 
90 
95.3 
tNCS 116_07 1.97 30% w/v P1 21 1 65.78, 96.7 
 232 
PEG MME 
2000, 0.1M 
Tris pH 8 
195.67, 
83.12, 
90, 
96.92, 90 
tNCS 118 1.83 30% w/v 
PEG MME 
2000, 0.1M 
Tris pH 8 
P1 21 1 65.43, 
194.98, 
82.96, 
90, 
97.13, 90 
86.4 
 
 
